<?xml version="1.0" encoding="UTF-8"?>
<data>
	<node>
		<id><![CDATA[2628]]></id>
		<title><![CDATA[Innovation in medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/innovation-in-medicines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240123]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/human-regulatory-overview/research-and-development/innovation-medicines#:https://www.raps.org:text=and%20with%20academia.-,Portfolio%20and%20technology%20meetings%20(new),-New%3A%20Pharmaceutical]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[innovation-in-medicines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2629]]></id>
		<title><![CDATA[Questions and answers for marketing authorization holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/questions-and-answers-for-marketing-authorization-holders-applicants-on-the-chmp-opinion-for-the-article-53-of-regulation-ec-no-726-2004-referral-on-nitrosamine-impurities-in-human-medicinal-produ/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240115]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/referral/nitrosamines-emea-h-a53-1490-questions-answers-marketing-authorisation-holders-applicants-chmp-opinion-article-53-regulation-ec-no-726-2004-referral-nitrosamine-impurities-human-medicinal-products_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[questions-and-answers-for-marketing-authorization-holders-applicants-on-the-chmp-opinion-for-the-article-53-of-regulation-ec-no-726-2004-referral-on-nitrosamine-impurities-in-human-medicinal-produ]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2630]]></id>
		<title><![CDATA[SOPP 8401: Administrative Processing of Original Biologics License Applications (BLA) and New Drug Applications (NDA)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/sopp-8401-administrative-processing-of-original-biologics-license-applications-bla-and-new-drug-applications-nda/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240108]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/85659/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[sopp-8401-administrative-processing-of-original-biologics-license-applications-bla-and-new-drug-applications-nda]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2631]]></id>
		<title><![CDATA[Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/enhanced-drug-distribution-security-at-the-package-level-under-the-drug-supply-chain-security-act/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171666/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[enhanced-drug-distribution-security-at-the-package-level-under-the-drug-supply-chain-security-act]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2632]]></id>
		<title><![CDATA[Labelling and packaging of medicinal products for human use following agreement of the Windsor Framework]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/labelling-and-packaging-of-medicinal-products-for-human-use-following-agreement-of-the-windsor-framework/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20231231]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/labelling-and-packaging-of-medicinal-products-for-human-use-following-agreement-of-the-windsor-framework/labelling-and-packaging-of-medicinal-products-for-human-use-following-agreement-of-the-windsor-framework]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[labelling-and-packaging-of-medicinal-products-for-human-use-following-agreement-of-the-windsor-framework]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2633]]></id>
		<title><![CDATA[SOPP 8201: Administrative Processing of Clinical Holds for Investigational New Drug Applications]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/sopp-8201-administrative-processing-of-clinical-holds-for-investigational-new-drug-applications/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231215]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/88774/download?attachment]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[sopp-8201-administrative-processing-of-clinical-holds-for-investigational-new-drug-applications]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2634]]></id>
		<title><![CDATA[Quality Considerations for Topical Ophthalmic Drug Products (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/quality-considerations-for-topical-ophthalmic-drug-products-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231201]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Quality]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172937/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[quality-considerations-for-topical-ophthalmic-drug-products-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2635]]></id>
		<title><![CDATA[Falsification of medical devices – Results of European survey]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/falsification-of-medical-devices-results-of-european-survey/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20231128]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/falsification-of-medical-devices-results-of-european-survey]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[falsification-of-medical-devices-results-of-european-survey]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2636]]></id>
		<title><![CDATA[Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/direct-to-consumer-prescription-drug-advertisements-presentation-of-the-major-statement-in-a-clear-conspicuous-and-neutral-manner-in-advertisements-in-television-and-radio-format/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231121]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2023/11/21/2023-25428/direct-to-consumer-prescription-drug-advertisements-presentation-of-the-major-statement-in-a-clear]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[direct-to-consumer-prescription-drug-advertisements-presentation-of-the-major-statement-in-a-clear-conspicuous-and-neutral-manner-in-advertisements-in-television-and-radio-format]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2637]]></id>
		<title><![CDATA[New medicine adverse event search for sponsors]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-medicine-adverse-event-search-for-sponsors/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20231120]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/new-medicine-adverse-event-search-sponsors]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-medicine-adverse-event-search-for-sponsors]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2638]]></id>
		<title><![CDATA[Interleukin inhibitors and the possible risk of pancreatitis]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/interleukin-inhibitors-and-the-possible-risk-of-pancreatitis/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[New Zealand]]></country_region>
		<health_authority><![CDATA[New Zealand Medicines and Medical Devices Safety]]></health_authority>
		<date_2><![CDATA[20231120]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://medsafe.govt.nz/safety/Alerts/Interleukin-Inhibitors-Possible-Risk-Pancreatitis.asp]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[interleukin-inhibitors-and-the-possible-risk-of-pancreatitis]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2639]]></id>
		<title><![CDATA[Assessing the Credibility of Computational Modeling and Simulation in Medical Device Submissions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/assessing-the-credibility-of-computational-modeling-and-simulation-in-medical-device-submissions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231117]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/154985/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[assessing-the-credibility-of-computational-modeling-and-simulation-in-medical-device-submissions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2640]]></id>
		<title><![CDATA[Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/notifying-fda-of-a-permanent-discontinuance-or-interruption-in-manufacturing-of-a-device-under-section-506j-of-the-fdc-act/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231117]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/155245/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[notifying-fda-of-a-permanent-discontinuance-or-interruption-in-manufacturing-of-a-device-under-section-506j-of-the-fdc-act]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2641]]></id>
		<title><![CDATA[Product-Specific Guidances for Generic Drug Development]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/product-specific-guidances-for-generic-drug-development/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231116]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.accessdata.fda.gov/scripts/cder/psg/index.cfm?utm_medium=email&utm_source=govdelivery]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[product-specific-guidances-for-generic-drug-development]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2642]]></id>
		<title><![CDATA[Modifications to health registration conditions, regulatory simplification strategy]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/modifications-to-health-registration-conditions-regulatory-simplification-strategy/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Mexico]]></country_region>
		<health_authority><![CDATA[COFEPRIS]]></health_authority>
		<date_2><![CDATA[20231113]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gob.mx/cofepris/articulos/modificaciones-a-las-condiciones-de-registro-sanitario-estrategia-de-simplificacion-regulatoria]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[modifications-to-health-registration-conditions-regulatory-simplification-strategy]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2643]]></id>
		<title><![CDATA[NMPA becomes the applicant for PIC/S]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/nmpa-becomes-the-applicant-for-pic-s/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[China]]></country_region>
		<health_authority><![CDATA[National Medical Products Administration]]></health_authority>
		<date_2><![CDATA[20231109]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://english.nmpa.gov.cn/2023-11/09/c_937791.htm]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[nmpa-becomes-the-applicant-for-pic-s]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2644]]></id>
		<title><![CDATA[Outcome of the Process – Public Consultation on proposed fees for Human Medicines, Compliance, Medical Devices and Veterinary Medicines for 2024]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/outcome-of-the-process-public-consultation-on-proposed-fees-for-human-medicines-compliance-medical-devices-and-veterinary-medicines-for-2024/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Ireland]]></country_region>
		<health_authority><![CDATA[Health Products Regulatory Authority]]></health_authority>
		<date_2><![CDATA[20231109]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.hpra.ie/docs/default-source/default-document-library/outcome-of-the-process—public-consultation-on-proposed-fees-for-2024.pdf?sfvrsn=4]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[outcome-of-the-process-public-consultation-on-proposed-fees-for-human-medicines-compliance-medical-devices-and-veterinary-medicines-for-2024]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2645]]></id>
		<title><![CDATA[ANMAT and ANVISA signed the first Mutual Recognition agreement on certificates for Medical Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/anmat-and-anvisa-signed-the-first-mutual-recognition-agreement-on-certificates-for-medical-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Brazil]]></country_region>
		<health_authority><![CDATA[Brazilian Health Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20231108]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.argentina.gob.ar/noticias/anmat-y-anvisa-firmaron-el-primer-acuerdo-de-reconocimiento-mutuo-en-certificados-para]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[anmat-and-anvisa-signed-the-first-mutual-recognition-agreement-on-certificates-for-medical-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2646]]></id>
		<title><![CDATA[First electronic product information (ePI) published for selected human medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/first-electronic-product-information-epi-published-for-selected-human-medicines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20231108]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/first-electronic-product-information-epi-published-selected-human-medicines]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[first-electronic-product-information-epi-published-for-selected-human-medicines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2647]]></id>
		<title><![CDATA[ICH adopts Q5A(R2) guideline on viral safety evaluation of biotechnology products and validation of analytical procedures Q2(R2)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:51]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ich-adopts-q5ar2-guideline-on-viral-safety-evaluation-of-biotechnology-products-and-validation-of-analytical-procedures-q2r2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Council for Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use]]></health_authority>
		<date_2><![CDATA[20231108]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://ich.org/pressrelease/press-release-ich-assembly-meeting-prague-czech-republic-octobernovember-2023]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ich-adopts-q5ar2-guideline-on-viral-safety-evaluation-of-biotechnology-products-and-validation-of-analytical-procedures-q2r2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:51]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2648]]></id>
		<title><![CDATA[International Recognition Procedure]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/international-recognition-procedure/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20231106]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/international-recognition-procedure/international-recognition-procedure]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[international-recognition-procedure]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2649]]></id>
		<title><![CDATA[Process to Request a Review of FDA’s Decision Not to Issue Certain Export Certificates for Devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/process-to-request-a-review-of-fdas-decision-not-to-issue-certain-export-certificates-for-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231103]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/115432/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[process-to-request-a-review-of-fdas-decision-not-to-issue-certain-export-certificates-for-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2650]]></id>
		<title><![CDATA[Enforcement Policy for Clinical Electronic Thermometers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/enforcement-policy-for-clinical-electronic-thermometers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231103]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/136698/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[enforcement-policy-for-clinical-electronic-thermometers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2651]]></id>
		<title><![CDATA[Enforcement Policy for Certain Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/enforcement-policy-for-certain-supplements-for-approved-premarket-approval-pma-or-humanitarian-device-exemption-hde-submissions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231102]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/138265/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[enforcement-policy-for-certain-supplements-for-approved-premarket-approval-pma-or-humanitarian-device-exemption-hde-submissions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2652]]></id>
		<title><![CDATA[Notice to manufacturers and notified bodies to ensure timely compliance with MDR and IVDR requirements]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/notice-to-manufacturers-and-notified-bodies-to-ensure-timely-compliance-with-mdr-and-ivdr-requirements/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20231101]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-11/mdcg_2022-11_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[notice-to-manufacturers-and-notified-bodies-to-ensure-timely-compliance-with-mdr-and-ivdr-requirements]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2653]]></id>
		<title><![CDATA[Pharmaceuticals and Medical Devices Safety Information No. 405 November 2023]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/pharmaceuticals-and-medical-devices-safety-information-no-405-november-2023/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Japan]]></country_region>
		<health_authority><![CDATA[Pharmaceuticals and Medical Devices Agency]]></health_authority>
		<date_2><![CDATA[20231101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.pmda.go.jp/files/000265346.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[pharmaceuticals-and-medical-devices-safety-information-no-405-november-2023]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2654]]></id>
		<title><![CDATA[Guideline for facilitated registration pathway]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guideline-for-facilitated-registration-pathway/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[National Pharmaceutical Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20231101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://npra.gov.my/easyarticles/images/users/1047/Direktif/Lampiran-A_FRP-Guidelines_Revision-1_2023.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guideline-for-facilitated-registration-pathway]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2655]]></id>
		<title><![CDATA[Guidance for consultation on clinical evaluation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-for-consultation-on-clinical-evaluation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Singapore]]></country_region>
		<health_authority><![CDATA[Health Sciences Authority]]></health_authority>
		<date_2><![CDATA[20231101]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.hsa.gov.sg/docs/default-source/hprg-mdb/regulatory-updates/for-consultation—gn-20-guidance-on-clinical-evaluation-(2023-nov).pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-for-consultation-on-clinical-evaluation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2656]]></id>
		<title><![CDATA[Valproate: review of safety data and expert advice on management of risks]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/valproate-review-of-safety-data-and-expert-advice-on-management-of-risks/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20231101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://assets.publishing.service.gov.uk/media/65660310312f400013e5d508/Valproate-report-review-and-expert-advice.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[valproate-review-of-safety-data-and-expert-advice-on-management-of-risks]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2657]]></id>
		<title><![CDATA[Real-Time Oncology Review (RTOR)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/real-time-oncology-review-rtor/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/173641/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[real-time-oncology-review-rtor]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2658]]></id>
		<title><![CDATA[Submitting Clinical Trial Datasets and Documentation for Clinical Outcome Assessments Using Item Response Theory]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/submitting-clinical-trial-datasets-and-documentation-for-clinical-outcome-assessments-using-item-response-theory/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/173587/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[submitting-clinical-trial-datasets-and-documentation-for-clinical-outcome-assessments-using-item-response-theory]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2659]]></id>
		<title><![CDATA[Submitting Patient Reported Outcome Data in Cancer Clinical Trials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/submitting-patient-reported-outcome-data-in-cancer-clinical-trials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/173581/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[submitting-patient-reported-outcome-data-in-cancer-clinical-trials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2660]]></id>
		<title><![CDATA[Landmark listing of first three countries as WHO-Listed regulatory Authorities]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/landmark-listing-of-first-three-countries-as-who-listed-regulatory-authorities/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[World Health Organization]]></health_authority>
		<date_2><![CDATA[20231031]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.who.int/news/item/31-10-2023-landmark-listing-of-first-three-countries-as-who-listed-regulatory-authorities]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[landmark-listing-of-first-three-countries-as-who-listed-regulatory-authorities]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2661]]></id>
		<title><![CDATA[Treatment with isotretinoin for patients under 18 must be approved by two prescribers, under new MHRA rules]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/treatment-with-isotretinoin-for-patients-under-18-must-be-approved-by-two-prescribers-under-new-mhra-rules/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20231031]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/treatment-with-isotretinoin-for-patients-under-18-must-be-approved-by-two-prescribers-under-new-mhra-rules]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[treatment-with-isotretinoin-for-patients-under-18-must-be-approved-by-two-prescribers-under-new-mhra-rules]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2662]]></id>
		<title><![CDATA[Questions and answers on data requirements when transitioning to low global warming potential (LGWP) propellants in oral pressurised metered dose inhalers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/questions-and-answers-on-data-requirements-when-transitioning-to-low-global-warming-potential-lgwp-propellants-in-oral-pressurised-metered-dose-inhalers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20231030]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/questions-and-answers-data-requirements-when-transitioning-low-global-warming-potential-lgwp-propellants-oral-pressurised-metered-dose-inhalers_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[questions-and-answers-on-data-requirements-when-transitioning-to-low-global-warming-potential-lgwp-propellants-in-oral-pressurised-metered-dose-inhalers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2663]]></id>
		<title><![CDATA[Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20231027]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-23-26-october-2023]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2664]]></id>
		<title><![CDATA[Good Machine Learning Practice for Medical Device Development: Guiding Principles]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/good-machine-learning-practice-for-medical-device-development-guiding-principles/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231027]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/software-medical-device-samd/good-machine-learning-practice-medical-device-development-guiding-principles]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[good-machine-learning-practice-for-medical-device-development-guiding-principles]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2665]]></id>
		<title><![CDATA[EMA takes further steps to address critical shortages of medicines in the EU]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ema-takes-further-steps-to-address-critical-shortages-of-medicines-in-the-eu/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20231024]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/ema-takes-further-steps-address-critical-shortages-medicines-eu]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ema-takes-further-steps-to-address-critical-shortages-of-medicines-in-the-eu]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2666]]></id>
		<title><![CDATA[Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices: Guiding Principles]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/predetermined-change-control-plans-for-machine-learning-enabled-medical-devices-guiding-principles/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231024]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/software-medical-device-samd/predetermined-change-control-plans-machine-learning-enabled-medical-devices-guiding-principles]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[predetermined-change-control-plans-for-machine-learning-enabled-medical-devices-guiding-principles]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2667]]></id>
		<title><![CDATA[Amending Regulation (EU) 2017/745 of the European Parliament and of the Council, as regards the assignment of Unique Device Identifiers for contact lenses]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/amending-regulation-eu-2017-745-of-the-european-parliament-and-of-the-council-as-regards-the-assignment-of-unique-device-identifiers-for-contact-lenses/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20231020]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L_202302197]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[amending-regulation-eu-2017-745-of-the-european-parliament-and-of-the-council-as-regards-the-assignment-of-unique-device-identifiers-for-contact-lenses]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2668]]></id>
		<title><![CDATA[Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Questions and Answers (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/communications-from-firms-to-health-care-providers-regarding-scientific-information-on-unapproved-uses-of-approved-cleared-medical-products-questions-and-answers-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231019]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/173172/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[communications-from-firms-to-health-care-providers-regarding-scientific-information-on-unapproved-uses-of-approved-cleared-medical-products-questions-and-answers-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2669]]></id>
		<title><![CDATA[Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/enforcement-policy-for-non-invasive-remote-monitoring-devices-used-to-support-patient-monitoring/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231019]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/136290/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[enforcement-policy-for-non-invasive-remote-monitoring-devices-used-to-support-patient-monitoring]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2670]]></id>
		<title><![CDATA[Team-NB asks manufacturers of class D devices to submit IVDR filings]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/team-nb-asks-manufacturers-of-class-d-devices-to-submit-ivdr-filings/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20231018]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.team-nb.org/wp-content/uploads/2023/10/Team-NB-PressRelease-Capacity-NotifiedBodies-during-transition-IVDR-MDR-October2023.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[team-nb-asks-manufacturers-of-class-d-devices-to-submit-ivdr-filings]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2671]]></id>
		<title><![CDATA[Guideline on the Development and Manufacture of Synthetic Peptides]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guideline-on-the-development-and-manufacture-of-synthetic-peptides/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20231012]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-development-and-manufacture-synthetic-peptides_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guideline-on-the-development-and-manufacture-of-synthetic-peptides]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2672]]></id>
		<title><![CDATA[Regulation of all Class C & D medical devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/regulation-of-all-class-c-d-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20231012]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTA1NzM=]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[regulation-of-all-class-c-d-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2673]]></id>
		<title><![CDATA[New streamlined notification scheme for lowest-risk clinical trials marks start of MHRA overhaul of regulation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-streamlined-notification-scheme-for-lowest-risk-clinical-trials-marks-start-of-mhra-overhaul-of-regulation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20231012]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/new-streamlined-notification-scheme-for-lowest-risk-clinical-trials-marks-start-of-mhra-overhaul-of-regulation]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-streamlined-notification-scheme-for-lowest-risk-clinical-trials-marks-start-of-mhra-overhaul-of-regulation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2674]]></id>
		<title><![CDATA[Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/testing-and-labeling-medical-devices-for-safety-in-the-magnetic-resonance-mr-environment/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231010]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/74201/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[testing-and-labeling-medical-devices-for-safety-in-the-magnetic-resonance-mr-environment]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2675]]></id>
		<title><![CDATA[Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/submission-of-premarket-notifications-for-magnetic-resonance-diagnostic-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231010]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/92921/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[submission-of-premarket-notifications-for-magnetic-resonance-diagnostic-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2676]]></id>
		<title><![CDATA[Recognized Consensus Standards: Medical Devices ANSI AAMI SW96:2023]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/recognized-consensus-standards-medical-devices-ansi-aami-sw962023/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231009]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfstandards/detail.cfm?standard__identification_no=44689]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[recognized-consensus-standards-medical-devices-ansi-aami-sw962023]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2677]]></id>
		<title><![CDATA[Recognized Consensus Standards: Medical Devices – ANSI AAMI 2700-2-1:2022]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/recognized-consensus-standards-medical-devices-ansi-aami-2700-2-12022/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231009]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfstandards/detail.cfm?standard__identification_no=44691]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[recognized-consensus-standards-medical-devices-ansi-aami-2700-2-12022]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2678]]></id>
		<title><![CDATA[Recognized Consensus Standards: Medical Devices – ISO IEC IEEE 29119-1 Second edition 2022-01 Software and systems engineering – Software testing – Part 1: General concepts]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/recognized-consensus-standards-medical-devices-iso-iec-ieee-29119-1-second-edition-2022-01-software-and-systems-engineering-software-testing-part-1-general-concepts/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231009]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfstandards/detail.cfm?standard__identification_no=44690]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[recognized-consensus-standards-medical-devices-iso-iec-ieee-29119-1-second-edition-2022-01-software-and-systems-engineering-software-testing-part-1-general-concepts]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2679]]></id>
		<title><![CDATA[Pharmacopoeial Discussion Group welcomes Indian Pharmacopoeia Commission as a member, facilitating reach and enhancing impact of pharmacopoeial standards harmonisation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/pharmacopoeial-discussion-group-welcomes-indian-pharmacopoeia-commission-as-a-member-facilitating-reach-and-enhancing-impact-of-pharmacopoeial-standards-harmonisation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20231005]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/pharmacopoeial-discussion-group-welcomes-indian-pharmacopoeia-commission-as-a-member-facilitating-reach-and-enhancing-impact-of-pharmacopoeial-standards-harmonisation]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[pharmacopoeial-discussion-group-welcomes-indian-pharmacopoeia-commission-as-a-member-facilitating-reach-and-enhancing-impact-of-pharmacopoeial-standards-harmonisation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2680]]></id>
		<title><![CDATA[Revised CTIS Transparency Rules]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/revised-ctis-transparency-rules/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20231005]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/other/revised-ctis-transparency-rules_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[revised-ctis-transparency-rules]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2681]]></id>
		<title><![CDATA[Refusals and Appeals Under Scientific Animal Protection Legislation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/refusals-and-appeals-under-scientific-animal-protection-legislation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Ireland]]></country_region>
		<health_authority><![CDATA[Health Products Regulatory Authority]]></health_authority>
		<date_2><![CDATA[20231005]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.hpra.ie/docs/default-source/publications-forms/guidance-documents/aut-g0122-guide-to-refusals-and-appeals-under-scientific-animal-protection-legislation-v3.pdf?sfvrsn=15]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[refusals-and-appeals-under-scientific-animal-protection-legislation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2682]]></id>
		<title><![CDATA[Filing Review of Abbreviated New Drug Applications]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/filing-review-of-abbreviated-new-drug-applications/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231003]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/144976/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[filing-review-of-abbreviated-new-drug-applications]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2683]]></id>
		<title><![CDATA[Guidance on the Implementation of Good Manufacturing Practice (GMP) Evidence for Drug Substance (DS) Manufacturers – Q&A]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-on-the-implementation-of-good-manufacturing-practice-gmp-evidence-for-drug-substance-ds-manufacturers-qa/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Singapore]]></country_region>
		<health_authority><![CDATA[Health Sciences Authority]]></health_authority>
		<date_2><![CDATA[20231002]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-on-the-implementation-of-good-manufacturing-practice-gmp-evidence-for-drug-substance-ds-manufacturers-qa]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2684]]></id>
		<title><![CDATA[Topical Dermatologic Corticosteroids: In Vivo Bioequivalence Guidance for Industry (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/topical-dermatologic-corticosteroids-in-vivo-bioequivalence-guidance-for-industry-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231002]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162457/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[topical-dermatologic-corticosteroids-in-vivo-bioequivalence-guidance-for-industry-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2685]]></id>
		<title><![CDATA[Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/remote-interactive-evaluations-of-drug-manufacturing-and-bioresearch-monitoring-facilities-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231002]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/173286/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[remote-interactive-evaluations-of-drug-manufacturing-and-bioresearch-monitoring-facilities-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2686]]></id>
		<title><![CDATA[Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/policy-for-testing-of-alcohol-ethanol-and-isopropyl-alcohol-for-methanol/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231002]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/173005/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[policy-for-testing-of-alcohol-ethanol-and-isopropyl-alcohol-for-methanol]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2687]]></id>
		<title><![CDATA[Diabetic Foot Infections: Developing Drugs for Treatment (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:52]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/diabetic-foot-infections-developing-drugs-for-treatment-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231002]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/173006/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[diabetic-foot-infections-developing-drugs-for-treatment-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:52]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2688]]></id>
		<title><![CDATA[Guidelines for the Use of Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection (STI) Prevention; Request for Comment and Informational Presentation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidelines-for-the-use-of-doxycycline-post-exposure-prophylaxis-for-bacterial-sexually-transmitted-infection-sti-prevention-request-for-comment-and-informational-presentation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231002]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2023/10/02/2023-21725/guidelines-for-the-use-of-doxycycline-post-exposure-prophylaxis-for-bacterial-sexually-transmitted]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidelines-for-the-use-of-doxycycline-post-exposure-prophylaxis-for-bacterial-sexually-transmitted-infection-sti-prevention-request-for-comment-and-informational-presentation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2689]]></id>
		<title><![CDATA[Stimulant Use Disorders: Developing Drugs for Treatment (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/stimulant-use-disorders-developing-drugs-for-treatment-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231002]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172703/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[stimulant-use-disorders-developing-drugs-for-treatment-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2690]]></id>
		<title><![CDATA[Human Prescription Drug and Biological Products — Labeling for Dosing Based on Weight or Body Surface Area for Readyto-Use Containers — “Dose Banding”]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/human-prescription-drug-and-biological-products-labeling-for-dosing-based-on-weight-or-body-surface-area-for-readyto-use-containers-dose-banding/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231002]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172571/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[human-prescription-drug-and-biological-products-labeling-for-dosing-based-on-weight-or-body-surface-area-for-readyto-use-containers-dose-banding]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2691]]></id>
		<title><![CDATA[Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/voluntary-consensus-standards-recognition-program-for-regenerative-medicine-therapies/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20231002]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/159237/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[voluntary-consensus-standards-recognition-program-for-regenerative-medicine-therapies]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2692]]></id>
		<title><![CDATA[Medical Device Software (MDSW) – Hardware combinations Guidance on MDSW intended to work in combination with hardware or hardware components]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/medical-device-software-mdsw-hardware-combinations-guidance-on-mdsw-intended-to-work-in-combination-with-hardware-or-hardware-components/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20231001]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-10/md_mdcg_2023-4_software_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[medical-device-software-mdsw-hardware-combinations-guidance-on-mdsw-intended-to-work-in-combination-with-hardware-or-hardware-components]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2693]]></id>
		<title><![CDATA[Nitrosamine impurities]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/nitrosamine-impurities/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20231001]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/referral-procedures-human-medicines/nitrosamine-impurities]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[nitrosamine-impurities]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2694]]></id>
		<title><![CDATA[FAQs on Electronic Study Data Submission]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/faqs-on-electronic-study-data-submission/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Japan]]></country_region>
		<health_authority><![CDATA[Pharmaceuticals and Medical Devices Agency]]></health_authority>
		<date_2><![CDATA[20231001]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.pmda.go.jp/files/000264582.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[faqs-on-electronic-study-data-submission]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2695]]></id>
		<title><![CDATA[New drug review with electronic data]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-drug-review-with-electronic-data/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Japan]]></country_region>
		<health_authority><![CDATA[Pharmaceuticals and Medical Devices Agency]]></health_authority>
		<date_2><![CDATA[20231001]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.pmda.go.jp/english/review-services/reviews/0002.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-drug-review-with-electronic-data]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2696]]></id>
		<title><![CDATA[IMDRF Standard Operating Procedures – Edition 10]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/imdrf-standard-operating-procedures-edition-10/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Medical Device Regulators Forum]]></health_authority>
		<date_2><![CDATA[20230930]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.imdrf.org/sites/default/files/2023-10/IMDRF%20Standard%20Operating%20Procedures%20ext_2023%20%28N2%20Edition%2010%29_0.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[imdrf-standard-operating-procedures-edition-10]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2697]]></id>
		<title><![CDATA[Technical Considerations for Medical Devices with Physiologic Closed-Loop Control Technology]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/technical-considerations-for-medical-devices-with-physiologic-closed-loop-control-technology/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230929]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/154994/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[technical-considerations-for-medical-devices-with-physiologic-closed-loop-control-technology]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2698]]></id>
		<title><![CDATA[Electronic Submission Template for Medical Device De Novo Requests]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/electronic-submission-template-for-medical-device-de-novo-requests/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230929]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Publishing]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172450/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[electronic-submission-template-for-medical-device-de-novo-requests]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2699]]></id>
		<title><![CDATA[Antimicrobial Susceptibility Test (AST) System Devices – Updating Breakpoints in Device Labeling]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/antimicrobial-susceptibility-test-ast-system-devices-updating-breakpoints-in-device-labeling/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230929]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172463/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[antimicrobial-susceptibility-test-ast-system-devices-updating-breakpoints-in-device-labeling]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2700]]></id>
		<title><![CDATA[Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cybersecurity-in-medical-devices-quality-system-considerations-and-content-of-premarket-submissions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230927]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/119933/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cybersecurity-in-medical-devices-quality-system-considerations-and-content-of-premarket-submissions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2701]]></id>
		<title><![CDATA[Using Four-Part Harmony in Quality-Related Assessment Communications]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/using-four-part-harmony-in-quality-related-assessment-communications/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230922]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171613/download?attachment]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[using-four-part-harmony-in-quality-related-assessment-communications]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2702]]></id>
		<title><![CDATA[Electronic Submission Template for Medical Device 510(k) Submissions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/electronic-submission-template-for-medical-device-510k-submissions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230922]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Publishing]]></domain>
		<url><![CDATA[https://www.fda.gov/media/152429/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[electronic-submission-template-for-medical-device-510k-submissions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2703]]></id>
		<title><![CDATA[Changes to the acceptability of CEP applications for sterile grade materials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/changes-to-the-acceptability-of-cep-applications-for-sterile-grade-materials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20230921]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/changes-to-the-acceptability-of-cep-applications-for-sterile-grade-materials]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[changes-to-the-acceptability-of-cep-applications-for-sterile-grade-materials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2704]]></id>
		<title><![CDATA[HSA is assessing the potential risk of suicidal thoughts and self-harm with glucagon-like peptide-1 receptor agonists (GLP-1 RA)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/hsa-is-assessing-the-potential-risk-of-suicidal-thoughts-and-self-harm-with-glucagon-like-peptide-1-receptor-agonists-glp-1-ra/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Singapore]]></country_region>
		<health_authority><![CDATA[Health Sciences Authority]]></health_authority>
		<date_2><![CDATA[20230921]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.hsa.gov.sg/announcements/safety-alert/hsa-is-assessing-the-potential-risk-of-suicidal-thoughts-and-self-harm-with-glucagon-like-peptide-1-receptor-agonists-(glp-1-ra)]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[hsa-is-assessing-the-potential-risk-of-suicidal-thoughts-and-self-harm-with-glucagon-like-peptide-1-receptor-agonists-glp-1-ra]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2705]]></id>
		<title><![CDATA[Guide for National Scientific and Regulatory Advice]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guide-for-national-scientific-and-regulatory-advice/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Ireland]]></country_region>
		<health_authority><![CDATA[Health Products Regulatory Authority]]></health_authority>
		<date_2><![CDATA[20230920]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.hpra.ie/docs/default-source/publications-forms/guidance-documents/ADV-G0017-guide-for-national-scientific-and-regulatory-advice-v6.pdf?sfvrsn=40]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guide-for-national-scientific-and-regulatory-advice]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2706]]></id>
		<title><![CDATA[Implementation of Good Manufacturing Practice (GMP) Evidence for Drug Substance (DS) manufacturers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/implementation-of-good-manufacturing-practice-gmp-evidence-for-drug-substance-ds-manufacturers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Singapore]]></country_region>
		<health_authority><![CDATA[Health Sciences Authority]]></health_authority>
		<date_2><![CDATA[20230919]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.hsa.gov.sg/announcements/regulatory-updates/implementation-of-good-manufacturing-practice-(gmp)-evidence-for-drug-substance-(ds)-manufacturers]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[implementation-of-good-manufacturing-practice-gmp-evidence-for-drug-substance-ds-manufacturers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2707]]></id>
		<title><![CDATA[The Innovative Devices Access Pathway (IDAP)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/the-innovative-devices-access-pathway-idap/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230919]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[the-innovative-devices-access-pathway-idap]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2708]]></id>
		<title><![CDATA[Changes to the guidance document Temporary authorisation of human medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/changes-to-the-guidance-document-temporary-authorisation-of-human-medicinal-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230915]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/authorisations/information/anpassung-wl-befristete-zl-human.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[changes-to-the-guidance-document-temporary-authorisation-of-human-medicinal-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2709]]></id>
		<title><![CDATA[Medical Devices with Indications Associated with Weight Loss – Non-Clinical Recommendations (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/medical-devices-with-indications-associated-with-weight-loss-non-clinical-recommendations-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230915]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Non-Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172063/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[medical-devices-with-indications-associated-with-weight-loss-non-clinical-recommendations-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2710]]></id>
		<title><![CDATA[Medical Devices with Indications 2 Associated with Weight Loss – Clinical 3 Study and Benefit-Risk Considerations (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/medical-devices-with-indications-2-associated-with-weight-loss-clinical-3-study-and-benefit-risk-considerations-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230915]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172084/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[medical-devices-with-indications-2-associated-with-weight-loss-clinical-3-study-and-benefit-risk-considerations-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2711]]></id>
		<title><![CDATA[Quality Management Maturity Program for Drug Manufacturing Establishments; Establishment of a Public Docket; Request for Comments]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/quality-management-maturity-program-for-drug-manufacturing-establishments-establishment-of-a-public-docket-request-for-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230915]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2023/09/15/2023-20015/quality-management-maturity-program-for-drug-manufacturing-establishments-establishment-of-a-public]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[quality-management-maturity-program-for-drug-manufacturing-establishments-establishment-of-a-public-docket-request-for-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2712]]></id>
		<title><![CDATA[Fostering Medical Device Improvement: FDA Activities and Engagement with the Voluntary Improvement Program]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fostering-medical-device-improvement-fda-activities-and-engagement-with-the-voluntary-improvement-program/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230915]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/158180/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fostering-medical-device-improvement-fda-activities-and-engagement-with-the-voluntary-improvement-program]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2713]]></id>
		<title><![CDATA[Breakthrough Devices Program]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/breakthrough-devices-program/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230915]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162413/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[breakthrough-devices-program]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2714]]></id>
		<title><![CDATA[Post market responsibilities for manufacturers and sponsors of medical devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/post-market-responsibilities-for-manufacturers-and-sponsors-of-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230911]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/medical-devices-vigilance-program-pilot]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[post-market-responsibilities-for-manufacturers-and-sponsors-of-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2715]]></id>
		<title><![CDATA[Demonstrating Substantial Evidence of Effectiveness with One Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/demonstrating-substantial-evidence-of-effectiveness-with-one-adequate-and-well-controlled-clinical-investigation-and-confirmatory-evidence-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230911]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172166/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[demonstrating-substantial-evidence-of-effectiveness-with-one-adequate-and-well-controlled-clinical-investigation-and-confirmatory-evidence-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2716]]></id>
		<title><![CDATA[Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program; Program Announcement – Sep 11, 2023]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/chemistry-manufacturing-and-controls-development-and-readiness-pilot-program-program-announcement-sep-11-2023/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230911]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Quality]]></domain>
		<url><![CDATA[https://www.regulations.gov/document/FDA-2022-N-2396-0004]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[chemistry-manufacturing-and-controls-development-and-readiness-pilot-program-program-announcement-sep-11-2023]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2717]]></id>
		<title><![CDATA[Swiss GMDP database]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/swiss-gmdp-database/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230910]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/bewilligungen_zertifikate/authorisations/swissgmdp.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[swiss-gmdp-database]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2718]]></id>
		<title><![CDATA[Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/use-of-international-standard-iso-10993-1-biological-evaluation-of-medical-devices-part-1-evaluation-and-testing-within-a-risk-management-process/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230908]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/142959/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[use-of-international-standard-iso-10993-1-biological-evaluation-of-medical-devices-part-1-evaluation-and-testing-within-a-risk-management-process]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2719]]></id>
		<title><![CDATA[Evidentiary Expectations for 510(k) Implant Devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/evidentiary-expectations-for-510k-implant-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230907]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171835/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[evidentiary-expectations-for-510k-implant-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2720]]></id>
		<title><![CDATA[Recommendations for the Use of Clinical Data in Premarket Notification [510(k)] Submissions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/recommendations-for-the-use-of-clinical-data-in-premarket-notification-510k-submissions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230907]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171837/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[recommendations-for-the-use-of-clinical-data-in-premarket-notification-510k-submissions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2721]]></id>
		<title><![CDATA[Best Practices for Selecting a Predicate Device to Support a Premarket Notification [510(k)] Submission (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/best-practices-for-selecting-a-predicate-device-to-support-a-premarket-notification-510k-submission-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230907]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171838/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[best-practices-for-selecting-a-predicate-device-to-support-a-premarket-notification-510k-submission-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2722]]></id>
		<title><![CDATA[Responsibilities for the Assessment of In Vitro Testing for Oral Drug Products Administered Via Enteral Feeding Tube]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/responsibilities-for-the-assessment-of-in-vitro-testing-for-oral-drug-products-administered-via-enteral-feeding-tube/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230905]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171786/download?attachment]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[responsibilities-for-the-assessment-of-in-vitro-testing-for-oral-drug-products-administered-via-enteral-feeding-tube]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2723]]></id>
		<title><![CDATA[Processing of adverse reaction reports received in New Zealand]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/processing-of-adverse-reaction-reports-received-in-new-zealand/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[New Zealand]]></country_region>
		<health_authority><![CDATA[New Zealand Medicines and Medical Devices Safety]]></health_authority>
		<date_2><![CDATA[20230904]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://medsafe.govt.nz/safety/Alerts/Processing-of-ADR-reports.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[processing-of-adverse-reaction-reports-received-in-new-zealand]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2724]]></id>
		<title><![CDATA[Changes to the regulation of sports supplements in medicinal dosage forms]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/changes-to-the-regulation-of-sports-supplements-in-medicinal-dosage-forms/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/changes-regulation-sports-supplements-medicinal-dosage-forms]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[changes-to-the-regulation-of-sports-supplements-in-medicinal-dosage-forms]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2725]]></id>
		<title><![CDATA[Renewal of medicinal product approvals – No longer required]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/renewal-of-medicinal-product-approvals-no-longer-required/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Colombia]]></country_region>
		<health_authority><![CDATA[The National Institute of Drug and Food Surveillance]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=219070]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[renewal-of-medicinal-product-approvals-no-longer-required]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2726]]></id>
		<title><![CDATA[Q&A on transitional provisions for products without an intended medical purpose covered by Annex XVI of the MDR]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:53]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/qa-on-transitional-provisions-for-products-without-an-intended-medical-purpose-covered-by-annex-xvi-of-the-mdr/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-09/md_new-reg_annex-xvi_q-n-a_transition-prov.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[qa-on-transitional-provisions-for-products-without-an-intended-medical-purpose-covered-by-annex-xvi-of-the-mdr]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:53]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2727]]></id>
		<title><![CDATA[Questions and answers for biological medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/questions-and-answers-for-biological-medicinal-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Biologics]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/human-regulatory-overview/research-and-development/scientific-guidelines/biological-guidelines/questions-and-answers-biological-medicinal-products]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[questions-and-answers-for-biological-medicinal-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2728]]></id>
		<title><![CDATA[Guideline on clinical investigation of medicinal products in the treatment of depression]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guideline-on-clinical-investigation-of-medicinal-products-in-the-treatment-of-depression/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-clinical-investigation-medicinal-products-treatment-depression-revision-3_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guideline-on-clinical-investigation-of-medicinal-products-in-the-treatment-of-depression]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2729]]></id>
		<title><![CDATA[PRAC recommends new measures to avoid topiramate exposure in pregnancy]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/prac-recommends-new-measures-to-avoid-topiramate-exposure-in-pregnancy/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/prac-recommends-new-measures-avoid-topiramate-exposure-pregnancy]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[prac-recommends-new-measures-to-avoid-topiramate-exposure-in-pregnancy]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2730]]></id>
		<title><![CDATA[Manual on borderline and classification for medical devices under Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/manual-on-borderline-and-classification-for-medical-devices-under-regulation-eu-2017-745-on-medical-devices-and-regulation-eu-2017-746-on-in-vitro-diagnostic-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-09/md_borderline_manual_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[manual-on-borderline-and-classification-for-medical-devices-under-regulation-eu-2017-745-on-medical-devices-and-regulation-eu-2017-746-on-in-vitro-diagnostic-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2731]]></id>
		<title><![CDATA[Personalized Medical Devices – Regulatory Pathways]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/personalized-medical-devices-regulatory-pathways/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Medical Device Regulators Forum]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.imdrf.org/sites/default/files/2023-09/IMDRF_PMD%20WG_N58%20FINAL_2023%20%28Edition%202%29_0.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[personalized-medical-devices-regulatory-pathways]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2732]]></id>
		<title><![CDATA[Guidelines on the Regulation of Therapeutic Products in New Zealand]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidelines-on-the-regulation-of-therapeutic-products-in-new-zealand/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[New Zealand]]></country_region>
		<health_authority><![CDATA[New Zealand Medicines and Medical Devices Safety]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://medsafe.govt.nz/regulatory/Guideline/GRTPNZ/manufacture-of-medicines.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidelines-on-the-regulation-of-therapeutic-products-in-new-zealand]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2733]]></id>
		<title><![CDATA[FAQs: General Pharmacovigilance]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/faqs-general-pharmacovigilance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/market-surveillance/pharmacovigilance/faqs/faqs–general-pharmacovigilance.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[faqs-general-pharmacovigilance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2734]]></id>
		<title><![CDATA[Regulatory Considerations for Prescription Drug Use Related Software (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/regulatory-considerations-for-prescription-drug-use-related-software-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172165/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[regulatory-considerations-for-prescription-drug-use-related-software-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2735]]></id>
		<title><![CDATA[Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/alternative-tools-assessing-drug-manufacturing-facilities-identified-in-pending-applications-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172290/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[alternative-tools-assessing-drug-manufacturing-facilities-identified-in-pending-applications-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2736]]></id>
		<title><![CDATA[Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health Emergencies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/considerations-for-the-conduct-of-clinical-trials-of-medical-products-during-major-disruptions-due-to-disasters-and-public-health-emergencies/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172258/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[considerations-for-the-conduct-of-clinical-trials-of-medical-products-during-major-disruptions-due-to-disasters-and-public-health-emergencies]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2737]]></id>
		<title><![CDATA[Labeling for Biosimilar and Interchangeable Biosimilar Products Guidance for Industry (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/labeling-for-biosimilar-and-interchangeable-biosimilar-products-guidance-for-industry-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Biologics]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172170/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[labeling-for-biosimilar-and-interchangeable-biosimilar-products-guidance-for-industry-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2738]]></id>
		<title><![CDATA[Endogenous Cushing’s Syndrome: Developing Drugs for Treatment]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/endogenous-cushings-syndrome-developing-drugs-for-treatment/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171900/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[endogenous-cushings-syndrome-developing-drugs-for-treatment]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2739]]></id>
		<title><![CDATA[Institutional Review Board (IRB) Review of Individual Patient Expanded Access Submissions for Investigational Drugs and Biological Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/institutional-review-board-irb-review-of-individual-patient-expanded-access-submissions-for-investigational-drugs-and-biological-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171902/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[institutional-review-board-irb-review-of-individual-patient-expanded-access-submissions-for-investigational-drugs-and-biological-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2740]]></id>
		<title><![CDATA[DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/dscsa-standards-for-the-interoperable-exchange-of-information-for-tracing-of-certain-human-finished-prescription-drugs/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171796/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[dscsa-standards-for-the-interoperable-exchange-of-information-for-tracing-of-certain-human-finished-prescription-drugs]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2741]]></id>
		<title><![CDATA[Application of Human Factors Engineering Principles for Combination Products: Questions and Answers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/application-of-human-factors-engineering-principles-for-combination-products-questions-and-answers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171855/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[application-of-human-factors-engineering-principles-for-combination-products-questions-and-answers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2742]]></id>
		<title><![CDATA[Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex: Developing Drugs for Treatment]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/nontuberculous-mycobacterial-pulmonary-disease-caused-by-mycobacterium-avium-complex-developing-drugs-for-treatment/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171783/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[nontuberculous-mycobacterial-pulmonary-disease-caused-by-mycobacterium-avium-complex-developing-drugs-for-treatment]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2743]]></id>
		<title><![CDATA[Post-Warning Letter Meetings Under GDUFA (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/post-warning-letter-meetings-under-gdufa-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171785/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[post-warning-letter-meetings-under-gdufa-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2744]]></id>
		<title><![CDATA[Graft-versus-Host Diseases: Developing Drugs, Biological Products, and Certain Devices for Prevention or Treatment (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/graft-versus-host-diseases-developing-drugs-biological-products-and-certain-devices-for-prevention-or-treatment-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230901]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172524/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[graft-versus-host-diseases-developing-drugs-biological-products-and-certain-devices-for-prevention-or-treatment-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2745]]></id>
		<title><![CDATA[Product Information inserts are no longer required for injectable medicines administered by health professionals]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/product-information-inserts-are-no-longer-required-for-injectable-medicines-administered-by-health-professionals/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230830]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/product-information-inserts-are-no-longer-required-injectable-medicines-administered-health-professionals]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[product-information-inserts-are-no-longer-required-for-injectable-medicines-administered-by-health-professionals]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2746]]></id>
		<title><![CDATA[Three new UK Approved Bodies to certify medical devices announced by the MHRA]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/three-new-uk-approved-bodies-to-certify-medical-devices-announced-by-the-mhra/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230829]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/three-new-uk-approved-bodies-to-certify-medical-devices-announced-by-the-mhra]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[three-new-uk-approved-bodies-to-certify-medical-devices-announced-by-the-mhra]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2747]]></id>
		<title><![CDATA[Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/formal-meetings-between-the-fda-and-sponsors-or-applicants-of-pdufa-products-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230829]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/172311/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[formal-meetings-between-the-fda-and-sponsors-or-applicants-of-pdufa-products-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2748]]></id>
		<title><![CDATA[Feedback from Australian Sponsors about the Medical Device Single Audit Program (MDSAP)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/feedback-from-australian-sponsors-about-the-medical-device-single-audit-program-mdsap/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230825]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://consultations.tga.gov.au/tga/mdsap-survey/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[feedback-from-australian-sponsors-about-the-medical-device-single-audit-program-mdsap]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2749]]></id>
		<title><![CDATA[Nitrosamine impurities in medicines – Information for sponsors and manufacturers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/nitrosamine-impurities-in-medicines-information-for-sponsors-and-manufacturers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230824]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/safety-alerts/nitrosamine-impurities-medicines-information-sponsors-and-manufacturers]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[nitrosamine-impurities-in-medicines-information-for-sponsors-and-manufacturers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2750]]></id>
		<title><![CDATA[Nitrosamines impurities in medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/nitrosamines-impurities-in-medicines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230824]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/nitrosamines-impurities-in-medicines/nitrosamines-impurities-in-medicines]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[nitrosamines-impurities-in-medicines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2751]]></id>
		<title><![CDATA[COFEPRIS accepts GMP certificates issued by WHO accredited Health Authorities/PIC/S]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cofepris-accepts-gmp-certificates-issued-by-who-accredited-health-authorities-pic-s/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Mexico]]></country_region>
		<health_authority><![CDATA[Official Journal of the Federation]]></health_authority>
		<date_2><![CDATA[20230823]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.dof.gob.mx/nota_detalle.php?codigo=5699574&fecha=23/08/2023#gsc.tab=0]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cofepris-accepts-gmp-certificates-issued-by-who-accredited-health-authorities-pic-s]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2752]]></id>
		<title><![CDATA[New reporting requirements for medicine shortages]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-reporting-requirements-for-medicine-shortages/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230817]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/new-reporting-requirements-medicine-shortages]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-reporting-requirements-for-medicine-shortages]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2753]]></id>
		<title><![CDATA[EMA review of data on paternal exposure to valproate]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ema-review-of-data-on-paternal-exposure-to-valproate/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230816]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/ema-review-data-paternal-exposure-valproate]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ema-review-of-data-on-paternal-exposure-to-valproate]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2754]]></id>
		<title><![CDATA[Off-The-Shelf Software Use in Medical Devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/off-the-shelf-software-use-in-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230811]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/71794/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[off-the-shelf-software-use-in-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2755]]></id>
		<title><![CDATA[TEAM-NB Position Paper New MDR Transition Timelines and Notified Body Capacity]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/team-nb-position-paper-new-mdr-transition-timelines-and-notified-body-capacity/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230810]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.team-nb.org/wp-content/uploads/2023/08/Team-NB-PositionPaper-MDRTransitionTimelines-NotifiedBodyCapacity-V1.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[team-nb-position-paper-new-mdr-transition-timelines-and-notified-body-capacity]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2756]]></id>
		<title><![CDATA[Swissmedic gains accreditation for GMP/GDP inspections in the field of ATMPs]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/swissmedic-gains-accreditation-for-gmp-gdp-inspections-in-the-field-of-atmps/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230809]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/news/mitteilungen/smc-erhaelt-akkreditierung-gmp-gdp-inspektionen-bereich-atmp.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[swissmedic-gains-accreditation-for-gmp-gdp-inspections-in-the-field-of-atmps]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2757]]></id>
		<title><![CDATA[Guidance to applicants /Marketing Authorization Holders (MAHs) on oral explanations at EMA]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-to-applicants-marketing-authorization-holders-mahs-on-oral-explanations-at-ema/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230807]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/guidance-applicants/marketing-authorisation-holders-oral-explanations-european-medicines-agency_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-to-applicants-marketing-authorization-holders-mahs-on-oral-explanations-at-ema]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2758]]></id>
		<title><![CDATA[Squamous cell carcinoma (SCC) and different types of lymphomas occurring in the capsule around breast implants]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/squamous-cell-carcinoma-scc-and-different-types-of-lymphomas-occurring-in-the-capsule-around-breast-implants/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230807]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/squamous-cell-carcinoma-scc-and-different-types-of-lymphomas-occurring-in-the-capsule-around-breast-implants/squamous-cell-carcinoma-scc-and-different-types-of-lymphomas-occurring-in-the-capsule-around-breast-implants]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[squamous-cell-carcinoma-scc-and-different-types-of-lymphomas-occurring-in-the-capsule-around-breast-implants]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2759]]></id>
		<title><![CDATA[Guidance for manufacturers on vigilance]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-for-manufacturers-on-vigilance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230803]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/collections/medical-devices-guidance-for-manufacturers-on-vigilance#full-publication-update-history]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-for-manufacturers-on-vigilance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2760]]></id>
		<title><![CDATA[Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/food-and-drug-administration-modernization-act-of-1997-modifications-to-the-list-of-recognized-standards-recognition-list-number/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230802]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://public-inspection.federalregister.gov/2023-16418.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[food-and-drug-administration-modernization-act-of-1997-modifications-to-the-list-of-recognized-standards-recognition-list-number]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2761]]></id>
		<title><![CDATA[FAQS on implementation of GSR 823(e) dated 17th November, 2022 with respect to bar code or QR code on top 300 brands]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/faqs-on-implementation-of-gsr-823e-dated-17th-november-2022-with-respect-to-bar-code-or-qr-code-on-top-300-brands/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[]]></domain>
		<url><![CDATA[https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTAzNzc=]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[faqs-on-implementation-of-gsr-823e-dated-17th-november-2022-with-respect-to-bar-code-or-qr-code-on-top-300-brands]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2762]]></id>
		<title><![CDATA[Points to be Consider for Informed Consent Using Electromagnetic Means in Clinical Trials and Post-marketing Clinical Trials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/points-to-be-consider-for-informed-consent-using-electromagnetic-means-in-clinical-trials-and-post-marketing-clinical-trials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Japan]]></country_region>
		<health_authority><![CDATA[Pharmaceuticals and Medical Devices Agency]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.pmda.go.jp/files/000263504.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[points-to-be-consider-for-informed-consent-using-electromagnetic-means-in-clinical-trials-and-post-marketing-clinical-trials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2763]]></id>
		<title><![CDATA[Update on nitrosamine contamination]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/update-on-nitrosamine-contamination/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Japan]]></country_region>
		<health_authority><![CDATA[Pharmaceuticals and Medical Devices Agency]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.pmda.go.jp/files/000263839.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[update-on-nitrosamine-contamination]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2764]]></id>
		<title><![CDATA[Wearable medical device – Guidance document]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/wearable-medical-device-guidance-document/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[Medical Device Authority]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://portal.mda.gov.my/doclink/draf-dokumen-panduan-wearable-medical-device-public-comment-pdf-1/eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWIiOiJkcmFmLWRva3VtZW4tcGFuZHVhbi13ZWFyYWJsZS1tZWRpY2FsLWRldmljZS1wdWJsaWMtY29tbWVudC1wZGYtMSIsImlhdCI6MTY5MjU5MTY3OSwiZXhwIjoxNjkyNjc4MDc5fQ.CA8KH1p-BdFSAV4U-hgqFchNFOrSPCN-383yBpnW0C8]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[wearable-medical-device-guidance-document]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2765]]></id>
		<title><![CDATA[Importation of medical device for personal use]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/importation-of-medical-device-for-personal-use/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[Medical Device Authority]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.mda.gov.my/announcement/1238-first-edition-guidance-document-importation-of-medical-device-for-personal-use.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[importation-of-medical-device-for-personal-use]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2766]]></id>
		<title><![CDATA[Draft for Comments || Application Process and Requirements for Post-Approval Changes of Biological Products Adopting the World Health Organization Guidelines for Changes to Approved Vaccines and Biotherapeutic Products for Human Use]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/draft-for-comments-application-process-and-requirements-for-post-approval-changes-of-biological-products-adopting-the-world-health-organization-guidelines-for-changes-to-approved-vaccines-and-bioth/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/draft-for-comments-application-process-and-requirements-for-post-approval-changes-of-biological-products-adopting-the-world-health-organization-guidelines-for-changes-to-approved-vaccines-and-bioth/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[draft-for-comments-application-process-and-requirements-for-post-approval-changes-of-biological-products-adopting-the-world-health-organization-guidelines-for-changes-to-approved-vaccines-and-bioth]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2767]]></id>
		<title><![CDATA[CE marking recognition for medical devices and in vitro diagnostics]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ce-marking-recognition-for-medical-devices-and-in-vitro-diagnostics/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/ce-marking-recognition-for-medical-devices-and-in-vitro-diagnostics]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ce-marking-recognition-for-medical-devices-and-in-vitro-diagnostics]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2768]]></id>
		<title><![CDATA[Wholesale Distributor Verification Requirement for Saleable Returned Drug Product and Dispenser Verification Requirements When Investigating a Suspect or Illegitimate Product— Compliance Policies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/wholesale-distributor-verification-requirement-for-saleable-returned-drug-product-and-dispenser-verification-requirements-when-investigating-a-suspect-or-illegitimate-product-compliance-polic/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171677/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[wholesale-distributor-verification-requirement-for-saleable-returned-drug-product-and-dispenser-verification-requirements-when-investigating-a-suspect-or-illegitimate-product-compliance-polic]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2769]]></id>
		<title><![CDATA[Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/considerations-for-the-use-of-real-world-data-and-real-world-evidence-to-support-regulatory-decision-making-for-drug-and-biological-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171667/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[considerations-for-the-use-of-real-world-data-and-real-world-evidence-to-support-regulatory-decision-making-for-drug-and-biological-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2770]]></id>
		<title><![CDATA[QTc Information in Human Prescription Drug and Biological Product Labeling]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/qtc-information-in-human-prescription-drug-and-biological-product-labeling/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/media/170814/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[qtc-information-in-human-prescription-drug-and-biological-product-labeling]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2771]]></id>
		<title><![CDATA[PDUFA Waivers, Reductions, and Refunds for Fixed Combinations and Single-Entity Versions of Previously Approved Antiretrovirals under PEPFAR (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/pdufa-waivers-reductions-and-refunds-for-fixed-combinations-and-single-entity-versions-of-previously-approved-antiretrovirals-under-pepfar-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/170813/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[pdufa-waivers-reductions-and-refunds-for-fixed-combinations-and-single-entity-versions-of-previously-approved-antiretrovirals-under-pepfar-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2772]]></id>
		<title><![CDATA[Recommended Acceptable Intake Limits for Nitrosamine Drug Substance Related Impurities (NDSRIs)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/recommended-acceptable-intake-limits-for-nitrosamine-drug-substance-related-impurities-ndsris/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Toxicology]]></domain>
		<url><![CDATA[https://www.fda.gov/media/170794/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[recommended-acceptable-intake-limits-for-nitrosamine-drug-substance-related-impurities-ndsris]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2773]]></id>
		<title><![CDATA[Waivers, Exceptions, and Exemptions From the Requirements of Section 582 of the Federal Food, Drug, and Cosmetic Act]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/waivers-exceptions-and-exemptions-from-the-requirements-of-section-582-of-the-federal-food-drug-and-cosmetic-act/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/media/113342/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[waivers-exceptions-and-exemptions-from-the-requirements-of-section-582-of-the-federal-food-drug-and-cosmetic-act]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2774]]></id>
		<title><![CDATA[Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment or Prevention of HIV-1 Under PEPFAR]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fixed-combinations-and-single-entity-versions-of-previously-approved-antiretrovirals-for-the-treatment-or-prevention-of-hiv-1-under-pepfar/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/72248/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fixed-combinations-and-single-entity-versions-of-previously-approved-antiretrovirals-for-the-treatment-or-prevention-of-hiv-1-under-pepfar]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2775]]></id>
		<title><![CDATA[PDUFA Waivers, Reductions, and Refunds for FixedCombinations and Single-Entity Versions of Previously Approved Antiretrovirals under PEPFAR (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/pdufa-waivers-reductions-and-refunds-for-fixedcombinations-and-single-entity-versions-of-previously-approved-antiretrovirals-under-pepfar-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/170813/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[pdufa-waivers-reductions-and-refunds-for-fixedcombinations-and-single-entity-versions-of-previously-approved-antiretrovirals-under-pepfar-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2776]]></id>
		<title><![CDATA[Classification Categories for Certain Supplements Under BsUFA III (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/classification-categories-for-certain-supplements-under-bsufa-iii-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/170906/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[classification-categories-for-certain-supplements-under-bsufa-iii-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2777]]></id>
		<title><![CDATA[Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA Products (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/formal-meetings-between-the-fda-and-sponsors-or-applicants-of-bsufa-products-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/113913/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[formal-meetings-between-the-fda-and-sponsors-or-applicants-of-bsufa-products-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2778]]></id>
		<title><![CDATA[Post marketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/post-marketing-approaches-to-obtain-data-on-populations-underrepresented-in-clinical-trials-for-drugs-and-biological-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/170899/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[post-marketing-approaches-to-obtain-data-on-populations-underrepresented-in-clinical-trials-for-drugs-and-biological-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2779]]></id>
		<title><![CDATA[Informed Consent Guidance for IRBs, Clinical Investigators, and Sponsors]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/informed-consent-guidance-for-irbs-clinical-investigators-and-sponsors/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/88915/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[informed-consent-guidance-for-irbs-clinical-investigators-and-sponsors]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2780]]></id>
		<title><![CDATA[Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act — Compliance Policies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/enhanced-drug-distribution-security-requirements-under-section-582g1-of-the-federal-food-drug-and-cosmetic-act-compliance-policies/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230801]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/171592/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[enhanced-drug-distribution-security-requirements-under-section-582g1-of-the-federal-food-drug-and-cosmetic-act-compliance-policies]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2781]]></id>
		<title><![CDATA[Clinical Considerations for Studies of Devices Intended to Treat Opioid Use Disorder (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/clinical-considerations-for-studies-of-devices-intended-to-treat-opioid-use-disorder-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230728]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/170561/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[clinical-considerations-for-studies-of-devices-intended-to-treat-opioid-use-disorder-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2782]]></id>
		<title><![CDATA[MRA between Switzerland and the USA on the manufacturing practice for medicinal products takes effect]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mra-between-switzerland-and-the-usa-on-the-manufacturing-practice-for-medicinal-products-takes-effect/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230727]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/news/mitteilungen/inkrafttreten-mra-swissmedic-fda.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mra-between-switzerland-and-the-usa-on-the-manufacturing-practice-for-medicinal-products-takes-effect]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2783]]></id>
		<title><![CDATA[Hydrogen Peroxide-Based Contact Lens Care Products: Consumer Labeling Recommendations – Premarket Notification (510(k)) Submissions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/hydrogen-peroxide-based-contact-lens-care-products-consumer-labeling-recommendations-premarket-notification-510k-submissions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230727]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/media/160909/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[hydrogen-peroxide-based-contact-lens-care-products-consumer-labeling-recommendations-premarket-notification-510k-submissions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2784]]></id>
		<title><![CDATA[Questions and Answers (Q&As) on the External Guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/questions-and-answers-qas-on-the-external-guidance-on-the-implementation-of-the-european-medicines-agency-policy-on-the-publication-of-clinical-data-for-medicinal-products-for-human-use/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230726]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/questions-answers-qas-external-guidance-policy-0070-clinical-data-publication-cdp_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[questions-and-answers-qas-on-the-external-guidance-on-the-implementation-of-the-european-medicines-agency-policy-on-the-publication-of-clinical-data-for-medicinal-products-for-human-use]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2785]]></id>
		<title><![CDATA[Commission acts to accelerate phasing out of animal testing in response to a European Citizens’ Initiative]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/commission-acts-to-accelerate-phasing-out-of-animal-testing-in-response-to-a-european-citizens-initiative/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20230725]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Non-Clinical]]></domain>
		<url><![CDATA[https://ec.europa.eu/commission/presscorner/detail/en/ip_23_3993]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[commission-acts-to-accelerate-phasing-out-of-animal-testing-in-response-to-a-european-citizens-initiative]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2786]]></id>
		<title><![CDATA[Paving the way towards coordinated clinical trials in public health emergencies in the EU]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/paving-the-way-towards-coordinated-clinical-trials-in-public-health-emergencies-in-the-eu/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230725]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/paving-way-towards-coordinated-clinical-trials-public-health-emergencies-eu]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[paving-the-way-towards-coordinated-clinical-trials-in-public-health-emergencies-in-the-eu]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2787]]></id>
		<title><![CDATA[N-nitrosamine impurities in Ph. Eur. monographs: update on approach]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/n-nitrosamine-impurities-in-ph-eur-monographs-update-on-approach/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Directorate for the Quality of Medicines and Healthcare]]></health_authority>
		<date_2><![CDATA[20230724]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/n-nitrosamine-impurities-in-ph.-eur.-monographs-update-on-approach]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[n-nitrosamine-impurities-in-ph-eur-monographs-update-on-approach]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2788]]></id>
		<title><![CDATA[CDRH Announces New Standards Recognition to Support Innovation in Medical Device Sterilization]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cdrh-announces-new-standards-recognition-to-support-innovation-in-medical-device-sterilization/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230724]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-announces-new-standards-recognition-support-innovation-medical-device-sterilization]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cdrh-announces-new-standards-recognition-to-support-innovation-in-medical-device-sterilization]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2789]]></id>
		<title><![CDATA[Concept paper on the revision of the Guideline on Radiopharmaceuticals Based on Monoclonal Antibodies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/concept-paper-on-the-revision-of-the-guideline-on-radiopharmaceuticals-based-on-monoclonal-antibodies/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230720]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-revision-guideline-guideline-radiopharmaceuticals-based-monoclonal-antibodies_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[concept-paper-on-the-revision-of-the-guideline-on-radiopharmaceuticals-based-on-monoclonal-antibodies]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2790]]></id>
		<title><![CDATA[Guidance for the Transition of clinical trials from the Clinical Trials Directive to the Clinical Trials Regulation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20230719]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-07/transition_ct_dir-reg_guidance_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-for-the-transition-of-clinical-trials-from-the-clinical-trials-directive-to-the-clinical-trials-regulation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2791]]></id>
		<title><![CDATA[Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/requests-for-feedback-and-meetings-for-medical-device-submissions-the-q-submission-program/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230717]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/114034/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[requests-for-feedback-and-meetings-for-medical-device-submissions-the-q-submission-program]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2792]]></id>
		<title><![CDATA[Qualification of Medical Device Development Tools]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/qualification-of-medical-device-development-tools/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230717]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Quality]]></domain>
		<url><![CDATA[https://www.fda.gov/media/87134/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[qualification-of-medical-device-development-tools]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2793]]></id>
		<title><![CDATA[Medical devices – single identifier for similar highly individualized devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/medical-devices-single-identifier-for-similar-highly-individualized-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20230710]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/13299-Medical-devices-single-identifier-for-similar-highly-individualised-devices_en]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[medical-devices-single-identifier-for-similar-highly-individualized-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2794]]></id>
		<title><![CDATA[Electronic Export Documents – Letter to Industry]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/electronic-export-documents-letter-to-industry/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230710]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/industry-medical-devices/electronic-export-documents-letter-industry]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[electronic-export-documents-letter-to-industry]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2795]]></id>
		<title><![CDATA[Post marketing Studies and Clinical Trials: Determining Good Cause for Noncompliance with Section 505(o)(3)(E)(ii) of the Federal Food, Drug, and Cosmetic Act (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/post-marketing-studies-and-clinical-trials-determining-good-cause-for-noncompliance-with-section-505o3eii-of-the-federal-food-drug-and-cosmetic-act-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230710]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/170187/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[post-marketing-studies-and-clinical-trials-determining-good-cause-for-noncompliance-with-section-505o3eii-of-the-federal-food-drug-and-cosmetic-act-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2796]]></id>
		<title><![CDATA[Nitrosamine impurities in medicinal products: Swissmedic sets up specialist group]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/nitrosamine-impurities-in-medicinal-products-swissmedic-sets-up-specialist-group/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230705]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/news/mitteilungen/nitrosamin-verunreinigungen-smc-fachgruppe.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[nitrosamine-impurities-in-medicinal-products-swissmedic-sets-up-specialist-group]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2797]]></id>
		<title><![CDATA[ICH M7 Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk – Scientific guideline]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ich-m7-assessment-and-control-of-dna-reactive-mutagenic-impurities-in-pharmaceuticals-to-limit-potential-carcinogenic-risk-scientific-guideline/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Toxicology]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/ich-m7-assessment-control-dna-reactive-mutagenic-impurities-pharmaceuticals-limit-potential]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ich-m7-assessment-and-control-of-dna-reactive-mutagenic-impurities-in-pharmaceuticals-to-limit-potential-carcinogenic-risk-scientific-guideline]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2798]]></id>
		<title><![CDATA[Questions and answers on remote batch certification / confirmation by the qualified person (QP) – NEW July 2023]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/questions-and-answers-on-remote-batch-certification-confirmation-by-the-qualified-person-qp-new-july-2023/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/human-regulatory/research-development/compliance/good-manufacturing-practice/guidance-good-manufacturing-practice-good-distribution-practice-questions-answers#questions-and-answers-on-remote-batch-certification-/-confirmation-by-the-qualified-person-(qp)—new-july-2023-section]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[questions-and-answers-on-remote-batch-certification-confirmation-by-the-qualified-person-qp-new-july-2023]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2799]]></id>
		<title><![CDATA[Extension of the MDR transitional period and removal of the ‘sell off’ periods]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/extension-of-the-mdr-transitional-period-and-removal-of-the-sell-off-periods/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-07/mdr_proposal_extension-q-n-a.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[extension-of-the-mdr-transitional-period-and-removal-of-the-sell-off-periods]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2800]]></id>
		<title><![CDATA[WHO Guidance for best practices for clinical trials Draft for public consultation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/who-guidance-for-best-practices-for-clinical-trials-draft-for-public-consultation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[World Health Organization]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://cdn.who.int/media/docs/default-source/research-for-health/2023-07_who-guidance-for-best-practices-for-clinical-trials_draft-for-public-consultation.pdf?sfvrsn=7a5c9fa5_4]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[who-guidance-for-best-practices-for-clinical-trials-draft-for-public-consultation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2801]]></id>
		<title><![CDATA[Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/multisource-generic-pharmaceutical-products-guidelines-on-registration-requirements-to-establish-interchangeability/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[World Health Organization]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.who.int/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1003-annex6-who-multisource-pharmaceutical-products-interchangeability.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[multisource-generic-pharmaceutical-products-guidelines-on-registration-requirements-to-establish-interchangeability]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2802]]></id>
		<title><![CDATA[International Harmonisation of Real-World Evidence Terminology and Convergence of General Principles Regarding Planning and Reporting of Studies Using Real-World Data, with a Focus on Effectiveness of Medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/international-harmonisation-of-real-world-evidence-terminology-and-convergence-of-general-principles-regarding-planning-and-reporting-of-studies-using-real-world-data-with-a-focus-on-effectiveness-of/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[The International Council for Harmonisation]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://admin.ich.org/sites/default/files/2023-06/ICH_ReflectionPaper_Harmonisation_RWE_Terminology_Endorsed-ForConsultation_2023_0613.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[international-harmonisation-of-real-world-evidence-terminology-and-convergence-of-general-principles-regarding-planning-and-reporting-of-studies-using-real-world-data-with-a-focus-on-effectiveness-of]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2803]]></id>
		<title><![CDATA[Public consultation on the proposed regulation for active ingredients under the health products act]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/public-consultation-on-the-proposed-regulation-for-active-ingredients-under-the-health-products-act/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Singapore]]></country_region>
		<health_authority><![CDATA[Health Sciences Authority]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.reach.gov.sg/Participate/Public-Consultation/Health-Sciences-Authority/public-consultation-on-the-proposed-regulation-for-active-ingredients-under-the-health-products-act]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[public-consultation-on-the-proposed-regulation-for-active-ingredients-under-the-health-products-act]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2804]]></id>
		<title><![CDATA[Rules and Regulations on the Issuance of Authorization for Registration Applications of Drug Products and Drug Substances by the Food and Drug Administration (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/rules-and-regulations-on-the-issuance-of-authorization-for-registration-applications-of-drug-products-and-drug-substances-by-the-food-and-drug-administration-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/draft-for-comments-rules-and-regulations-on-the-issuance-of-authorization-for-registration-applications-of-drug-products-and-drug-substances-by-the-food-and-drug-administration/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[rules-and-regulations-on-the-issuance-of-authorization-for-registration-applications-of-drug-products-and-drug-substances-by-the-food-and-drug-administration-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2805]]></id>
		<title><![CDATA[Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/manufacturing-changes-and-comparability-for-human-cellular-and-gene-therapy-products-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Biologics]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/170198/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[manufacturing-changes-and-comparability-for-human-cellular-and-gene-therapy-products-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2806]]></id>
		<title><![CDATA[CDER’s Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cders-program-for-the-recognition-of-voluntary-consensus-standards-related-to-pharmaceutical-quality/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/121305/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cders-program-for-the-recognition-of-voluntary-consensus-standards-related-to-pharmaceutical-quality]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2807]]></id>
		<title><![CDATA[Understanding CDER’s Risk-Based Site Selection Model]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/understanding-cders-risk-based-site-selection-model/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230703]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/116004/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[understanding-cders-risk-based-site-selection-model]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2808]]></id>
		<title><![CDATA[Inborn Errors of Metabolism That Use Dietary Management: Considerations for Optimizing and Standardizing Diet in Clinical Trials for Drug Product Development (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/inborn-errors-of-metabolism-that-use-dietary-management-considerations-for-optimizing-and-standardizing-diet-in-clinical-trials-for-drug-product-development-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230629]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/114764/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[inborn-errors-of-metabolism-that-use-dietary-management-considerations-for-optimizing-and-standardizing-diet-in-clinical-trials-for-drug-product-development-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2809]]></id>
		<title><![CDATA[CDRH Seeks Public Comment: Increasing Patient Access to At-Home Use Medical Technologies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cdrh-seeks-public-comment-increasing-patient-access-to-at-home-use-medical-technologies/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230628]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/about-fda/cdrh-strategic-priorities-and-updates/cdrh-seeks-public-comment-increasing-patient-access-home-use-medical-technologies]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cdrh-seeks-public-comment-increasing-patient-access-to-at-home-use-medical-technologies]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2810]]></id>
		<title><![CDATA[Migraine: Developing Drugs for Preventive Treatment (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/migraine-developing-drugs-for-preventive-treatment-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230623]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/168871/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[migraine-developing-drugs-for-preventive-treatment-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2811]]></id>
		<title><![CDATA[Great Britain to accept European CE marks until June 2030 to ensure continued supply]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/great-britain-to-accept-european-ce-marks-until-june-2030-to-ensure-continued-supply/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230616]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/implementation-of-the-future-regulation-of-medical-devices-and-extension-of-standstill-period/implementation-of-the-future-regulations]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[great-britain-to-accept-european-ce-marks-until-june-2030-to-ensure-continued-supply]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2812]]></id>
		<title><![CDATA[Interstitial Cystitis/Bladder Pain Syndrome: Establishing Drug Development Programs for Treatment]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/interstitial-cystitis-bladder-pain-syndrome-establishing-drug-development-programs-for-treatment/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230605]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Non-Clinical]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2023/06/05/2023-11899/interstitial-cystitisbladder-pain-syndrome-establishing-drug-development-programs-for-treatment]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[interstitial-cystitis-bladder-pain-syndrome-establishing-drug-development-programs-for-treatment]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2813]]></id>
		<title><![CDATA[Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/nonclinical-evaluation-of-the-immunotoxic-potential-of-pharmaceuticals/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230605]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Non-Clinical]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2023/06/05/2023-11898/nonclinical-evaluation-of-the-immunotoxic-potential-of-pharmaceuticals-guidance-for-industry]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[nonclinical-evaluation-of-the-immunotoxic-potential-of-pharmaceuticals]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2814]]></id>
		<title><![CDATA[Drug-Drug Interaction Assessment for Therapeutic Proteins]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/drug-drug-interaction-assessment-for-therapeutic-proteins/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230601]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/140909/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[drug-drug-interaction-assessment-for-therapeutic-proteins]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2815]]></id>
		<title><![CDATA[Progress with EU-US mutual recognition agreement for inspections for veterinary medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/progress-with-eu-us-mutual-recognition-agreement-for-inspections-for-veterinary-medicines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230531]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/progress-eu-us-mutual-recognition-agreement-inspections-veterinary-medicines]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[progress-with-eu-us-mutual-recognition-agreement-for-inspections-for-veterinary-medicines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2816]]></id>
		<title><![CDATA[FDA Proposes New, Easy-to-Read Medication Guide for Patients, Patient Medication Information]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fda-proposes-new-easy-to-read-medication-guide-for-patients-patient-medication-information/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230530]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/news-events/press-announcements/fda-proposes-new-easy-read-medication-guide-patients-patient-medication-information]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fda-proposes-new-easy-to-read-medication-guide-for-patients-patient-medication-information]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2817]]></id>
		<title><![CDATA[Scientific opinion on the tolerable upper intake level for vitamin B6]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/scientific-opinion-on-the-tolerable-upper-intake-level-for-vitamin-b6/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Food Safety Authority]]></health_authority>
		<date_2><![CDATA[20230526]]></date_2>
		<product_type><![CDATA[Food & Food Supplement]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.efsa.europa.eu/en/efsajournal/pub/8006]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[scientific-opinion-on-the-tolerable-upper-intake-level-for-vitamin-b6]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2818]]></id>
		<title><![CDATA[New regulatory pathway set to support safe patient access to innovative medical technologies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-regulatory-pathway-set-to-support-safe-patient-access-to-innovative-medical-technologies/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230526]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/new-regulatory-pathway-set-to-support-safe-patient-access-to-innovative-medical-technologies]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-regulatory-pathway-set-to-support-safe-patient-access-to-innovative-medical-technologies]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2819]]></id>
		<title><![CDATA[Template for NB – Confirmation letter in the framework of Regulation (EU) 2023/607]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/template-for-nb-confirmation-letter-in-the-framework-of-regulation-eu-2023-607/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20230524]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/latest-updates/template-nb-confirmation-letter-framework-regulation-eu-2023607-2023-05-24_en]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[template-for-nb-confirmation-letter-in-the-framework-of-regulation-eu-2023-607]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2820]]></id>
		<title><![CDATA[Send and Track Medical Device Premarket Submissions Online: CDRH Portal]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/send-and-track-medical-device-premarket-submissions-online-cdrh-portal/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230522]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/industry-medical-devices/send-and-track-medical-device-premarket-submissions-online-cdrh-portal]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[send-and-track-medical-device-premarket-submissions-online-cdrh-portal]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2821]]></id>
		<title><![CDATA[Good Clinical Practice (GCP) E6(R3) (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/good-clinical-practice-gcp-e6r3-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Council for Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use]]></health_authority>
		<date_2><![CDATA[20230519]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://database.ich.org/sites/default/files/ICH_E6%28R3%29_DraftGuideline_2023_0519.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[good-clinical-practice-gcp-e6r3-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2822]]></id>
		<title><![CDATA[GMP Clearance: Extension processing times]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/gmp-clearance-extension-processing-times/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230517]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/notices/gmp-clearance-extension-processing-times]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[gmp-clearance-extension-processing-times]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2823]]></id>
		<title><![CDATA[Safety of yellow/orange tomato extract as a novel food pursuant to Regulation (EU) 2015/2283]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/safety-of-yellow-orange-tomato-extract-as-a-novel-food-pursuant-to-regulation-eu-2015-2283/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Food Safety Authority]]></health_authority>
		<date_2><![CDATA[20230517]]></date_2>
		<product_type><![CDATA[Food & Food Supplement]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.efsa.europa.eu/en/efsajournal/pub/7994]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[safety-of-yellow-orange-tomato-extract-as-a-novel-food-pursuant-to-regulation-eu-2015-2283]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2824]]></id>
		<title><![CDATA[Guidance for manufacturers on reporting adverse incidents involving Software as a Medical Device under the vigilance system]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-for-manufacturers-on-reporting-adverse-incidents-involving-software-as-a-medical-device-under-the-vigilance-system/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230515]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/reporting-adverse-incidents-involving-software-as-a-medical-device-under-the-vigilance-system/guidance-for-manufacturers-on-reporting-adverse-incidents-involving-software-as-a-medical-device-under-the-vigilance-system]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-for-manufacturers-on-reporting-adverse-incidents-involving-software-as-a-medical-device-under-the-vigilance-system]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2825]]></id>
		<title><![CDATA[Supply and Shortages of Medical Devices: Frequently Asked Questions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/supply-and-shortages-of-medical-devices-frequently-asked-questions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230512]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/medical-device-supply-chain-and-shortages/supply-and-shortages-medical-devices-frequently-asked-questions]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[supply-and-shortages-of-medical-devices-frequently-asked-questions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2826]]></id>
		<title><![CDATA[Medical Device Supply Chain and Shortages]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/medical-device-supply-chain-and-shortages/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230512]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/medical-device-safety/medical-device-supply-chain-and-shortages]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[medical-device-supply-chain-and-shortages]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2827]]></id>
		<title><![CDATA[New safety warning for medicines used in arthritis and other inflammatory conditions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-safety-warning-for-medicines-used-in-arthritis-and-other-inflammatory-conditions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230511]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/safety-alerts/new-safety-warning-medicines-used-arthritis-and-other-inflammatory-conditions]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-safety-warning-for-medicines-used-in-arthritis-and-other-inflammatory-conditions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2828]]></id>
		<title><![CDATA[FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fda-updating-warnings-to-improve-safe-use-of-prescription-stimulants-used-to-treat-adhd-and-other-conditions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230511]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.fda.gov/drugs/drug-safety-and-availability/fda-updating-warnings-improve-safe-use-prescription-stimulants-used-treat-adhd-and-other-conditions]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fda-updating-warnings-to-improve-safe-use-of-prescription-stimulants-used-to-treat-adhd-and-other-conditions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2829]]></id>
		<title><![CDATA[Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products; Availability]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/using-artificial-intelligence-and-machine-learning-in-the-development-of-drug-and-biological-products-availability/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230511]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://public-inspection.federalregister.gov/2023-09985.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[using-artificial-intelligence-and-machine-learning-in-the-development-of-drug-and-biological-products-availability]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2830]]></id>
		<title><![CDATA[EMA and European medicines regulatory network lift COVID-19 business continuity status]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ema-and-european-medicines-regulatory-network-lift-covid-19-business-continuity-status/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230510]]></date_2>
		<product_type><![CDATA[Vaccine]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/ema-european-medicines-regulatory-network-lift-covid-19-business-continuity-status]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ema-and-european-medicines-regulatory-network-lift-covid-19-business-continuity-status]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2831]]></id>
		<title><![CDATA[Commission guidance on the content and structure of the summary of the clinical investigation report]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/commission-guidance-on-the-content-and-structure-of-the-summary-of-the-clinical-investigation-report/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230508]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52023XC0508(01)]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[commission-guidance-on-the-content-and-structure-of-the-summary-of-the-clinical-investigation-report]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2832]]></id>
		<title><![CDATA[Review of pholcodine-containing medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/review-of-pholcodine-containing-medicines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[New Zealand]]></country_region>
		<health_authority><![CDATA[New Zealand Medicines and Medical Devices Safety]]></health_authority>
		<date_2><![CDATA[20230508]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://medsafe.govt.nz/safety/Alerts/Review-of-pholcodine-containing-medicines.asp]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[review-of-pholcodine-containing-medicines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2833]]></id>
		<title><![CDATA[EU MDR transition extension]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/eu-mdr-transition-extension/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230505]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/eu-mdr-transition-extension]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[eu-mdr-transition-extension]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2834]]></id>
		<title><![CDATA[Adoption of the World Health Organization Updated Guidelines on the Evaluation of Similar Biotherapeutic Products (SBPs) in Compliance with Administrative Order No. 2014-0016]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/adoption-of-the-world-health-organization-updated-guidelines-on-the-evaluation-of-similar-biotherapeutic-products-sbps-in-compliance-with-administrative-order-no-2014-0016/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20230505]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/fda-advisory-no-2023-0771-adoption-of-the-world-health-organization-updated-guidelines-on-the-evaluation-of-similar-biotherapeutic-products-sbps-in-compliance-with-administrative-order-no-2014/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[adoption-of-the-world-health-organization-updated-guidelines-on-the-evaluation-of-similar-biotherapeutic-products-sbps-in-compliance-with-administrative-order-no-2014-0016]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2835]]></id>
		<title><![CDATA[Anvisa updates the rule governing requirements for clinical analysis exams]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/anvisa-updates-the-rule-governing-requirements-for-clinical-analysis-exams/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Brazil]]></country_region>
		<health_authority><![CDATA[Brazilian Health Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230504]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2023/anvisa-atualiza-norma-que-disciplina-osrequisitosparaos-exames-de-analises-clinicas]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[anvisa-updates-the-rule-governing-requirements-for-clinical-analysis-exams]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2836]]></id>
		<title><![CDATA[Identification, Assessment, and Control of Nitrosamine Drug Substance-Related Impurities in Human Drug Products; Establishment of a Public Docket; Request for Comments]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/identification-assessment-and-control-of-nitrosamine-drug-substance-related-impurities-in-human-drug-products-establishment-of-a-public-docket-request-for-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230504]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2023/05/04/2023-09526/identification-assessment-and-control-of-nitrosamine-drug-substance-related-impurities-in-human-drug]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[identification-assessment-and-control-of-nitrosamine-drug-substance-related-impurities-in-human-drug-products-establishment-of-a-public-docket-request-for-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2837]]></id>
		<title><![CDATA[TGA makes final decision to reduce paracetamol pack sizes]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/tga-makes-final-decision-to-reduce-paracetamol-pack-sizes/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230503]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Packaging]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/media-releases/tga-makes-final-decision-reduce-paracetamol-pack-sizes]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[tga-makes-final-decision-to-reduce-paracetamol-pack-sizes]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2838]]></id>
		<title><![CDATA[Interim guidance document on how to approach the protection of personal data and commercially confidential information while using the Clinical Trials Information System (CTIS) version 1.0]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/interim-guidance-document-on-how-to-approach-the-protection-of-personal-data-and-commercially-confidential-information-while-using-the-clinical-trials-information-system-ctis-version-1-0/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230503]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/other/interim-guidance-document-how-approach-protection-personal-data-commercially-confidential_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[interim-guidance-document-on-how-to-approach-the-protection-of-personal-data-and-commercially-confidential-information-while-using-the-clinical-trials-information-system-ctis-version-1-0]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2839]]></id>
		<title><![CDATA[Review of transparency rules for the EU Clinical Trials Information System (CTIS)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/review-of-transparency-rules-for-the-eu-clinical-trials-information-system-ctis/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230503]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/review-transparency-rules-eu-clinical-trials-information-system-ctis]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[review-of-transparency-rules-for-the-eu-clinical-trials-information-system-ctis]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2840]]></id>
		<title><![CDATA[Streamlining of medical device regulations]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/streamlining-of-medical-device-regulations/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20230502]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://pharmaceuticals.gov.in/sites/default/files/Gazette%20Notification%20%20National%20Medical%20Devices%20Policy%202023_0.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[streamlining-of-medical-device-regulations]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2841]]></id>
		<title><![CDATA[Consultation on GN-14 Guidance on the Risk Classification of In Vitro Diagnostic Medical Devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/consultation-on-gn-14-guidance-on-the-risk-classification-of-in-vitro-diagnostic-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Singapore]]></country_region>
		<health_authority><![CDATA[Health Sciences Authority]]></health_authority>
		<date_2><![CDATA[20230502]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.hsa.gov.sg/announcements/regulatory-updates/consultation-on-gn-14-guidance-on-the-risk-classification-of-in-vitro-diagnostic-medical-devices]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[consultation-on-gn-14-guidance-on-the-risk-classification-of-in-vitro-diagnostic-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2842]]></id>
		<title><![CDATA[Antibiotics shortage update and substitution allowed to address shortage of Cefaclor]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/antibiotics-shortage-update-and-substitution-allowed-to-address-shortage-of-cefaclor/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/antibiotics-shortage-update-and-substitution-allowed-address-shortage-cefaclor]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[antibiotics-shortage-update-and-substitution-allowed-to-address-shortage-of-cefaclor]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2843]]></id>
		<title><![CDATA[Electronic product information (ePI)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/electronic-product-information-epi/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/product-information/electronic-product-information-epi]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[electronic-product-information-epi]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2844]]></id>
		<title><![CDATA[Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regards to devices covered by certificates according to MDD or AIMDD]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-on-significant-changes-regarding-the-transitional-provision-under-article-120-of-the-mdr-with-regards-to-devices-covered-by-certificates-according-to-mdd-or-aimdd/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-05/mdcg_2020-3_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-on-significant-changes-regarding-the-transitional-provision-under-article-120-of-the-mdr-with-regards-to-devices-covered-by-certificates-according-to-mdd-or-aimdd]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2845]]></id>
		<title><![CDATA[Changes to the forms for new authorizations of and variations to human and veterinary medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/changes-to-the-forms-for-new-authorizations-of-and-variations-to-human-and-veterinary-medicinal-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/authorisations/information/anpassung-fo-na-und-aenderung-ham-und-tam.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[changes-to-the-forms-for-new-authorizations-of-and-variations-to-human-and-veterinary-medicinal-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2846]]></id>
		<title><![CDATA[Changes to the guidance document GMP compliance by foreign manufacturers and the form Declaration by the Responsible Person for foreign manufacturers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/changes-to-the-guidance-document-gmp-compliance-by-foreign-manufacturers-and-the-form-declaration-by-the-responsible-person-for-foreign-manufacturers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/news/mitteilungen/praezisierung-der-vorgaben-fuer-die-einreichung-von-auditberichten.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[changes-to-the-guidance-document-gmp-compliance-by-foreign-manufacturers-and-the-form-declaration-by-the-responsible-person-for-foreign-manufacturers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2847]]></id>
		<title><![CDATA[Guidelines for the Importation and Exportation of Finished Drug Products and Raw Materials (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidelines-for-the-importation-and-exportation-of-finished-drug-products-and-raw-materials-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/draft-for-comments-guidelines-for-the-importation-and-exportation-of-finished-drug-products-and-raw-materials/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidelines-for-the-importation-and-exportation-of-finished-drug-products-and-raw-materials-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2848]]></id>
		<title><![CDATA[Testing of Glycerin, Propylene Glycol, Maltitol Solution, Hydrogenated Starch Hydrolysate, Sorbitol Solution, and other High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/testing-of-glycerin-propylene-glycol-maltitol-solution-hydrogenated-starch-hydrolysate-sorbitol-solution-and-other-high-risk-drug-components-for-diethylene-glycol-and-ethylene-glycol/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/167974/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[testing-of-glycerin-propylene-glycol-maltitol-solution-hydrogenated-starch-hydrolysate-sorbitol-solution-and-other-high-risk-drug-components-for-diethylene-glycol-and-ethylene-glycol]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2849]]></id>
		<title><![CDATA[Diabetes Mellitus: Efficacy Endpoints for Clinical Trials Investigating Antidiabetic Drugs and Biological Products (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/diabetes-mellitus-efficacy-endpoints-for-clinical-trials-investigating-antidiabetic-drugs-and-biological-products-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/168475/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[diabetes-mellitus-efficacy-endpoints-for-clinical-trials-investigating-antidiabetic-drugs-and-biological-products-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2850]]></id>
		<title><![CDATA[Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/adjusting-for-covariates-in-randomized-clinical-trials-for-drugs-and-biological-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/148910/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[adjusting-for-covariates-in-randomized-clinical-trials-for-drugs-and-biological-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2851]]></id>
		<title><![CDATA[Use of Whole Slide Imaging in Nonclinical Toxicology Studies: Questions and Answers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/use-of-whole-slide-imaging-in-nonclinical-toxicology-studies-questions-and-answers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Non-Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/168431/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[use-of-whole-slide-imaging-in-nonclinical-toxicology-studies-questions-and-answers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2852]]></id>
		<title><![CDATA[Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products: Nonclinical Information (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/generally-accepted-scientific-knowledge-in-applications-for-drug-and-biological-products-nonclinical-information-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Non-Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/168408/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[generally-accepted-scientific-knowledge-in-applications-for-drug-and-biological-products-nonclinical-information-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2853]]></id>
		<title><![CDATA[Pediatric Drug Development: Regulatory Considerations — Complying With the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/pediatric-drug-development-regulatory-considerations-complying-with-the-pediatric-research-equity-act-and-qualifying-for-pediatric-exclusivity-under-the-best-pharmaceuticals-for-children-ac/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/168201/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[pediatric-drug-development-regulatory-considerations-complying-with-the-pediatric-research-equity-act-and-qualifying-for-pediatric-exclusivity-under-the-best-pharmaceuticals-for-children-ac]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2854]]></id>
		<title><![CDATA[Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/recommendations-for-evaluating-donor-eligibility-using-individual-risk-based-questions-to-reduce-the-risk-of-human-immunodeficiency-virus-transmission-by-blood-and-blood-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/164829/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[recommendations-for-evaluating-donor-eligibility-using-individual-risk-based-questions-to-reduce-the-risk-of-human-immunodeficiency-virus-transmission-by-blood-and-blood-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2855]]></id>
		<title><![CDATA[Q9(R1) Quality Risk Management]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/q9r1-quality-risk-management/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Quality]]></domain>
		<url><![CDATA[https://www.fda.gov/media/167721/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[q9r1-quality-risk-management]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2856]]></id>
		<title><![CDATA[Assessing User Fees Under the Prescription Drug User Fee Amendments of 2022]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/assessing-user-fees-under-the-prescription-drug-user-fee-amendments-of-2022/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/167877/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[assessing-user-fees-under-the-prescription-drug-user-fee-amendments-of-2022]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2857]]></id>
		<title><![CDATA[Decentralized Clinical Trials for Drugs, Biological Products, and Devices (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/decentralized-clinical-trials-for-drugs-biological-products-and-devices-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/167696/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[decentralized-clinical-trials-for-drugs-biological-products-and-devices-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2858]]></id>
		<title><![CDATA[Smoking Cessation and Related Indications: Developing Nicotine Replacement Therapy]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/smoking-cessation-and-related-indications-developing-nicotine-replacement-therapy/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/167599/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[smoking-cessation-and-related-indications-developing-nicotine-replacement-therapy]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2859]]></id>
		<title><![CDATA[S12 Nonclinical Biodistribution Considerations for Gene Therapy Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/s12-nonclinical-biodistribution-considerations-for-gene-therapy-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230501]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.fda.gov/media/167605/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[s12-nonclinical-biodistribution-considerations-for-gene-therapy-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2860]]></id>
		<title><![CDATA[Intellectual property: harmonised EU patent rules boost innovation, investment, and competitiveness in the Single Market]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/intellectual-property-harmonised-eu-patent-rules-boost-innovation-investment-and-competitiveness-in-the-single-market/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20230427]]></date_2>
		<product_type><![CDATA[Patents]]></product_type>
		<domain><![CDATA[Intellectual property (IP)]]></domain>
		<url><![CDATA[https://ec.europa.eu/commission/presscorner/detail/en/ip_23_2454]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[intellectual-property-harmonised-eu-patent-rules-boost-innovation-investment-and-competitiveness-in-the-single-market]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2861]]></id>
		<title><![CDATA[Concept paper on revision of the guideline on clinical investigation of medicinal products in the treatment of patients with acute respiratory distress syndrome]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/concept-paper-on-revision-of-the-guideline-on-clinical-investigation-of-medicinal-products-in-the-treatment-of-patients-with-acute-respiratory-distress-syndrome/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230426]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-revision-guideline-clinical-investigation-medicinal-products-treatment-patients-acute_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[concept-paper-on-revision-of-the-guideline-on-clinical-investigation-of-medicinal-products-in-the-treatment-of-patients-with-acute-respiratory-distress-syndrome]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2862]]></id>
		<title><![CDATA[Harmonized bioequivalence guideline paves the way for global generic medicine development and access to medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/harmonized-bioequivalence-guideline-paves-the-way-for-global-generic-medicine-development-and-access-to-medicines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230426]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.medicinesforeurope.com/wp-content/uploads/2023/04/BIOEQ23-PR_20230426_FV.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[harmonized-bioequivalence-guideline-paves-the-way-for-global-generic-medicine-development-and-access-to-medicines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2863]]></id>
		<title><![CDATA[Commission proposes pharmaceuticals reform for more accessible, affordable and innovative medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/commission-proposes-pharmaceuticals-reform-for-more-accessible-affordable-and-innovative-medicines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20230426]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://ec.europa.eu/commission/presscorner/detail/en/ip_23_1843]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[commission-proposes-pharmaceuticals-reform-for-more-accessible-affordable-and-innovative-medicines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2864]]></id>
		<title><![CDATA[Medical Product Alert N°4/2023: Substandard (contaminated) syrup medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/medical-product-alert-n4-2023-substandard-contaminated-syrup-medicines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[World Health Organization]]></health_authority>
		<date_2><![CDATA[20230425]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.who.int/news/item/25-04-2023-medical-product-alert-n-4-2023–substandard-(contaminated)-syrup-medicines]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[medical-product-alert-n4-2023-substandard-contaminated-syrup-medicines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2865]]></id>
		<title><![CDATA[Product-Specific Guidance Meetings Between the Food and Drug Administration and Abbreviated New Drug Applicants Under the Generic Drug User Fee Act (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/product-specific-guidance-meetings-between-the-food-and-drug-administration-and-abbreviated-new-drug-applicants-under-the-generic-drug-user-fee-act-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230424]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.regulations.gov/document/FDA-2023-D-0044-0001]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[product-specific-guidance-meetings-between-the-food-and-drug-administration-and-abbreviated-new-drug-applicants-under-the-generic-drug-user-fee-act-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2866]]></id>
		<title><![CDATA[Single-arm trials as pivotal evidence for the authorization of medicines in the EU]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/single-arm-trials-as-pivotal-evidence-for-the-authorization-of-medicines-in-the-eu/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230421]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/single-arm-trials-pivotal-evidence-authorisation-medicines-eu]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[single-arm-trials-as-pivotal-evidence-for-the-authorization-of-medicines-in-the-eu]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2867]]></id>
		<title><![CDATA[Best Practice Guidance for the Submission of Technical Documentation under Annex II and III of Medical Device Regulation (EU) 2017/745]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/best-practice-guidance-for-the-submission-of-technical-documentation-under-annex-ii-and-iii-of-medical-device-regulation-eu-2017-745/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20230419]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.team-nb.org/wp-content/uploads/members/M2023/Team-NB-PositionPaper-BPG-TechnicalDocEU-MDR-2017-745-V2-20230419.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[best-practice-guidance-for-the-submission-of-technical-documentation-under-annex-ii-and-iii-of-medical-device-regulation-eu-2017-745]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2868]]></id>
		<title><![CDATA[data.ansm: An online platform to learn more about adverse drug reactions and stock-outs]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/data-ansm-an-online-platform-to-learn-more-about-adverse-drug-reactions-and-stock-outs/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[France]]></country_region>
		<health_authority><![CDATA[French National Agency for the Safety of Medicines and Health Products]]></health_authority>
		<date_2><![CDATA[20230419]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://ansm.sante.fr/actualites/data-ansm-une-plateforme-en-ligne-pour-en-savoir-plus-sur-les-effets-indesirables-des-medicaments-et-les-ruptures-de-stock]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[data-ansm-an-online-platform-to-learn-more-about-adverse-drug-reactions-and-stock-outs]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2869]]></id>
		<title><![CDATA[New developments in regulatory QSAR modeling: a new QSAR model for predicting blood brain barrier permeability]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-developments-in-regulatory-qsar-modeling-a-new-qsar-model-for-predicting-blood-brain-barrier-permeability/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230419]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/drugs/regulatory-science-action/new-developments-regulatory-qsar-modeling-new-qsar-model-predicting-blood-brain-barrier-permeability]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-developments-in-regulatory-qsar-modeling-a-new-qsar-model-for-predicting-blood-brain-barrier-permeability]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2870]]></id>
		<title><![CDATA[Coronavirus (COVID-19) Update: FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/coronavirus-covid-19-update-fda-authorizes-changes-to-simplify-use-of-bivalent-mrna-covid-19-vaccines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230418]]></date_2>
		<product_type><![CDATA[Vaccine]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-changes-simplify-use-bivalent-mrna-covid-19-vaccines]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[coronavirus-covid-19-update-fda-authorizes-changes-to-simplify-use-of-bivalent-mrna-covid-19-vaccines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2871]]></id>
		<title><![CDATA[Industry consultation on Electronic Common Technical Document (eCTD) implementation in Singapore]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/industry-consultation-on-electronic-common-technical-document-ectd-implementation-in-singapore/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Singapore]]></country_region>
		<health_authority><![CDATA[Health Sciences Authority]]></health_authority>
		<date_2><![CDATA[20230417]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.hsa.gov.sg/announcements/regulatory-updates/industry-consultation-on-electronic-common-technical-document-(ectd)-implementation-in-singapore]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[industry-consultation-on-electronic-common-technical-document-ectd-implementation-in-singapore]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2872]]></id>
		<title><![CDATA[Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters – Premarket Notification (510(k)) Submissions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/peripheral-percutaneous-transluminal-angioplasty-pta-and-specialty-catheters-premarket-notification-510k-submissions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230414]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/134016/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[peripheral-percutaneous-transluminal-angioplasty-pta-and-specialty-catheters-premarket-notification-510k-submissions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2873]]></id>
		<title><![CDATA[Announcements on clinical trials with medical devices and performance studies with vitro diagnostic medical devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/announcements-on-clinical-trials-with-medical-devices-and-performance-studies-with-vitro-diagnostic-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230413]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/medical-devices/overview-medical-devices/mitteilung-klv-und-leistungsstudien-ivd.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[announcements-on-clinical-trials-with-medical-devices-and-performance-studies-with-vitro-diagnostic-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2874]]></id>
		<title><![CDATA[FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fda-updates-prescribing-information-for-all-opioid-pain-medicines-to-provide-additional-guidance-for-safe-use/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230413]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-prescribing-information-all-opioid-pain-medicines-provide-additional-guidance-safe-use]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fda-updates-prescribing-information-for-all-opioid-pain-medicines-to-provide-additional-guidance-for-safe-use]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2875]]></id>
		<title><![CDATA[EPA Proposes New Standards to Protect Public Health, Reduce Exposure to Ethylene Oxide Pollution]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/epa-proposes-new-standards-to-protect-public-health-reduce-exposure-to-ethylene-oxide-pollution/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230411]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.epa.gov/newsreleases/epa-proposes-new-standards-protect-public-health-reduce-exposure-ethylene-oxide]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[epa-proposes-new-standards-to-protect-public-health-reduce-exposure-to-ethylene-oxide-pollution]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2876]]></id>
		<title><![CDATA[Food and Drug Administration Data and Technology Strategic Plan; Request for Information and Comments]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/food-and-drug-administration-data-and-technology-strategic-plan-request-for-information-and-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230410]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://public-inspection.federalregister.gov/2023-07766.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[food-and-drug-administration-data-and-technology-strategic-plan-request-for-information-and-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2877]]></id>
		<title><![CDATA[Software and Artificial Intelligence (AI) as a Medical Device]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/software-and-artificial-intelligence-ai-as-a-medical-device/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230406]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/software-and-artificial-intelligence-ai-as-a-medical-device/software-and-artificial-intelligence-ai-as-a-medical-device]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[software-and-artificial-intelligence-ai-as-a-medical-device]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2878]]></id>
		<title><![CDATA[Dual labelled medicines begin transition to sole medicine ingredient names soon]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/dual-labelled-medicines-begin-transition-to-sole-medicine-ingredient-names-soon/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230405]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/dual-labelled-medicines-begin-transition-sole-medicine-ingredient-names-soon]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[dual-labelled-medicines-begin-transition-to-sole-medicine-ingredient-names-soon]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2879]]></id>
		<title><![CDATA[New features further strengthen Priority Medicines scheme (PRIME)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-features-further-strengthen-priority-medicines-scheme-prime/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230404]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/new-features-further-strengthen-priority-medicines-scheme-prime]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-features-further-strengthen-priority-medicines-scheme-prime]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2880]]></id>
		<title><![CDATA[Post Market Surveillance National Competent Authority Report Exchange Criteria and Report Form]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/post-market-surveillance-national-competent-authority-report-exchange-criteria-and-report-form/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Medical Device Regulators Forum]]></health_authority>
		<date_2><![CDATA[20230404]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.imdrf.org/sites/default/files/2023-04/IMDRF%20NCAR%20WG%20N14Final%202023_edition4.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[post-market-surveillance-national-competent-authority-report-exchange-criteria-and-report-form]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2881]]></id>
		<title><![CDATA[An Analysis of Deficiencies Observed During On-Site Good Manufacturing Practice (GMP) Inspections of Local and Foreign Manufacturing Premise of Medicinal Registered Products in the Year 2022]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/an-analysis-of-deficiencies-observed-during-on-site-good-manufacturing-practice-gmp-inspections-of-local-and-foreign-manufacturing-premise-of-medicinal-registered-products-in-the-year-2022/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[National Pharmaceutical Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230404]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.npra.gov.my/index.php/en/component/content/article/436-english/announcement-main/announcement-2023/1527480-an-analysis-of-deficiencies-observed-during-on-site-good-manufacturing-practice-gmp-inspections-of-local-and-foreign-manufacturing-premise-of-medicinal-registered-products-in-the-year-2023.html?Itemid=1391]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[an-analysis-of-deficiencies-observed-during-on-site-good-manufacturing-practice-gmp-inspections-of-local-and-foreign-manufacturing-premise-of-medicinal-registered-products-in-the-year-2022]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2882]]></id>
		<title><![CDATA[Publishes Tolerances for Deltamethrin on Various Agricultural Commodities]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/publishes-tolerances-for-deltamethrin-on-various-agricultural-commodities/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Environmental Protection Agency]]></health_authority>
		<date_2><![CDATA[20230404]]></date_2>
		<product_type><![CDATA[Food & Food Supplement]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.govinfo.gov/content/pkg/FR-2023-04-04/pdf/2023-06939.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[publishes-tolerances-for-deltamethrin-on-various-agricultural-commodities]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2883]]></id>
		<title><![CDATA[Health Technology Assessment Policy and Methods Review Consultation 1 Survey Questions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/health-technology-assessment-policy-and-methods-review-consultation-1-survey-questions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://ohta-consultations.health.gov.au/ohta/hta-review-consultation1/supporting_documents/HTA%20Review%20Consultation%201%20Survey%20Questions.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[health-technology-assessment-policy-and-methods-review-consultation-1-survey-questions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2884]]></id>
		<title><![CDATA[Clinical Trial Highlights]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/clinical-trial-highlights/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/newsletter/clinical-trials-highlights-april-2023_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[clinical-trial-highlights]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2885]]></id>
		<title><![CDATA[Personalized Medical Devices – Production Verification and Validation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/personalized-medical-devices-production-verification-and-validation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Medical Device Regulators Forum]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.imdrf.org/sites/default/files/2023-04/IMDRF%20Personalised%20Medical%20Devices%20WG%20N74%20FINAL%20%202023.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[personalized-medical-devices-production-verification-and-validation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2886]]></id>
		<title><![CDATA[Principles and Practices for the Cybersecurity of Legacy Medical Devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/principles-and-practices-for-the-cybersecurity-of-legacy-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Medical Device Regulators Forum]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.imdrf.org/sites/default/files/2023-04/IMDRF%20Principles%20and%20Practices%20of%20Cybersecurity%20for%20%20Legacy%20Medical%20Devices%20Final%20%28N70%29_0.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[principles-and-practices-for-the-cybersecurity-of-legacy-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2887]]></id>
		<title><![CDATA[Principles and Practices for Software Bill of Materials for Medical Device Cybersecurity]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/principles-and-practices-for-software-bill-of-materials-for-medical-device-cybersecurity/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Medical Device Regulators Forum]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.imdrf.org/sites/default/files/2023-04/Principles%20and%20Practices%20for%20Software%20Bill%20of%20Materials%20for%20Medical%20Device%20Cybersecurity%20%28N73%29.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[principles-and-practices-for-software-bill-of-materials-for-medical-device-cybersecurity]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2888]]></id>
		<title><![CDATA[Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk M7(R2)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/assessment-and-control-of-dna-reactive-mutagenic-impurities-in-pharmaceuticals-to-limit-potential-carcinogenic-risk-m7r2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Council for Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://database.ich.org/sites/default/files/ICH_M7%28R2%29_Guideline_Step4_2023_0216_0.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[assessment-and-control-of-dna-reactive-mutagenic-impurities-in-pharmaceuticals-to-limit-potential-carcinogenic-risk-m7r2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2889]]></id>
		<title><![CDATA[Application of the principles of the ICH M7 guideline to calculation of compound-specific acceptable intakes – Addendum to M7(R2)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/application-of-the-principles-of-the-ich-m7-guideline-to-calculation-of-compound-specific-acceptable-intakes-addendum-to-m7r2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Council for Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://database.ich.org/sites/default/files/ICH_M7%28R2%29_Addendum_Step4_2023_0216.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[application-of-the-principles-of-the-ich-m7-guideline-to-calculation-of-compound-specific-acceptable-intakes-addendum-to-m7r2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2890]]></id>
		<title><![CDATA[Guideline on electronic labelling (E-LABELLING) for pharmaceutical products in malaysia]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guideline-on-electronic-labelling-e-labelling-for-pharmaceutical-products-in-malaysia/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[National Pharmaceutical Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://npra.gov.my/easyarticles/images/users/1047/Lampiran-A-Guideline-on-E-Labelling-for-Pharmaceutical-Products-in-Malaysia.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guideline-on-electronic-labelling-e-labelling-for-pharmaceutical-products-in-malaysia]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2891]]></id>
		<title><![CDATA[Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/marketing-submission-recommendations-for-a-predetermined-change-control-plan-for-artificial-intelligence-machine-learning-ai-ml-enabled-device-software-functions-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166704/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[marketing-submission-recommendations-for-a-predetermined-change-control-plan-for-artificial-intelligence-machine-learning-ai-ml-enabled-device-software-functions-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2892]]></id>
		<title><![CDATA[Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions (draft guidance]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/marketing-submission-recommendations-for-a-predetermined-change-control-plan-for-artificial-intelligence-machine-learning-ai-ml-enabled-device-software-functions-draft-guidance-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166704/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[marketing-submission-recommendations-for-a-predetermined-change-control-plan-for-artificial-intelligence-machine-learning-ai-ml-enabled-device-software-functions-draft-guidance-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2893]]></id>
		<title><![CDATA[Mpox: Development of Drugs and Biological Products (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mpox-development-of-drugs-and-biological-products-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230403]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/164642/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mpox-development-of-drugs-and-biological-products-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2894]]></id>
		<title><![CDATA[Guidelines on the Regulatory Flexibility for Class B, C and D Medical Devices that are Not Included in the List of Registrable Medical Devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidelines-on-the-regulatory-flexibility-for-class-b-c-and-d-medical-devices-that-are-not-included-in-the-list-of-registrable-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20230401]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/fda-circular-no-2021-002-c-guidelines-on-the-regulatory-flexibility-for-class-b-c-and-d-medical-devices/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidelines-on-the-regulatory-flexibility-for-class-b-c-and-d-medical-devices-that-are-not-included-in-the-list-of-registrable-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2895]]></id>
		<title><![CDATA[Acute Radiation Syndrome: Developing Drugs for Prevention and Treatment (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/acute-radiation-syndrome-developing-drugs-for-prevention-and-treatment-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230401]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/167172/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[acute-radiation-syndrome-developing-drugs-for-prevention-and-treatment-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2896]]></id>
		<title><![CDATA[Over-the-Counter Monograph Order Requests (OMORs): Format and Content (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/over-the-counter-monograph-order-requests-omors-format-and-content-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230401]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/167035/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[over-the-counter-monograph-order-requests-omors-format-and-content-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2897]]></id>
		<title><![CDATA[Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/assessing-the-irritation-and-sensitization-potential-of-transdermal-and-topical-delivery-systems-for-andas-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230401]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/167073/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[assessing-the-irritation-and-sensitization-potential-of-transdermal-and-topical-delivery-systems-for-andas-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2898]]></id>
		<title><![CDATA[Assessing Adhesion with Transdermal and Topical Delivery (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/assessing-adhesion-with-transdermal-and-topical-delivery-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230401]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/167043/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[assessing-adhesion-with-transdermal-and-topical-delivery-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2899]]></id>
		<title><![CDATA[A Risk-Based Approach to Monitoring of Clinical Investigations]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/a-risk-based-approach-to-monitoring-of-clinical-investigations/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230401]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/121479/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[a-risk-based-approach-to-monitoring-of-clinical-investigations]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2900]]></id>
		<title><![CDATA[Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Under Section 506C of the FD&C Act (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/notifying-fda-of-a-discontinuance-or-interruption-in-manufacturing-of-finished-products-or-active-pharmaceutical-ingredients-under-section-506c-of-the-fdc-act-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230401]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166837/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[notifying-fda-of-a-discontinuance-or-interruption-in-manufacturing-of-finished-products-or-active-pharmaceutical-ingredients-under-section-506c-of-the-fdc-act-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2901]]></id>
		<title><![CDATA[Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision-Making (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/patient-focused-drug-development-incorporating-clinical-outcome-assessments-into-endpoints-for-regulatory-decision-making-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230401]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166830/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[patient-focused-drug-development-incorporating-clinical-outcome-assessments-into-endpoints-for-regulatory-decision-making-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2902]]></id>
		<title><![CDATA[Regulatory information – adjusted fees for applications to EMA from 1 April 2023]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/regulatory-information-adjusted-fees-for-applications-to-ema-from-1-april-2023/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230331]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/regulatory-information-adjusted-fees-applications-ema-1-april-2023]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[regulatory-information-adjusted-fees-for-applications-to-ema-from-1-april-2023]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2903]]></id>
		<title><![CDATA[Guideline on influenza vaccines – submission and procedural requirements]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guideline-on-influenza-vaccines-submission-and-procedural-requirements/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230330]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-influenza-vaccines-submission-procedural-requirements-rev2_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guideline-on-influenza-vaccines-submission-and-procedural-requirements]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2904]]></id>
		<title><![CDATA[EMA GCP IWG points to consider regarding the management of ongoing clinical trials impacted by political conflicts, natural disasters, or other major disruptions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ema-gcp-iwg-points-to-consider-regarding-the-management-of-ongoing-clinical-trials-impacted-by-political-conflicts-natural-disasters-or-other-major-disruptions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230330]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/other/ema-gcp-iwg-points-consider-regarding-management-ongoing-clinical-trials-impacted-political_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ema-gcp-iwg-points-to-consider-regarding-the-management-of-ongoing-clinical-trials-impacted-by-political-conflicts-natural-disasters-or-other-major-disruptions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2905]]></id>
		<title><![CDATA[Questions and answers on data requirements when replacing hydrofluorocarbons as propellants in oral pressurized metered dose inhalers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/questions-and-answers-on-data-requirements-when-replacing-hydrofluorocarbons-as-propellants-in-oral-pressurized-metered-dose-inhalers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20230330]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-data-requirements-when-replacing-hydrofluorocarbons-propellants-oral-pressurised_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[questions-and-answers-on-data-requirements-when-replacing-hydrofluorocarbons-as-propellants-in-oral-pressurized-metered-dose-inhalers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2906]]></id>
		<title><![CDATA[Medical Device Development Tools (MDDT)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/medical-device-development-tools-mddt/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230330]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/medical-device-development-tools-mddt]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[medical-device-development-tools-mddt]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2907]]></id>
		<title><![CDATA[Cybersecurity in Medical Devices: Refuse to Accept Policy for Cyber Devices and Related Systems Under Section 524B of the FD&C Act]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cybersecurity-in-medical-devices-refuse-to-accept-policy-for-cyber-devices-and-related-systems-under-section-524b-of-the-fdc-act/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230330]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166614/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cybersecurity-in-medical-devices-refuse-to-accept-policy-for-cyber-devices-and-related-systems-under-section-524b-of-the-fdc-act]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2908]]></id>
		<title><![CDATA[Substitution of in-vivo Method(s) by in-vitro Method(s) for the Quality Control of Vaccines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/substitution-of-in-vivo-methods-by-in-vitro-methods-for-the-quality-control-of-vaccines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Indian Pharmacopoeia Commission]]></health_authority>
		<date_2><![CDATA[20230329]]></date_2>
		<product_type><![CDATA[Vaccine]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ipc.gov.in/images/Substitution_of_invivo_methods_by_invitro_methods_dated_29-03-23.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[substitution-of-in-vivo-methods-by-in-vitro-methods-for-the-quality-control-of-vaccines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2909]]></id>
		<title><![CDATA[MDR/IVDR amendment: Equivalence with EU Regulation on Medical Devices ensured]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mdr-ivdr-amendment-equivalence-with-eu-regulation-on-medical-devices-ensured/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230329]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/medical-devices/market-access/abgelaufene_bescheinigungen.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mdr-ivdr-amendment-equivalence-with-eu-regulation-on-medical-devices-ensured]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2910]]></id>
		<title><![CDATA[Orthopedic Non-Spinal Bone Plates, Screws, and Washers – Premarket Notification (510(k)) Submissions (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/orthopedic-non-spinal-bone-plates-screws-and-washers-premarket-notification-510k-submissions-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230329]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166507/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[orthopedic-non-spinal-bone-plates-screws-and-washers-premarket-notification-510k-submissions-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2911]]></id>
		<title><![CDATA[Extension of CE certificates]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/extension-of-ce-certificates/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230328]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/extension-of-ce-certificates]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[extension-of-ce-certificates]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2912]]></id>
		<title><![CDATA[General Considerations for Animal Studies Intended to Evaluate Medical Devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/general-considerations-for-animal-studies-intended-to-evaluate-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230328]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.fda.gov/media/93963/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[general-considerations-for-animal-studies-intended-to-evaluate-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2913]]></id>
		<title><![CDATA[Findings on manufacturers failing to meet post market surveillance requirements]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/findings-on-manufacturers-failing-to-meet-post-market-surveillance-requirements/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230327]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/medical-devices/market-surveillance-of-medical-devices/announcements-on-market-control-issues.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[findings-on-manufacturers-failing-to-meet-post-market-surveillance-requirements]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2914]]></id>
		<title><![CDATA[Update on In-Person Face-to-Face ANDA Meetings]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/update-on-in-person-face-to-face-anda-meetings/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230327]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/industry/generic-drug-user-fee-amendments/update-person-face-face-anda-meetings?utm_medium=email&utm_source=govdelivery]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[update-on-in-person-face-to-face-anda-meetings]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2915]]></id>
		<title><![CDATA[Transition Plan for Medical Devices That Fall Within Enforcement Policies Issued During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/transition-plan-for-medical-devices-that-fall-within-enforcement-policies-issued-during-the-coronavirus-disease-2019-covid-19-public-health-emergency/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230327]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/155038/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[transition-plan-for-medical-devices-that-fall-within-enforcement-policies-issued-during-the-coronavirus-disease-2019-covid-19-public-health-emergency]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2916]]></id>
		<title><![CDATA[Transition Plan for Medical Devices Issued Emergency Use Authorizations (EUAs) Related to Coronavirus Disease 2019 (COVID-19)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/transition-plan-for-medical-devices-issued-emergency-use-authorizations-euas-related-to-coronavirus-disease-2019-covid-19/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230327]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/155039/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[transition-plan-for-medical-devices-issued-emergency-use-authorizations-euas-related-to-coronavirus-disease-2019-covid-19]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2917]]></id>
		<title><![CDATA[TGA’s new powers will help reduce the impact of medicine shortages on patients]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/tgas-new-powers-will-help-reduce-the-impact-of-medicine-shortages-on-patients/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230324]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/tgas-new-powers-will-help-reduce-impact-medicine-shortages-patients]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[tgas-new-powers-will-help-reduce-the-impact-of-medicine-shortages-on-patients]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2918]]></id>
		<title><![CDATA[Withdrawal of medical device registration (new and re-register) and change of notification application]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/withdrawal-of-medical-device-registration-new-and-re-register-and-change-of-notification-application/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[Medical Device Authority]]></health_authority>
		<date_2><![CDATA[20230323]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://portal.mda.gov.my/announcement/1168-withdrawal-of-medical-device-registration-new-and-re-register-and-change-of-notification-application.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[withdrawal-of-medical-device-registration-new-and-re-register-and-change-of-notification-application]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2919]]></id>
		<title><![CDATA[Consultation outcome – Government response to consultation on legislative proposals for clinical trials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/consultation-outcome-government-response-to-consultation-on-legislative-proposals-for-clinical-trials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230321]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.gov.uk/government/consultations/consultation-on-proposals-for-legislative-changes-for-clinical-trials/outcome/government-response-to-consultation-on-legislative-proposals-for-clinical-trials#summary-and-evaluation-of-responses]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[consultation-outcome-government-response-to-consultation-on-legislative-proposals-for-clinical-trials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2920]]></id>
		<title><![CDATA[MHRA to streamline clinical trial approvals in biggest overhaul of trial regulation in 20 years]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mhra-to-streamline-clinical-trial-approvals-in-biggest-overhaul-of-trial-regulation-in-20-years/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230321]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/mhra-to-streamline-clinical-trial-approvals-in-biggest-overhaul-of-trial-regulation-in-20-years#%5D]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mhra-to-streamline-clinical-trial-approvals-in-biggest-overhaul-of-trial-regulation-in-20-years]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2921]]></id>
		<title><![CDATA[GMP Clearance: Additional countries added to MRA pathway]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/gmp-clearance-additional-countries-added-to-mra-pathway/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230320]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/notices/gmp-clearance-additional-countries-added-mra-pathway]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[gmp-clearance-additional-countries-added-to-mra-pathway]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2922]]></id>
		<title><![CDATA[Request for an update of the guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates, which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/request-for-an-update-of-the-guidelines-on-the-benefit-risk-assessment-of-the-presence-of-phthalates-in-certain-medical-devices-covering-phthalates-which-are-carcinogenic-mutagenic-toxic-to-reprodu/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230320]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-03/scheer_q_027.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[request-for-an-update-of-the-guidelines-on-the-benefit-risk-assessment-of-the-presence-of-phthalates-in-certain-medical-devices-covering-phthalates-which-are-carcinogenic-mutagenic-toxic-to-reprodu]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2923]]></id>
		<title><![CDATA[Topiramate: Neurodevelopmental disorders in children exposed to topiramate during pregnancy]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/topiramate-neurodevelopmental-disorders-in-children-exposed-to-topiramate-during-pregnancy/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[National Pharmaceutical Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230317]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://npra.gov.my/index.php/en/component/content/article/449-english/safety-alerts-main/safety-alerts-2023/1527474-topiramate-neurodevelopmental-disorders-in-children-exposed-to-topiramate-during-pregnancy.html?Itemid=1391]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[topiramate-neurodevelopmental-disorders-in-children-exposed-to-topiramate-during-pregnancy]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2924]]></id>
		<title><![CDATA[ANMAT signed a Memorandum of Understanding with the United States Pharmacopoeia]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/anmat-signed-a-memorandum-of-understanding-with-the-united-states-pharmacopoeia/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Argentina]]></country_region>
		<health_authority><![CDATA[ANMAT]]></health_authority>
		<date_2><![CDATA[20230316]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.argentina.gob.ar/noticias/anmat-firmo-un-memorandum-de-entendimiento-con-la-farmacopea-de-estados-unidos]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[anmat-signed-a-memorandum-of-understanding-with-the-united-states-pharmacopoeia]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2925]]></id>
		<title><![CDATA[Pharmacogenomic Data Submissions (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/pharmacogenomic-data-submissions-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230316]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166258/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[pharmacogenomic-data-submissions-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2926]]></id>
		<title><![CDATA[ICH Q9(R1): Quality Risk Management]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ich-q9r1-quality-risk-management/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Council for Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use]]></health_authority>
		<date_2><![CDATA[20230314]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Quality]]></domain>
		<url><![CDATA[https://database.ich.org/sites/default/files/ICH%20Q9R1_Step_4_Presentation_2023_0314_final.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ich-q9r1-quality-risk-management]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2927]]></id>
		<title><![CDATA[Declaration of Worldwide Registration Status for Generic Medicines in QUEST System]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/declaration-of-worldwide-registration-status-for-generic-medicines-in-quest-system/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[National Pharmaceutical Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230313]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.npra.gov.my/index.php/en/component/content/article/436-english/announcement-main/announcement-2023/1527472-declaration-of-worldwide-registration-status-for-generic-medicines-in-quest-system.html?Itemid=1391]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[declaration-of-worldwide-registration-status-for-generic-medicines-in-quest-system]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2928]]></id>
		<title><![CDATA[Evaluation of Gastric pH Dependent Drug Interactions with Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/evaluation-of-gastric-ph-dependent-drug-interactions-with-acid-reducing-agents-study-design-data-analysis-and-clinical-implications/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230310]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/regulatory-information/search-fda-guidance-documents/evaluation-gastric-ph-dependent-drug-interactions-acid-reducing-agents-study-design-data-analysis]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[evaluation-of-gastric-ph-dependent-drug-interactions-with-acid-reducing-agents-study-design-data-analysis-and-clinical-implications]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2929]]></id>
		<title><![CDATA[Guideline on computerized systems and electronic data in clinical trials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guideline-on-computerized-systems-and-electronic-data-in-clinical-trials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230309]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/guideline-computerised-systems-electronic-data-clinical-trials_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guideline-on-computerized-systems-and-electronic-data-in-clinical-trials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2930]]></id>
		<title><![CDATA[Amendment of Regulation (EU) 2017/745 of the European Parliament and of the Council as regards the frequency of complete re-assessments of notified bodies (MDR)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/amendment-of-regulation-eu-2017-745-of-the-european-parliament-and-of-the-council-as-regards-the-frequency-of-complete-re-assessments-of-notified-bodies-mdr/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230308]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2023.070.01.0001.01.ENG&toc=OJ%3AL%3A2023%3A070%3ATOC]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[amendment-of-regulation-eu-2017-745-of-the-european-parliament-and-of-the-council-as-regards-the-frequency-of-complete-re-assessments-of-notified-bodies-mdr]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2931]]></id>
		<title><![CDATA[Amendment of Regulation (EU) 2017/746 of the European Parliament and of the Council as regards the frequency of complete re-assessments of notified bodies (IVDR)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/amendment-of-regulation-eu-2017-746-of-the-european-parliament-and-of-the-council-as-regards-the-frequency-of-complete-re-assessments-of-notified-bodies-ivdr/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230308]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2023.070.01.0003.01.ENG&toc=OJ%3AL%3A2023%3A070%3ATOC]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[amendment-of-regulation-eu-2017-746-of-the-european-parliament-and-of-the-council-as-regards-the-frequency-of-complete-re-assessments-of-notified-bodies-ivdr]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2932]]></id>
		<title><![CDATA[Classification of rehabilitation, physiotherapy, and speech therapy device]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/classification-of-rehabilitation-physiotherapy-and-speech-therapy-device/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[Medical Device Authority]]></health_authority>
		<date_2><![CDATA[20230308]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://portal.mda.gov.my/doclink/classification-of-rehabilitation-physiotherapy-and-speech-therapy-devices-second-edition-pdf/eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWIiOiJjbGFzc2lmaWNhdGlvbi1vZi1yZWhhYmlsaXRhdGlvbi1waHlzaW90aGVyYXB5LWFuZC1zcGVlY2gtdGhlcmFweS1kZXZpY2VzLXNlY29uZC1lZGl0aW9uLXBkZiIsImlhdCI6MTY3ODMyOTExMiwiZXhwIjoxNjc4NDE1NTEyfQ.drD7nzpn6a12rRFLpsCqxFyhYNbScPA_x0vxgePpejo]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[classification-of-rehabilitation-physiotherapy-and-speech-therapy-device]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2933]]></id>
		<title><![CDATA[Council takes action to mitigate risk of medical devices shortage y extending the MDR deadlines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/council-takes-action-to-mitigate-risk-of-medical-devices-shortage-y-extending-the-mdr-deadlines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230307]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.consilium.europa.eu/en/press/press-releases/2023/03/07/council-takes-action-to-mitigate-risk-of-medical-devices-shortage/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[council-takes-action-to-mitigate-risk-of-medical-devices-shortage-y-extending-the-mdr-deadlines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2934]]></id>
		<title><![CDATA[Questions and Answers about the raw data proof-of-concept pilot for industry]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/questions-and-answers-about-the-raw-data-proof-of-concept-pilot-for-industry/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230307]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/other/questions-answers-about-raw-data-proof-concept-pilot-industry_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[questions-and-answers-about-the-raw-data-proof-of-concept-pilot-for-industry]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2935]]></id>
		<title><![CDATA[Update to the Life Sciences Council Joint Statement on Medical Devices Regulatory Reform]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/update-to-the-life-sciences-council-joint-statement-on-medical-devices-regulatory-reform/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230307]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/advisory-group-reform-proposals]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[update-to-the-life-sciences-council-joint-statement-on-medical-devices-regulatory-reform]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2936]]></id>
		<title><![CDATA[Nitrosamine Impurities: Latest USP Tool Further Aids Understanding and Control]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/nitrosamine-impurities-latest-usp-tool-further-aids-understanding-and-control/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230307]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://qualitymatters.usp.org/nitrosamine-impurities-latest-usp-tool-further-aids-understanding-and-control]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[nitrosamine-impurities-latest-usp-tool-further-aids-understanding-and-control]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2937]]></id>
		<title><![CDATA[Guidelines on Regulatory Reliance on the Conduct of Clinical Trials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidelines-on-regulatory-reliance-on-the-conduct-of-clinical-trials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20230306]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/fda-circular-no-2023-004-guidelines-on-regulatory-reliance-on-the-conduct-of-clinical-trials/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidelines-on-regulatory-reliance-on-the-conduct-of-clinical-trials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2938]]></id>
		<title><![CDATA[FDA Launches New Directory of Ingredients Used in Products Marketed as Dietary Supplements]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fda-launches-new-directory-of-ingredients-used-in-products-marketed-as-dietary-supplements/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230306]]></date_2>
		<product_type><![CDATA[Food & Food Supplement]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.fda.gov/food/cfsan-constituent-updates/fda-launches-new-directory-ingredients-used-products-marketed-dietary-supplements]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fda-launches-new-directory-of-ingredients-used-in-products-marketed-as-dietary-supplements]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2939]]></id>
		<title><![CDATA[Soft (Hydrophilic) Daily Wear Contact Lenses – Performance Criteria for Safety and Performance Based Pathway]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/soft-hydrophilic-daily-wear-contact-lenses-performance-criteria-for-safety-and-performance-based-pathway/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230304]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/135629/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[soft-hydrophilic-daily-wear-contact-lenses-performance-criteria-for-safety-and-performance-based-pathway]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2940]]></id>
		<title><![CDATA[European Pharmacopoeia Commission creates new Excipients Strategy Working Party]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/european-pharmacopoeia-commission-creates-new-excipients-strategy-working-party/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230303]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/european-pharmacopoeia-commission-creates-new-excipients-strategy-working-party]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[european-pharmacopoeia-commission-creates-new-excipients-strategy-working-party]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2941]]></id>
		<title><![CDATA[Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting Viral Pathogens; Draft Guidance for Industry]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/potency-assay-considerations-for-monoclonal-antibodies-and-other-therapeutic-proteins-targeting-viral-pathogens-draft-guidance-for-industry/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230302]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2023/03/02/2023-04267/potency-assay-considerations-for-monoclonal-antibodies-and-other-therapeutic-proteins-targeting]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[potency-assay-considerations-for-monoclonal-antibodies-and-other-therapeutic-proteins-targeting-viral-pathogens-draft-guidance-for-industry]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2942]]></id>
		<title><![CDATA[Expert decision and opinion in the context of the Clinical Evaluation Consultation Procedure (CECP)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/expert-decision-and-opinion-in-the-context-of-the-clinical-evaluation-consultation-procedure-cecp/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230301]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-03/cecp-2022-000225_opinion_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[expert-decision-and-opinion-in-the-context-of-the-clinical-evaluation-consultation-procedure-cecp]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2943]]></id>
		<title><![CDATA[WHO Good Manufacturing Practices for excipients used in pharmaceutical products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/who-good-manufacturing-practices-for-excipients-used-in-pharmaceutical-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[World Health Organization]]></health_authority>
		<date_2><![CDATA[20230301]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://cdn.who.int/media/docs/default-source/health-products-policy-and-standards/qas23_921_gmp_for_excipients_pharmaceutical_products_public-consultation.pdf?sfvrsn=c9ef88da_3]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[who-good-manufacturing-practices-for-excipients-used-in-pharmaceutical-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2944]]></id>
		<title><![CDATA[New Mobile technologies guidance document for human and veterinary medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:58]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-mobile-technologies-guidance-document-for-human-and-veterinary-medicinal-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20230301]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Packaging]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/authorisations/information/neue-wl-mobile-technologien-ham-tam.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-mobile-technologies-guidance-document-for-human-and-veterinary-medicinal-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:58]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2945]]></id>
		<title><![CDATA[Research Involving Children as Subjects and Not Otherwise Approvable by an IRB: Process for Referrals to FDA and OHRP (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/research-involving-children-as-subjects-and-not-otherwise-approvable-by-an-irb-process-for-referrals-to-fda-and-ohrp-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230301]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166731/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[research-involving-children-as-subjects-and-not-otherwise-approvable-by-an-irb-process-for-referrals-to-fda-and-ohrp-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2946]]></id>
		<title><![CDATA[Identification of Medicinal Products — Implementation and Use]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/identification-of-medicinal-products-implementation-and-use/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230301]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166736/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[identification-of-medicinal-products-implementation-and-use]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2947]]></id>
		<title><![CDATA[Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/clinical-trial-considerations-to-support-accelerated-approval-of-oncology-therapeutics-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230301]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166431/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[clinical-trial-considerations-to-support-accelerated-approval-of-oncology-therapeutics-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2948]]></id>
		<title><![CDATA[Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/definitions-of-suspect-product-and-illegitimate-product-for-verification-obligations-under-the-drug-supply-chain-security-act/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230301]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/111468/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[definitions-of-suspect-product-and-illegitimate-product-for-verification-obligations-under-the-drug-supply-chain-security-act]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2949]]></id>
		<title><![CDATA[Development of Local Anesthetic Drug Products with Prolonged Duration of Effect]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/development-of-local-anesthetic-drug-products-with-prolonged-duration-of-effect/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230301]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/166210/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[development-of-local-anesthetic-drug-products-with-prolonged-duration-of-effect]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2950]]></id>
		<title><![CDATA[Total Product Life Cycle Advisory Program (TAP)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/total-product-life-cycle-advisory-program-tap/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230301]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/how-study-and-market-your-device/total-product-life-cycle-advisory-program-tap]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[total-product-life-cycle-advisory-program-tap]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2951]]></id>
		<title><![CDATA[Discussion Paper: Artificial Intelligence in Drug Manufacturing, Notice; Request for Information and Comments]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/discussion-paper-artificial-intelligence-in-drug-manufacturing-notice-request-for-information-and-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230301]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-6-9-february-2023]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[discussion-paper-artificial-intelligence-in-drug-manufacturing-notice-request-for-information-and-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2952]]></id>
		<title><![CDATA[Notification of custom-made medical device]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/notification-of-custom-made-medical-device/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[Medical Device Authority]]></health_authority>
		<date_2><![CDATA[20230228]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://portal.mda.gov.my/doclink/notification-of-custom-made-medical-device-pdf/eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWIiOiJub3RpZmljYXRpb24tb2YtY3VzdG9tLW1hZGUtbWVkaWNhbC1kZXZpY2UtcGRmIiwiaWF0IjoxNjc3NjQ0Nzc0LCJleHAiOjE2Nzc3MzExNzR9.z_40MQIFtE_l_rKFt3XjY5yDmuq0d_U17_VtahVWmdo]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[notification-of-custom-made-medical-device]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2953]]></id>
		<title><![CDATA[CDER Continues to Advance Rare Disease Drug Development with New Efforts, Including the Accelerating Rare Disease Cures (ARC) Program]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cder-continues-to-advance-rare-disease-drug-development-with-new-efforts-including-the-accelerating-rare-disease-cures-arc-program/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230228]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/drugs/news-events-human-drugs/cder-continues-advance-rare-disease-drug-development-new-efforts-including-accelerating-rare-disease]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cder-continues-to-advance-rare-disease-drug-development-with-new-efforts-including-the-accelerating-rare-disease-cures-arc-program]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2954]]></id>
		<title><![CDATA[Windsor Framework unveiled to fix problems of the Northern Ireland Protocol]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/windsor-framework-unveiled-to-fix-problems-of-the-northern-ireland-protocol/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20230227]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/windsor-framework-unveiled-to-fix-problems-of-the-northern-ireland-protocol]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[windsor-framework-unveiled-to-fix-problems-of-the-northern-ireland-protocol]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2955]]></id>
		<title><![CDATA[Question and Answer on the submission of applications for the expert panels’ advice to manufacturers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/question-and-answer-on-the-submission-of-applications-for-the-expert-panels-advice-to-manufacturers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230222]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/other/question-answer-information-session-pilot-expert-panels-scientific-advice-manufacturers-high-risk_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[question-and-answer-on-the-submission-of-applications-for-the-expert-panels-advice-to-manufacturers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2956]]></id>
		<title><![CDATA[Questions and answers – Clinical Trials Information System (CTIS) and Clinical Trials Regulation (CTR)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/questions-and-answers-clinical-trials-information-system-ctis-and-clinical-trials-regulation-ctr/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230209]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/other/questions-answers-query-management-working-group-ctis-ctr_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[questions-and-answers-clinical-trials-information-system-ctis-and-clinical-trials-regulation-ctr]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2957]]></id>
		<title><![CDATA[IMDRF Terms of Reference]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/imdrf-terms-of-reference/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Medical Device Regulators Forum]]></health_authority>
		<date_2><![CDATA[20230207]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.imdrf.org/sites/default/files/2023-02/IMDRF%20Terms%20of%20Reference_2023%20%28N1%20ToR%29.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[imdrf-terms-of-reference]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2958]]></id>
		<title><![CDATA[Changes to medical device essential principles for nanomaterials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/changes-to-medical-device-essential-principles-for-nanomaterials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20230201]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/sites/default/files/essential-principles-checklist-medical-devices.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[changes-to-medical-device-essential-principles-for-nanomaterials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2959]]></id>
		<title><![CDATA[Surveying, Leveling, and Alignment Laser Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/surveying-leveling-and-alignment-laser-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230131]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/88325/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[surveying-leveling-and-alignment-laser-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2960]]></id>
		<title><![CDATA[Mexico proposes a Latin American Medicines Agency for health self-sufficiency]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mexico-proposes-a-latin-american-medicines-agency-for-health-self-sufficiency/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Mexico]]></country_region>
		<health_authority><![CDATA[COFEPRIS]]></health_authority>
		<date_2><![CDATA[20230125]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gob.mx/sre/en/articulos/mexico-proposes-a-latin-american-medicines-agency-for-health-self-sufficiency-324517]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mexico-proposes-a-latin-american-medicines-agency-for-health-self-sufficiency]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2961]]></id>
		<title><![CDATA[Gastroenterology-Urology Devices; Classification of the Computerized Behavioral Therapy Device for Treating Symptoms of Gastrointestinal Conditions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/gastroenterology-urology-devices-classification-of-the-computerized-behavioral-therapy-device-for-treating-symptoms-of-gastrointestinal-conditions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230120]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2023/01/20/2023-01048/medical-devices-gastroenterology-urology-devices-classification-of-the-computerized-behavioral]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[gastroenterology-urology-devices-classification-of-the-computerized-behavioral-therapy-device-for-treating-symptoms-of-gastrointestinal-conditions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2962]]></id>
		<title><![CDATA[Ophthalmic Devices; Classification of the Intense Pulsed Light Device for Managing Dry Eye]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ophthalmic-devices-classification-of-the-intense-pulsed-light-device-for-managing-dry-eye/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230120]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2023/01/20/2023-01049/medical-devices-ophthalmic-devices-classification-of-the-intense-pulsed-light-device-for-managing]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ophthalmic-devices-classification-of-the-intense-pulsed-light-device-for-managing-dry-eye]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2963]]></id>
		<title><![CDATA[Radiological Health Regulations: Amendments to Records and Reports for Radiation Emitting Electronic Products; Amendments to Performance Standards for Diagnostic X-ray, Laser, and Ultrasonic Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/radiological-health-regulations-amendments-to-records-and-reports-for-radiation-emitting-electronic-products-amendments-to-performance-standards-for-diagnostic-x-ray-laser-and-ultrasonic-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230120]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2023/01/20/2023-00922/radiological-health-regulations-amendments-to-records-and-reports-for-radiation-emitting-electronic]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[radiological-health-regulations-amendments-to-records-and-reports-for-radiation-emitting-electronic-products-amendments-to-performance-standards-for-diagnostic-x-ray-laser-and-ultrasonic-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2964]]></id>
		<title><![CDATA[Requirements for application of Certificate Of Free Sale (CFS), Manufacturing Certificate (MC) and Certificate Of Free Sale For Export only (CFS EO) medical devices (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/requirements-for-application-of-certificate-of-free-sale-cfs-manufacturing-certificate-mc-and-certificate-of-free-sale-for-export-only-cfs-eo-medical-devices-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[Medical Device Authority]]></health_authority>
		<date_2><![CDATA[20230113]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://portal.mda.gov.my/doclink/gd-public-comment-cfs-mc-and-cfs-eo-pdf/eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWIiOiJnZC1wdWJsaWMtY29tbWVudC1jZnMtbWMtYW5kLWNmcy1lby1wZGYiLCJpYXQiOjE2NzE3Njk2ODEsImV4cCI6MTY3MTg1NjA4MX0._4cu7SpcvSkUvWW9q43OIV7cXW2gdTzC7MKFD_m9_00]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[requirements-for-application-of-certificate-of-free-sale-cfs-manufacturing-certificate-mc-and-certificate-of-free-sale-for-export-only-cfs-eo-medical-devices-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2965]]></id>
		<title><![CDATA[More time to certify medical devices under MDR to mitigate risks of shortages]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/more-time-to-certify-medical-devices-under-mdr-to-mitigate-risks-of-shortages/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20230106]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://ec.europa.eu/commission/presscorner/detail/en/ip_23_23]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[more-time-to-certify-medical-devices-under-mdr-to-mitigate-risks-of-shortages]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2966]]></id>
		<title><![CDATA[Coordination of pharmacovigilance inspections]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/coordination-of-pharmacovigilance-inspections/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230103]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/compliance/coordination-pharmacovigilance-inspections]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[coordination-of-pharmacovigilance-inspections]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2967]]></id>
		<title><![CDATA[List of standard fees]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/list-of-standard-fees/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20230103]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-01/mdcg_2023-2_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[list-of-standard-fees]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2968]]></id>
		<title><![CDATA[Pharmeuropa 35.1 just released]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/pharmeuropa-35-1-just-released/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20230103]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/pharmeuropa-35.1-just-released]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[pharmeuropa-35-1-just-released]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2969]]></id>
		<title><![CDATA[Questions and Answers: Commission proposes an extension of the transitional periods for the application of the Medical Devices Regulation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/questions-and-answers-commission-proposes-an-extension-of-the-transitional-periods-for-the-application-of-the-medical-devices-regulation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[Medical Device Authority]]></health_authority>
		<date_2><![CDATA[20230101]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://ec.europa.eu/commission/presscorner/detail/en/qanda_23_24]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[questions-and-answers-commission-proposes-an-extension-of-the-transitional-periods-for-the-application-of-the-medical-devices-regulation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2970]]></id>
		<title><![CDATA[Changes to fees for human medicinal products and devices as of 1 January 2023]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/changes-to-fees-for-human-medicinal-products-and-devices-as-of-1-january-2023/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Netherlands]]></country_region>
		<health_authority><![CDATA[Medicines Evaluation Board]]></health_authority>
		<date_2><![CDATA[20230101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://english.cbg-meb.nl/latest/news/2023/01/02/changes-to-fees-for-human-medicinal-products-and-devices-as-of-1-january-2023]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[changes-to-fees-for-human-medicinal-products-and-devices-as-of-1-january-2023]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2971]]></id>
		<title><![CDATA[Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/optimizing-the-dosage-of-human-prescription-drugs-and-biological-products-for-the-treatment-of-oncologic-diseases-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20230101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/164555/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[optimizing-the-dosage-of-human-prescription-drugs-and-biological-products-for-the-treatment-of-oncologic-diseases-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2972]]></id>
		<title><![CDATA[FDA alerts drug manufacturers to the risk of benzene contamination in certain drugs]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fda-alerts-drug-manufacturers-to-the-risk-of-benzene-contamination-in-certain-drugs/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221223]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/drugs/pharmaceutical-quality-resources/fda-alerts-drug-manufacturers-risk-benzene-contamination-certain-drugs]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fda-alerts-drug-manufacturers-to-the-risk-of-benzene-contamination-in-certain-drugs]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2973]]></id>
		<title><![CDATA[Controlled Correspondence Related to Generic Drug Development (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/controlled-correspondence-related-to-generic-drug-development-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221222]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/164111/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[controlled-correspondence-related-to-generic-drug-development-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2974]]></id>
		<title><![CDATA[Bioequivalence for immediate release solid oral dosage forms M13A]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/bioequivalence-for-immediate-release-solid-oral-dosage-forms-m13a/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Ireland]]></country_region>
		<health_authority><![CDATA[The International Council for Harmonisation]]></health_authority>
		<date_2><![CDATA[20221220]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://database.ich.org/sites/default/files/ICH_M13A_Step2_draft_Guideline_2022_1125.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[bioequivalence-for-immediate-release-solid-oral-dosage-forms-m13a]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2975]]></id>
		<title><![CDATA[Exemptions, Variances, and Alternative Forms of Adverse Event Reporting for Medical Devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/exemptions-variances-and-alternative-forms-of-adverse-event-reporting-for-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221220]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/medical-device-reporting-mdr-how-report-medical-device-problems/exemptions-variances-and-alternative-forms-adverse-event-reporting-medical-devices]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[exemptions-variances-and-alternative-forms-of-adverse-event-reporting-for-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2976]]></id>
		<title><![CDATA[IMDRF Standard Operating Procedures – Edition 8]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/imdrf-standard-operating-procedures-edition-8/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Medical Device Regulators Forum]]></health_authority>
		<date_2><![CDATA[20221219]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.imdrf.org/sites/default/files/2022-12/IMDRF%20Standard%20Operating%20Procedures%20Dec%2022.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[imdrf-standard-operating-procedures-edition-8]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2977]]></id>
		<title><![CDATA[EMA Management Board: highlights of December 2022 meeting]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ema-management-board-highlights-of-december-2022-meeting/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20221216]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/ema-management-board-highlights-december-2022-meeting]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ema-management-board-highlights-of-december-2022-meeting]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2978]]></id>
		<title><![CDATA[Guidance on Periodic Safety Update Report (PSUR) according to regulation (EU) 2017/745 (MDR)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-on-periodic-safety-update-report-psur-according-to-regulation-eu-2017-745-mdr/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20221216]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2023-01/mdcg_2022-21_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-on-periodic-safety-update-report-psur-according-to-regulation-eu-2017-745-mdr]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2979]]></id>
		<title><![CDATA[Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/circumstances-that-constitute-delaying-denying-limiting-or-refusing-a-drug-or-device-inspection-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221215]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/163927/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[circumstances-that-constitute-delaying-denying-limiting-or-refusing-a-drug-or-device-inspection-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2980]]></id>
		<title><![CDATA[Guidance for Industry Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-for-industry-circumstances-that-constitute-delaying-denying-limiting-or-refusing-a-drug-or-device-inspection-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221215]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/163927/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-for-industry-circumstances-that-constitute-delaying-denying-limiting-or-refusing-a-drug-or-device-inspection-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2981]]></id>
		<title><![CDATA[Substantial modification of performance study under Regulation (EU) 2017/746]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/substantial-modification-of-performance-study-under-regulation-eu-2017-746/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20221214]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2022-12/mdcg_2022-20_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[substantial-modification-of-performance-study-under-regulation-eu-2017-746]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2982]]></id>
		<title><![CDATA[Mean applicant screening response time]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mean-applicant-screening-response-time/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Singapore]]></country_region>
		<health_authority><![CDATA[Health Sciences Authority]]></health_authority>
		<date_2><![CDATA[20221214]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.hsa.gov.sg/announcements/regulatory-updates/mean-applicant-screening-response-time]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mean-applicant-screening-response-time]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2983]]></id>
		<title><![CDATA[FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fda-approves-updated-drug-labeling-including-new-indications-and-dosing-regimens-for-capecitabine-tablets-under-project-renewal/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221214]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-updated-drug-labeling-including-new-indications-and-dosing-regimens-capecitabine?utm_medium=email&utm_source=govdelivery]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fda-approves-updated-drug-labeling-including-new-indications-and-dosing-regimens-for-capecitabine-tablets-under-project-renewal]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2984]]></id>
		<title><![CDATA[Failure to Respond to an ANDA Complete Response Letter Within the Regulatory Timeframe]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:11:59]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/failure-to-respond-to-an-anda-complete-response-letter-within-the-regulatory-timeframe/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221214]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/160166/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[failure-to-respond-to-an-anda-complete-response-letter-within-the-regulatory-timeframe]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:11:59]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2985]]></id>
		<title><![CDATA[Commission proposes updated EMA fees]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/commission-proposes-updated-ema-fees/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20221213]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/latest-updates/pharmaceuticals-commission-proposes-updated-ema-fees-2022-12-13_en]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[commission-proposes-updated-ema-fees]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2986]]></id>
		<title><![CDATA[Inspections/Audits of Pharmacovigilance (PV) system of importers and manufacturers of human vaccine]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/inspections-audits-of-pharmacovigilance-pv-system-of-importers-and-manufacturers-of-human-vaccine/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20221213]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTczNQ==]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[inspections-audits-of-pharmacovigilance-pv-system-of-importers-and-manufacturers-of-human-vaccine]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2987]]></id>
		<title><![CDATA[Safety advisory – Low levels of contamination with N-nitroso-quinapril]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/safety-advisory-low-levels-of-contamination-with-n-nitroso-quinapril/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20221209]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/safety-alerts/quinapril-blood-pressure-medicines]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[safety-advisory-low-levels-of-contamination-with-n-nitroso-quinapril]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2988]]></id>
		<title><![CDATA[Pulmonary Tuberculosis: Developing Drugs for Treatment (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/pulmonary-tuberculosis-developing-drugs-for-treatment-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221209]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/87194/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[pulmonary-tuberculosis-developing-drugs-for-treatment-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2989]]></id>
		<title><![CDATA[Content of Human Factors Information in Medical Device Marketing Submissions (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/content-of-human-factors-information-in-medical-device-marketing-submissions-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221209]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/163694/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[content-of-human-factors-information-in-medical-device-marketing-submissions-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2990]]></id>
		<title><![CDATA[CMC Reviews of Type III DMFs for Packaging Materials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cmc-reviews-of-type-iii-dmfs-for-packaging-materials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221209]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Packaging]]></domain>
		<url><![CDATA[https://www.fda.gov/media/78608/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cmc-reviews-of-type-iii-dmfs-for-packaging-materials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2991]]></id>
		<title><![CDATA[Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/recommendations-to-reduce-the-risk-of-transfusion-transmitted-malaria/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221209]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/163737/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[recommendations-to-reduce-the-risk-of-transfusion-transmitted-malaria]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2992]]></id>
		<title><![CDATA[Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/voluntary-malfunction-summary-reporting-vmsr-program-for-manufacturers-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221209]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/163692/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[voluntary-malfunction-summary-reporting-vmsr-program-for-manufacturers-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2993]]></id>
		<title><![CDATA[MDCG position paper on ‘hybrid audits’]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mdcg-position-paper-on-hybrid-audits/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20221208]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2022-12/mdcg_2022-17_en_0.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mdcg-position-paper-on-hybrid-audits]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2994]]></id>
		<title><![CDATA[Acceptability of Standards from Alternative Compendia (BP/EP/JP)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/acceptability-of-standards-from-alternative-compendia-bp-ep-jp/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221208]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/72412/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[acceptability-of-standards-from-alternative-compendia-bp-ep-jp]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2995]]></id>
		<title><![CDATA[Changes to pharmaceutical database based on feedback received]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/changes-to-pharmaceutical-database-based-on-feedback-received/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20221207]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.nppaindia.nic.in/wp-content/uploads/2022/12/Action-taken-and-Comments.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[changes-to-pharmaceutical-database-based-on-feedback-received]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2996]]></id>
		<title><![CDATA[Augmented Reality and Virtual Reality in Medical Devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/augmented-reality-and-virtual-reality-in-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221207]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/digital-health-center-excellence/augmented-reality-and-virtual-reality-medical-devices?utm_source=FDALinkedin]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[augmented-reality-and-virtual-reality-in-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2997]]></id>
		<title><![CDATA[Product Quality Microbiology Information in the Common Technical Document – Quality (CTD-Q)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/product-quality-microbiology-information-in-the-common-technical-document-quality-ctd-q/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221207]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/72541/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[product-quality-microbiology-information-in-the-common-technical-document-quality-ctd-q]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2998]]></id>
		<title><![CDATA[Proposal to delay the implementation of the Medical Device Regulation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/proposal-to-delay-the-implementation-of-the-medical-device-regulation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20221206]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://data.consilium.europa.eu/doc/document/ST-15520-2022-INIT/en/pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[proposal-to-delay-the-implementation-of-the-medical-device-regulation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[2999]]></id>
		<title><![CDATA[Homeopathic Drug Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/homeopathic-drug-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221206]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/163755/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[homeopathic-drug-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3000]]></id>
		<title><![CDATA[E19 A selective approach to safety data collection in specific late-stage preapproval or post-approval clinical trials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/e19-a-selective-approach-to-safety-data-collection-in-specific-late-stage-preapproval-or-post-approval-clinical-trials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221205]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/163670/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[e19-a-selective-approach-to-safety-data-collection-in-specific-late-stage-preapproval-or-post-approval-clinical-trials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3001]]></id>
		<title><![CDATA[Statistical Approaches to Establishing Bioequivalence (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/statistical-approaches-to-establishing-bioequivalence-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221205]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/163638/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[statistical-approaches-to-establishing-bioequivalence-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3002]]></id>
		<title><![CDATA[Regulations to lay down common specifications and rules for reclassification of products without an intended medical purpose under the Medical Devices Regulation (MDR)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/regulations-to-lay-down-common-specifications-and-rules-for-reclassification-of-products-without-an-intended-medical-purpose-under-the-medical-devices-regulation-mdr/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20221202]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2022.311.01.0060.01.ENG&toc=OJ%3AL%3A2022%3A311%3ATOC]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[regulations-to-lay-down-common-specifications-and-rules-for-reclassification-of-products-without-an-intended-medical-purpose-under-the-medical-devices-regulation-mdr]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3003]]></id>
		<title><![CDATA[EMA recommends withdrawal of pholcodine medicines from EU market]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ema-recommends-withdrawal-of-pholcodine-medicines-from-eu-market/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20221202]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/ema-recommends-withdrawal-pholcodine-medicines-eu-market]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ema-recommends-withdrawal-of-pholcodine-medicines-from-eu-market]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3004]]></id>
		<title><![CDATA[ANDAs: Pre-Submission Facility Correspondence Related to Prioritized Generic Drug Submissions (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/andas-pre-submission-facility-correspondence-related-to-prioritized-generic-drug-submissions-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221202]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/163643/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[andas-pre-submission-facility-correspondence-related-to-prioritized-generic-drug-submissions-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3005]]></id>
		<title><![CDATA[A warning that advertising Ozempic (semaglutide) is prohibited]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/a-warning-that-advertising-ozempic-semaglutide-is-prohibited/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20221130]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/warning-advertising-ozempic-semaglutide-prohibited]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[a-warning-that-advertising-ozempic-semaglutide-is-prohibited]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3006]]></id>
		<title><![CDATA[Update on review of over-the-counter medicines containing codeine.]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/update-on-review-of-over-the-counter-medicines-containing-codeine/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Ireland]]></country_region>
		<health_authority><![CDATA[Health Products Regulatory Authority]]></health_authority>
		<date_2><![CDATA[20221128]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.hpra.ie/homepage/medicines/news-events/item?t=/upate-on-review-of-over-the-counter-medicines-containing-codeine&id=885e1326-9782-6eee-9b55-ff00008c97d0]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[update-on-review-of-over-the-counter-medicines-containing-codeine]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3007]]></id>
		<title><![CDATA[Change notification for registered medical device]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/change-notification-for-registered-medical-device/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[Medical Device Authority]]></health_authority>
		<date_2><![CDATA[20221121]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://portal.mda.gov.my/doclink/guidance-document-change-notification-for-registered-medical-device-4th-edition-final-pdf/eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWIiOiJndWlkYW5jZS1kb2N1bWVudC1jaGFuZ2Utbm90aWZpY2F0aW9uLWZvci1yZWdpc3RlcmVkLW1lZGljYWwtZGV2aWNlLTR0aC1lZGl0aW9uLWZpbmFsLXBkZiIsImlhdCI6MTY2OTAxNjAzMCwiZXhwIjoxNjY5MTAyNDMwfQ.3__JOAp0HT55-AWy4HcMyt5jZV9YKpK8rIVWLeaoFvU]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[change-notification-for-registered-medical-device]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3008]]></id>
		<title><![CDATA[NMPA Announcement on putting into use the electronic certificates of Documentation for Export of APIs to EU and Certificate of a Pharmaceutical Product]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/nmpa-announcement-on-putting-into-use-the-electronic-certificates-of-documentation-for-export-of-apis-to-eu-and-certificate-of-a-pharmaceutical-product/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[Medical Device Authority]]></health_authority>
		<date_2><![CDATA[20221121]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[http://english.nmpa.gov.cn/2022-11/08/c_828838.htm]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[nmpa-announcement-on-putting-into-use-the-electronic-certificates-of-documentation-for-export-of-apis-to-eu-and-certificate-of-a-pharmaceutical-product]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3009]]></id>
		<title><![CDATA[Upcoming Product-Specific Guidances for Generic Drug Product Development]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/upcoming-product-specific-guidances-for-generic-drug-product-development/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221117]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/drugs/guidances-drugs/upcoming-product-specific-guidances-generic-drug-product-development?utm_medium=email&utm_source=govdelivery]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[upcoming-product-specific-guidances-for-generic-drug-product-development]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3010]]></id>
		<title><![CDATA[Continuous manufacturing of drug substances and drug products Q13]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/continuous-manufacturing-of-drug-substances-and-drug-products-q13/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Council for Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use]]></health_authority>
		<date_2><![CDATA[20221116]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://database.ich.org/sites/default/files/ICH_Q13_Step4_Guideline_2022_1116.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[continuous-manufacturing-of-drug-substances-and-drug-products-q13]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3011]]></id>
		<title><![CDATA[Referencing the Definition of “Device” in the Federal Food, Drug, and Cosmetic Act in Guidance, Regulatory Documents, Communications, and Other Public Documents]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/referencing-the-definition-of-device-in-the-federal-food-drug-and-cosmetic-act-in-guidance-regulatory-documents-communications-and-other-public-documents/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221114]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/154866/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[referencing-the-definition-of-device-in-the-federal-food-drug-and-cosmetic-act-in-guidance-regulatory-documents-communications-and-other-public-documents]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3012]]></id>
		<title><![CDATA[Explanation of BPOM RI number HM.01.1.2.11.22.178 dated 9 November 2022 regarding development of results of supervision of drug syrup and procedure of propylene glycol raw materials containing contaminants EG and DEG exceed the limits]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/explanation-of-bpom-ri-number-hm-01-1-2-11-22-178-dated-9-november-2022-regarding-development-of-results-of-supervision-of-drug-syrup-and-procedure-of-propylene-glycol-raw-materials-containing-contami/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Indonesia]]></country_region>
		<health_authority><![CDATA[BADAN POM]]></health_authority>
		<date_2><![CDATA[20221109]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.pom.go.id/new/view/more/klarifikasi/164/PENJELASAN-BPOM-RI-NOMOR-HM-01-1-2-11-22-178-TANGGAL-9-NOVEMBER-2022-TENTANG–PERKEMBANGAN-HASIL-PENGAWASAN-SIRUP-OBAT-DAN-PENINDAKAN-BAHAN-BAKU-PROPILEN-GLIKOL-YANG-MENGANDUNG-CEMARAN-EG-DAN-DEG-MELEBIHI-AMBANG-BATAS.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[explanation-of-bpom-ri-number-hm-01-1-2-11-22-178-dated-9-november-2022-regarding-development-of-results-of-supervision-of-drug-syrup-and-procedure-of-propylene-glycol-raw-materials-containing-contami]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3013]]></id>
		<title><![CDATA[Notification of custom-made medical device – Guidance document]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/notification-of-custom-made-medical-device-guidance-document/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[Medical Device Authority]]></health_authority>
		<date_2><![CDATA[20221109]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://mda.gov.my/doclink/public-comment-guidance-document-notification-of-custom-made-medical-device/eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWIiOiJwdWJsaWMtY29tbWVudC1ndWlkYW5jZS1kb2N1bWVudC1ub3RpZmljYXRpb24tb2YtY3VzdG9tLW1hZGUtbWVkaWNhbC1kZXZpY2UiLCJpYXQiOjE2NjcyMDQ3MDEsImV4cCI6MTY2NzI5MTEwMX0._RZPo5MAzQed3Tmjazo4HlInuyFqN-x6WGmXW7iUymI]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[notification-of-custom-made-medical-device-guidance-document]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3014]]></id>
		<title><![CDATA[Submission of Suspected Unexpected Serious Adverse Reactions reports using ICSR submissions or MHRA gateway]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/submission-of-suspected-unexpected-serious-adverse-reactions-reports-using-icsr-submissions-or-mhra-gateway/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20221108]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.gov.uk/guidance/clinical-trials-for-medicines-manage-your-authorisation-report-safety-issues#full-publication-update-history]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[submission-of-suspected-unexpected-serious-adverse-reactions-reports-using-icsr-submissions-or-mhra-gateway]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3015]]></id>
		<title><![CDATA[International harmonisation of ingredient names (IHIN) – Dual labelling transition to sole medicine ingredient names]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/international-harmonisation-of-ingredient-names-ihin-dual-labelling-transition-to-sole-medicine-ingredient-names/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20221107]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://consultations.tga.gov.au/medicines-regulation-division/international-harmonisation-of-ingredient-names-ih/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[international-harmonisation-of-ingredient-names-ihin-dual-labelling-transition-to-sole-medicine-ingredient-names]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3016]]></id>
		<title><![CDATA[Guidance on the licensing of biosimilar products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-on-the-licensing-of-biosimilar-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20221107]]></date_2>
		<product_type><![CDATA[Biologics]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/guidance-on-the-licensing-of-biosimilar-products/guidance-on-the-licensing-of-biosimilar-products]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-on-the-licensing-of-biosimilar-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3017]]></id>
		<title><![CDATA[Changes to the Guidance document Variations TAM HMV4]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/changes-to-the-guidance-document-variations-tam-hmv4/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20221104]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/tierarzneimittel/information/anpassung-wl-aenderungen-tam.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[changes-to-the-guidance-document-variations-tam-hmv4]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3018]]></id>
		<title><![CDATA[Post-market review of spinal cord stimulation (SCS) devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/post-market-review-of-spinal-cord-stimulation-scs-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20221103]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/post-market-review-spinal-cord-stimulation-scs-devices]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[post-market-review-of-spinal-cord-stimulation-scs-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3019]]></id>
		<title><![CDATA[Regulatory update – EMA encourages companies to submit type I variations for 2022 by end of November]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:00]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/regulatory-update-ema-encourages-companies-to-submit-type-i-variations-for-2022-by-end-of-november/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20221103]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/regulatory-update-ema-encourages-companies-submit-type-i-variations-2022-end-november]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[regulatory-update-ema-encourages-companies-to-submit-type-i-variations-for-2022-by-end-of-november]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:00]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3020]]></id>
		<title><![CDATA[Guidelines Prescribing the Principle of Reliance for Regulatory Decisions of the Food and Drug Administration]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidelines-prescribing-the-principle-of-reliance-for-regulatory-decisions-of-the-food-and-drug-administration/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20221101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/wp-content/uploads/2022/11/Guidelines-Prescribing-the-Principle-of-Reliance-for-Regulatory-Decisions-of-the-Food-and-Drug-Administration.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidelines-prescribing-the-principle-of-reliance-for-regulatory-decisions-of-the-food-and-drug-administration]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3021]]></id>
		<title><![CDATA[Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National Public Health Emergencies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidelines-on-food-and-drug-administrations-regulatory-responses-during-declared-national-public-health-emergencies/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20221101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/wp-content/uploads/2022/11/Guidelines-on-Food-and-Drug-Administrations-Regulatory-Responses-During-Declared-National-Public-Health-Emergencies.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidelines-on-food-and-drug-administrations-regulatory-responses-during-declared-national-public-health-emergencies]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3022]]></id>
		<title><![CDATA[Sameness Evaluations in an ANDA — Active Ingredients (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/sameness-evaluations-in-an-anda-active-ingredients-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/163018/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[sameness-evaluations-in-an-anda-active-ingredients-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3023]]></id>
		<title><![CDATA[Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/regulation-of-human-cells-tissues-and-cellular-and-tissue-based-products-hct-ps/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221101]]></date_2>
		<product_type><![CDATA[Biologics]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/70689/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[regulation-of-human-cells-tissues-and-cellular-and-tissue-based-products-hct-ps]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3024]]></id>
		<title><![CDATA[M10 Bioanalytical method validation and study sample analysis]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/m10-bioanalytical-method-validation-and-study-sample-analysis/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162903/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[m10-bioanalytical-method-validation-and-study-sample-analysis]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3025]]></id>
		<title><![CDATA[Cross Labeling Oncology Drugs in Combination Regimens]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cross-labeling-oncology-drugs-in-combination-regimens/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162806/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cross-labeling-oncology-drugs-in-combination-regimens]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3026]]></id>
		<title><![CDATA[S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/s1br1-addendum-to-s1b-testing-for-carcinogenicity-of-pharmaceuticals/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Non-Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/152777/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[s1br1-addendum-to-s1b-testing-for-carcinogenicity-of-pharmaceuticals]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3027]]></id>
		<title><![CDATA[Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/studying-multiple-versions-of-a-cellular-or-gene-therapy-product-in-an-early-phase-clinical-trial/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221101]]></date_2>
		<product_type><![CDATA[Biologics]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/152536/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[studying-multiple-versions-of-a-cellular-or-gene-therapy-product-in-an-early-phase-clinical-trial]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3028]]></id>
		<title><![CDATA[Expanded Access to Investigational Drugs for Treatment Use Questions and Answers (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/expanded-access-to-investigational-drugs-for-treatment-use-questions-and-answers-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162793/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[expanded-access-to-investigational-drugs-for-treatment-use-questions-and-answers-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3029]]></id>
		<title><![CDATA[Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program; Program Announcement – updated on 10/31/2022]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/chemistry-manufacturing-and-controls-development-and-readiness-pilot-program-program-announcement-updated-on-10-31-2022/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221031]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2022/10/31/2022-23575/chemistry-manufacturing-and-controls-development-and-readiness-pilot-program-program-announcement?utm_medium=email&utm_source=govdelivery]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[chemistry-manufacturing-and-controls-development-and-readiness-pilot-program-program-announcement-updated-on-10-31-2022]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3030]]></id>
		<title><![CDATA[The Council of Europe/EDQM and the European Union conclude an agreement expanding the scope of their co-operation in the field of substances of human origin]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/the-council-of-europe-edqm-and-the-european-union-conclude-an-agreement-expanding-the-scope-of-their-co-operation-in-the-field-of-substances-of-human-origin/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20221028]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/the-council-of-europe/edqm-and-the-european-union-conclude-an-agreement-expanding-the-scope-of-their-co-operation-in-the-field-of-substances-of-human-origin]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[the-council-of-europe-edqm-and-the-european-union-conclude-an-agreement-expanding-the-scope-of-their-co-operation-in-the-field-of-substances-of-human-origin]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3031]]></id>
		<title><![CDATA[IPC’s Notice Regarding General Chapters of IP 2022]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ipcs-notice-regarding-general-chapters-of-ip-2022/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20221027]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ipc.gov.in/news-highlights/1051-ipc-s-notice-regarding-general-chapters-of-ip-2022.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ipcs-notice-regarding-general-chapters-of-ip-2022]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3032]]></id>
		<title><![CDATA[Measuring Growth and Evaluating Pubertal Development in Pediatric Clinical Trials (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/measuring-growth-and-evaluating-pubertal-development-in-pediatric-clinical-trials-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221027]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162725/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[measuring-growth-and-evaluating-pubertal-development-in-pediatric-clinical-trials-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3033]]></id>
		<title><![CDATA[Developing and Responding to Deficiencies in Accordance with the Least Burdensome Provisions]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/developing-and-responding-to-deficiencies-in-accordance-with-the-least-burdensome-provisions/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221026]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/71735/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[developing-and-responding-to-deficiencies-in-accordance-with-the-least-burdensome-provisions]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3034]]></id>
		<title><![CDATA[Implementation of the Future Regulations]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/implementation-of-the-future-regulations/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20221025]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/implementation-of-the-future-regulation-of-medical-devices-and-extension-of-standstill-period/implementation-of-the-future-regulations]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[implementation-of-the-future-regulations]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3035]]></id>
		<title><![CDATA[In Vitro Permeation Test Studies for Topical Drug Products Submitted in ANDAs (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/in-vitro-permeation-test-studies-for-topical-drug-products-submitted-in-andas-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221025]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162475/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[in-vitro-permeation-test-studies-for-topical-drug-products-submitted-in-andas-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3036]]></id>
		<title><![CDATA[Human Gene Therapy for Neurodegenerative Diseases]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/human-gene-therapy-for-neurodegenerative-diseases/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221025]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/144886/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[human-gene-therapy-for-neurodegenerative-diseases]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3037]]></id>
		<title><![CDATA[Information about the raw data proof-of-concept pilot for industry]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/information-about-the-raw-data-proof-of-concept-pilot-for-industry/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20221024]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/other/information-about-raw-data-proof-concept-pilot-industry_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[information-about-the-raw-data-proof-of-concept-pilot-for-industry]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3038]]></id>
		<title><![CDATA[GMP Clearance: Temporary changes to target processing times]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/gmp-clearance-temporary-changes-to-target-processing-times/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20221021]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/notices/gmp-clearance-temporary-changes-target-processing-times]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[gmp-clearance-temporary-changes-to-target-processing-times]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3039]]></id>
		<title><![CDATA[In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/in-vitro-release-test-studies-for-topical-drug-products-submitted-in-andas-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221021]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162476/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[in-vitro-release-test-studies-for-topical-drug-products-submitted-in-andas-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3040]]></id>
		<title><![CDATA[Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/physicochemical-and-structural-q3-characterization-of-topical-drug-products-submitted-in-andas-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221021]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162471/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[physicochemical-and-structural-q3-characterization-of-topical-drug-products-submitted-in-andas-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3041]]></id>
		<title><![CDATA[Topical Dermatologic Corticosteroids: In Vivo Bioequivalence (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/topical-dermatologic-corticosteroids-in-vivo-bioequivalence-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221021]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162457/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[topical-dermatologic-corticosteroids-in-vivo-bioequivalence-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3042]]></id>
		<title><![CDATA[Select Updates for the Breakthrough Devices Program Guidance: Reducing Disparities in Health and Health Care (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/select-updates-for-the-breakthrough-devices-program-guidance-reducing-disparities-in-health-and-health-care-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221021]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162413/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[select-updates-for-the-breakthrough-devices-program-guidance-reducing-disparities-in-health-and-health-care-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3043]]></id>
		<title><![CDATA[Multiple Endpoints in Clinical Trials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/multiple-endpoints-in-clinical-trials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221020]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162416/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[multiple-endpoints-in-clinical-trials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3044]]></id>
		<title><![CDATA[Advancing Real-World Evidence Program]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/advancing-real-world-evidence-program/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221019]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/drugs/development-resources/advancing-real-world-evidence-program]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[advancing-real-world-evidence-program]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3045]]></id>
		<title><![CDATA[Anonymization of Protected Personal Data and assessment of Commercially Confidential Information during the preparation of RMPs (main body and annexes 4 and 6)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/anonymization-of-protected-personal-data-and-assessment-of-commercially-confidential-information-during-the-preparation-of-rmps-main-body-and-annexes-4-and-6/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20221018]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/guidance-anonymisation-protected-personal-data-assessment-commercially-confidential-information_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[anonymization-of-protected-personal-data-and-assessment-of-commercially-confidential-information-during-the-preparation-of-rmps-main-body-and-annexes-4-and-6]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3046]]></id>
		<title><![CDATA[Software and AI as a Medical Device Change Programme – Roadmap]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/software-and-ai-as-a-medical-device-change-programme-roadmap/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20221017]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/software-and-ai-as-a-medical-device-change-programme/software-and-ai-as-a-medical-device-change-programme-roadmap]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[software-and-ai-as-a-medical-device-change-programme-roadmap]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3047]]></id>
		<title><![CDATA[Complex Generics News]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/complex-generics-news/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221017]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/drugs/generic-drugs/complex-generics-news?utm_medium=email&utm_source=govdelivery]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[complex-generics-news]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3048]]></id>
		<title><![CDATA[European Medicines Agency Guidance for Applicants seeking scientific advice and protocol assistance]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/european-medicines-agency-guidance-for-applicants-seeking-scientific-advice-and-protocol-assistance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20221014]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-guidance-applicants-seeking-scientific-advice-protocol-assistance-track_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[european-medicines-agency-guidance-for-applicants-seeking-scientific-advice-and-protocol-assistance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3049]]></id>
		<title><![CDATA[EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ema-pilot-offers-enhanced-support-to-academic-and-non-profit-developers-of-advanced-therapy-medicinal-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20221011]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/ema-pilot-offers-enhanced-support-academic-non-profit-developers-advanced-therapy-medicinal-products]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ema-pilot-offers-enhanced-support-to-academic-and-non-profit-developers-of-advanced-therapy-medicinal-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3050]]></id>
		<title><![CDATA[Prioritization of the Review of Original ANDAs, Amendments, and Supplements]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/prioritization-of-the-review-of-original-andas-amendments-and-supplements/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221005]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/89061/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[prioritization-of-the-review-of-original-andas-amendments-and-supplements]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3051]]></id>
		<title><![CDATA[Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/formal-meetings-between-fda-and-anda-applicants-of-complex-products-under-gdufa/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221005]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/107626/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[formal-meetings-between-fda-and-anda-applicants-of-complex-products-under-gdufa]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3052]]></id>
		<title><![CDATA[Information Requests and Discipline Review Letters Under GDUFA]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/information-requests-and-discipline-review-letters-under-gdufa/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221005]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/109915/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[information-requests-and-discipline-review-letters-under-gdufa]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3053]]></id>
		<title><![CDATA[Post-Complete Response Letter Clarification Teleconferences Between FDA and ANDA Applicants Under GDUFA]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/post-complete-response-letter-clarification-teleconferences-between-fda-and-anda-applicants-under-gdufa/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221005]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/108337/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[post-complete-response-letter-clarification-teleconferences-between-fda-and-anda-applicants-under-gdufa]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3054]]></id>
		<title><![CDATA[Competitive Generic Therapies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:01]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/competitive-generic-therapies/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221005]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/136063/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[competitive-generic-therapies]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:01]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3055]]></id>
		<title><![CDATA[Guidance on Authorized Representatives Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-on-authorized-representatives-regulation-eu-2017-745-on-medical-devices-mdr-and-regulation-eu-2017-746-on-in-vitro-diagnostic-medical-devices-ivdr/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Union]]></health_authority>
		<date_2><![CDATA[20221003]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/system/files/2022-10/mdcg_202216_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-on-authorized-representatives-regulation-eu-2017-745-on-medical-devices-mdr-and-regulation-eu-2017-746-on-in-vitro-diagnostic-medical-devices-ivdr]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3056]]></id>
		<title><![CDATA[Assessing User Fees Under the Over-the-Counter Monograph Drug User Fee Program (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/assessing-user-fees-under-the-over-the-counter-monograph-drug-user-fee-program-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221003]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162759/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[assessing-user-fees-under-the-over-the-counter-monograph-drug-user-fee-program-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3057]]></id>
		<title><![CDATA[Review of Drug Master Files in Advance of Certain ANDA Submissions Under GDUFA (Draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/review-of-drug-master-files-in-advance-of-certain-anda-submissions-under-gdufa-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221003]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162019/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[review-of-drug-master-files-in-advance-of-certain-anda-submissions-under-gdufa-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3058]]></id>
		<title><![CDATA[FDA and Industry Actions on Premarket Notification (510(k)) Submissions: Effect on FDA Review Clock and Goals]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fda-and-industry-actions-on-premarket-notification-510k-submissions-effect-on-fda-review-clock-and-goals/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221003]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/73507/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fda-and-industry-actions-on-premarket-notification-510k-submissions-effect-on-fda-review-clock-and-goals]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3059]]></id>
		<title><![CDATA[FDA and Industry Actions on Premarket Approval Applications (PMAs): Effect on FDA Review Clock and Goals]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fda-and-industry-actions-on-premarket-approval-applications-pmas-effect-on-fda-review-clock-and-goals/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221003]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/73504/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fda-and-industry-actions-on-premarket-approval-applications-pmas-effect-on-fda-review-clock-and-goals]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3060]]></id>
		<title><![CDATA[FDA and Industry Actions on De Novo Classification Requests: Effect on FDA Review Clock and Goals]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fda-and-industry-actions-on-de-novo-classification-requests-effect-on-fda-review-clock-and-goals/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221003]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/107652/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fda-and-industry-actions-on-de-novo-classification-requests-effect-on-fda-review-clock-and-goals]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3061]]></id>
		<title><![CDATA[Facility Readiness: Goal Date Decisions Under GDUFA (Draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/facility-readiness-goal-date-decisions-under-gdufa-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221003]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/162018/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[facility-readiness-goal-date-decisions-under-gdufa-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3062]]></id>
		<title><![CDATA[Split Real Time Application Review (STAR)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/split-real-time-application-review-star/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20221003]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/drugs/development-resources/split-real-time-application-review-star?utm_medium=email&utm_source=govdelivery]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[split-real-time-application-review-star]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3063]]></id>
		<title><![CDATA[Clinical electronic structured harmonized protocol (CESHARP) M11]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/clinical-electronic-structured-harmonized-protocol-cesharp-m11/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[International Council for Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use]]></health_authority>
		<date_2><![CDATA[20220927]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://database.ich.org/sites/default/files/ICH_M11_draft_Guideline_Step2_2022_0904.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[clinical-electronic-structured-harmonized-protocol-cesharp-m11]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3064]]></id>
		<title><![CDATA[Abridged Processing of Application for Registration of Medical Devices Approved by the National Regulatory Authority of Any ASEAN Member Country]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/abridged-processing-of-application-for-registration-of-medical-devices-approved-by-the-national-regulatory-authority-of-any-asean-member-country/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20220927]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/fda-circular-no-2022-008-abridged-processing-of-application-for-registration-of-medical-devices-approved-by-the-national-regulatory-authority-of-any-asean-member-country/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[abridged-processing-of-application-for-registration-of-medical-devices-approved-by-the-national-regulatory-authority-of-any-asean-member-country]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3065]]></id>
		<title><![CDATA[MDCG 2022-13 – Designation, re-assessment and notification of conformity assessment bodies and notified bodies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mdcg-2022-13-designation-re-assessment-and-notification-of-conformity-assessment-bodies-and-notified-bodies/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20220810]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/latest-updates/mdcg-2022-13-designation-re-assessment-and-notification-conformity-assessment-bodies-and-notified-2022-08-10_en]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mdcg-2022-13-designation-re-assessment-and-notification-of-conformity-assessment-bodies-and-notified-bodies]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3066]]></id>
		<title><![CDATA[itrosamines – Deadline extension for all CEP holders to complete step 3 Revision to the CEP (now 1 October 2023)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/itrosamines-deadline-extension-for-all-cep-holders-to-complete-step-3-revision-to-the-cep-now-1-october-2023/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Directorate for the Quality of Medicines and Healthcare]]></health_authority>
		<date_2><![CDATA[20220804]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/nitrosamines-deadline-extension-to-all-cep-holders-to-complete-step-3-revision-to-the-cep-now-1st-october-2023-.]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[itrosamines-deadline-extension-for-all-cep-holders-to-complete-step-3-revision-to-the-cep-now-1-october-2023]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3067]]></id>
		<title><![CDATA[Classification of medical devices pertaining to rehabilitation under the provisions of Medical Devices rule]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/classification-of-medical-devices-pertaining-to-rehabilitation-under-the-provisions-of-medical-devices-rule/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20220804]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=ODg1OA==]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[classification-of-medical-devices-pertaining-to-rehabilitation-under-the-provisions-of-medical-devices-rule]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3068]]></id>
		<title><![CDATA[Price control on medical devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:12:02]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/price-control-on-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20220729]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.nppaindia.nic.in/wp-content/uploads/2022/08/Gazett-Notification.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[price-control-on-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:12:02]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3069]]></id>
		<title><![CDATA[Chemical Monographs/General Chapters]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/chemical-monographs-general-chapters/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[CDSCO]]></health_authority>
		<date_2><![CDATA[20240619]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ipc.gov.in/news-highlights/8-category-en/744-amendments-chemical-monographs-revised-general-chapters.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[chemical-monographs-general-chapters]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3070]]></id>
		<title><![CDATA[Characterization of Metallic Coatings and/or Calcium Phosphate Coatings on Orthopedic Devices (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/characterization-of-metallic-coatings-and-or-calcium-phosphate-coatings-on-orthopedic-devices-draft-for-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240523]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/175564/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[characterization-of-metallic-coatings-and-or-calcium-phosphate-coatings-on-orthopedic-devices-draft-for-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3071]]></id>
		<title><![CDATA[Apply for a licence to market a medicine in the UK]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/apply-for-a-licence-to-market-a-medicine-in-the-uk/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240514]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/guidance/apply-for-a-licence-to-market-a-medicine-in-the-uk]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[apply-for-a-licence-to-market-a-medicine-in-the-uk]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3072]]></id>
		<title><![CDATA[CDER Center for Clinical Trial Innovation (C3TI)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cder-center-for-clinical-trial-innovation-c3ti/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240508]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/cder-center-clinical-trial-innovation-c3ti]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cder-center-for-clinical-trial-innovation-c3ti]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3073]]></id>
		<title><![CDATA[Guideline for application of clinical trial import licence and clinical trial exemption]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guideline-for-application-of-clinical-trial-import-licence-and-clinical-trial-exemption/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[National Pharmaceutical Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240430]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://npra.gov.my/easyarticles/images/users/1140/Malaysian-Guideline-for-Application-of-CTIL-and-CTX-8th-Ed-Final.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guideline-for-application-of-clinical-trial-import-licence-and-clinical-trial-exemption]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3074]]></id>
		<title><![CDATA[Commission welcomes adoption by European Parliament of measures to improve the availability of in vitro diagnostics]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/commission-welcomes-adoption-by-european-parliament-of-measures-to-improve-the-availability-of-in-vitro-diagnostics/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20240425]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://ec.europa.eu/commission/presscorner/detail/en/ip_24_2291]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[commission-welcomes-adoption-by-european-parliament-of-measures-to-improve-the-availability-of-in-vitro-diagnostics]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3075]]></id>
		<title><![CDATA[Nitrosamine impurities acceptable intakes update]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/nitrosamine-impurities-acceptable-intakes-update/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20240424]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/nitrosamine-impurities-acceptable-intakes-update]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[nitrosamine-impurities-acceptable-intakes-update]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3076]]></id>
		<title><![CDATA[Charting the path forward: Joint stakeholder statement on the implementation of the EHDS]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/charting-the-path-forward-joint-stakeholder-statement-on-the-implementation-of-the-ehds/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20240422]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.medtecheurope.org/wp-content/uploads/2024/04/240422-joint-statement-ehds-final.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[charting-the-path-forward-joint-stakeholder-statement-on-the-implementation-of-the-ehds]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3077]]></id>
		<title><![CDATA[Prescribing the Guidelines on Good Manufacturing Practice (GMP) for Drug Manufacturers Repealing AO No. 2013-0022 (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/prescribing-the-guidelines-on-good-manufacturing-practice-gmp-for-drug-manufacturers-repealing-ao-no-2013-0022-draft-for-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20240416]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/draft-for-comments-prescribing-the-guidelines-on-good-manufacturing-practice-gmp-for-drug-manufacturers-repealing-ao-no-2013-0022/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[prescribing-the-guidelines-on-good-manufacturing-practice-gmp-for-drug-manufacturers-repealing-ao-no-2013-0022-draft-for-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3078]]></id>
		<title><![CDATA[Clarification on the requirements for change of Qualified Person initially registered in a licensed drug establishment]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/clarification-on-the-requirements-for-change-of-qualified-person-initially-registered-in-a-licensed-drug-establishment/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20240415]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/fda-advisory-no-2024-0639-clarification-on-the-requirements-for-change-of-qualified-person-initially-registered-in-a-licensed-drug-establishment/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[clarification-on-the-requirements-for-change-of-qualified-person-initially-registered-in-a-licensed-drug-establishment]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3079]]></id>
		<title><![CDATA[Updates in uniform Rules for conducting bioequivalence studies of medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/updates-in-uniform-rules-for-conducting-bioequivalence-studies-of-medicinal-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[The Eurasian Economic Union]]></health_authority>
		<date_2><![CDATA[20240412]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://eec.eaeunion.org/en/news/izmeneny-pravila-provedeniya-issledovaniy-bioekvivalentnosti-lekarstvennykh-preparatov-/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[updates-in-uniform-rules-for-conducting-bioequivalence-studies-of-medicinal-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3080]]></id>
		<title><![CDATA[Updates in the unified Rules for conducting pharmaceutical inspections of pharmacovigilance systems of drug manufacturers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/updates-in-the-unified-rules-for-conducting-pharmaceutical-inspections-of-pharmacovigilance-systems-of-drug-manufacturers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[The Eurasian Economic Union]]></health_authority>
		<date_2><![CDATA[20240412]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://eec.eaeunion.org/en/news/v-eaes-prinyaty-edinye-pravila-provedeniya-farmatsevticheskikh-inspektsiy-sistem-farmakonadzora-proi/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[updates-in-the-unified-rules-for-conducting-pharmaceutical-inspections-of-pharmacovigilance-systems-of-drug-manufacturers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3081]]></id>
		<title><![CDATA[Outcome of the consultation on standards for contraceptive devices in New Zealand]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/outcome-of-the-consultation-on-standards-for-contraceptive-devices-in-new-zealand/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[New Zealand]]></country_region>
		<health_authority><![CDATA[New Zealand Medicines and Medical Devices Safety]]></health_authority>
		<date_2><![CDATA[20240411]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://medsafe.govt.nz/consultations/ContraceptiveDevicesOUTCOME.asp]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[outcome-of-the-consultation-on-standards-for-contraceptive-devices-in-new-zealand]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3082]]></id>
		<title><![CDATA[JP and Ph. Eur. launch a bilateral prospective harmonisation project for active substance and medicinal product monographs]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/jp-and-ph-eur-launch-a-bilateral-prospective-harmonisation-project-for-active-substance-and-medicinal-product-monographs/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Directorate for the Quality of Medicines and Healthcare]]></health_authority>
		<date_2><![CDATA[20240409]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/jp-and-ph.-eur.-launch-a-bilateral-prospective-harmonisation-project-for-active-substance-and-medicinal-product-monographs]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[jp-and-ph-eur-launch-a-bilateral-prospective-harmonisation-project-for-active-substance-and-medicinal-product-monographs]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3083]]></id>
		<title><![CDATA[New drug review with electronic data]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-drug-review-with-electronic-data-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Japan]]></country_region>
		<health_authority><![CDATA[Pharmaceuticals and Medical Devices Agency]]></health_authority>
		<date_2><![CDATA[20240408]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.pmda.go.jp/english/review-services/reviews/0002.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-drug-review-with-electronic-data-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3084]]></id>
		<title><![CDATA[Malaysian guideline for Bioequivalence inspection 2nd edition (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/malaysian-guideline-for-bioequivalence-inspection-2nd-edition-draft-for-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[National Pharmaceutical Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240408]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://npra.gov.my/index.php/en/component/content/article/453-english/announcement-main/announcement-2024/1527594-jemputan.html?Itemid=1391]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[malaysian-guideline-for-bioequivalence-inspection-2nd-edition-draft-for-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3085]]></id>
		<title><![CDATA[ANVSIA will use assessment from foreign authorities to register medical devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/anvsia-will-use-assessment-from-foreign-authorities-to-register-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Brazil]]></country_region>
		<health_authority><![CDATA[Brazilian Health Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240408]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-ira-utilizar-analises-de-autoridades-estrangeiras-para-registro-de-dispositivos-medicos]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[anvsia-will-use-assessment-from-foreign-authorities-to-register-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3086]]></id>
		<title><![CDATA[Disapplication of Falsified Medicines Directive Safety Features: Requirements for Parallel Imports]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/disapplication-of-falsified-medicines-directive-safety-features-requirements-for-parallel-imports/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240405]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/disapplication-of-falsified-medicines-directive-safety-features-requirements-for-parallel-imports/disapplication-of-falsified-medicines-directive-safety-features-requirements-for-parallel-imports]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[disapplication-of-falsified-medicines-directive-safety-features-requirements-for-parallel-imports]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3087]]></id>
		<title><![CDATA[UK Parallel Import Licences Following Agreement of the Windsor Framework]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:54]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/uk-parallel-import-licences-following-agreement-of-the-windsor-framework/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240405]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/uk-parallel-import-licences-following-agreement-of-the-windsor-framework/uk-parallel-import-licences-following-agreement-of-the-windsor-framework]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[uk-parallel-import-licences-following-agreement-of-the-windsor-framework]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:54]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3088]]></id>
		<title><![CDATA[As a CEP applicant, you want to improve the quality of your dossier? The revised EDQM guideline “content of the dossier” and other key documents will be useful tools]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/as-a-cep-applicant-you-want-to-improve-the-quality-of-your-dossier-the-revised-edqm-guideline-content-of-the-dossier-and-other-key-documents-will-be-useful-tools/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Directorate for the Quality of Medicines and Healthcare]]></health_authority>
		<date_2><![CDATA[20240404]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/as-a-cep-applicant-you-want-to-improve-the-quality-of-your-dossier-the-revised-edqm-guideline-content-of-the-dossier-and-other-key-documents-will-be-useful-tools]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[as-a-cep-applicant-you-want-to-improve-the-quality-of-your-dossier-the-revised-edqm-guideline-content-of-the-dossier-and-other-key-documents-will-be-useful-tools]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3089]]></id>
		<title><![CDATA[Strengthening of private medical devices testing laboratory in India]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/strengthening-of-private-medical-devices-testing-laboratory-in-india/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20240403]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTEwNzI=]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[strengthening-of-private-medical-devices-testing-laboratory-in-india]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3090]]></id>
		<title><![CDATA[Submitting a Request for a New National Application Procedure for a Human Medicinal Product]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/submitting-a-request-for-a-new-national-application-procedure-for-a-human-medicinal-product/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Ireland]]></country_region>
		<health_authority><![CDATA[Health Products Regulatory Authority]]></health_authority>
		<date_2><![CDATA[20240403]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.hpra.ie/docs/default-source/publications-forms/guidance-documents/aut-g0183-guide-to-submitting-a-request-for-a-new-national-application-(h)-v1.pdf?sfvrsn=7]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[submitting-a-request-for-a-new-national-application-procedure-for-a-human-medicinal-product]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3091]]></id>
		<title><![CDATA[Updated guidelines for Assessed listed medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/updated-guidelines-for-assessed-listed-medicines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20240402]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/news/updated-guidelines-assessed-listed-medicines]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[updated-guidelines-for-assessed-listed-medicines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3092]]></id>
		<title><![CDATA[WHO Good Manufacturing Practices considerations for the prevention and control of nitrosamine contamination in pharmaceutical products (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/who-good-manufacturing-practices-considerations-for-the-prevention-and-control-of-nitrosamine-contamination-in-pharmaceutical-products-draft-for-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[International]]></country_region>
		<health_authority><![CDATA[World Health Organization]]></health_authority>
		<date_2><![CDATA[20240401]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/current-projects/qas24_943_gmp_nitrosamines_forpublic52f95166-1c71-4cc2-a499-05bc4967bf14.pdf?sfvrsn=2140e3f4_2]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[who-good-manufacturing-practices-considerations-for-the-prevention-and-control-of-nitrosamine-contamination-in-pharmaceutical-products-draft-for-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3093]]></id>
		<title><![CDATA[Guidelines on the Classification of Deficiencies Observed During Inspection of Drug Distributors, Drugstores, Hospital Pharmacies and Retail Outlet for Non-Prescription Drugs (RONPD) (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidelines-on-the-classification-of-deficiencies-observed-during-inspection-of-drug-distributors-drugstores-hospital-pharmacies-and-retail-outlet-for-non-prescription-drugs-ronpd-draft-for-commen/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20240401]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/draft-for-comments-guidelines-on-the-classification-of-deficiencies-observed-during-inspection-of-drug-distributors-drugstores-hospital-pharmacies-and-retail-outlet-for-non-prescription-drugs-ro/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidelines-on-the-classification-of-deficiencies-observed-during-inspection-of-drug-distributors-drugstores-hospital-pharmacies-and-retail-outlet-for-non-prescription-drugs-ronpd-draft-for-commen]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3094]]></id>
		<title><![CDATA[Safety reporting in performance studies of in vitro diagnostic medical devices under Regulation (EU) 2017/746]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/safety-reporting-in-performance-studies-of-in-vitro-diagnostic-medical-devices-under-regulation-eu-2017-746/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20240401]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/document/download/5cc894e0-331d-4fa2-8ab3-cdd4437c48fc_en?filename=mdcg_2024-4_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[safety-reporting-in-performance-studies-of-in-vitro-diagnostic-medical-devices-under-regulation-eu-2017-746]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3095]]></id>
		<title><![CDATA[Guidance on content of the Investigator’s Brochure for clinical investigations of medical devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-on-content-of-the-investigators-brochure-for-clinical-investigations-of-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20240401]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/document/download/ee7ee8eb-841a-4085-a8dc-af6d55ebf1bd_en?filename=mdcg_2024-5_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-on-content-of-the-investigators-brochure-for-clinical-investigations-of-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3096]]></id>
		<title><![CDATA[Consultation: Proposed changes to the regulation of exempt medical devices and exempt Other Therapeutic Goods (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/consultation-proposed-changes-to-the-regulation-of-exempt-medical-devices-and-exempt-other-therapeutic-goods-draft-for-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20240401]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://consultations.tga.gov.au/tga/proposed-changes-to-exempt-devices-and-otgs/supporting_documents/Exempt%20devices%20consultation.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[consultation-proposed-changes-to-the-regulation-of-exempt-medical-devices-and-exempt-other-therapeutic-goods-draft-for-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3097]]></id>
		<title><![CDATA[Instructions for Use for Medical Devices Consultation on availability of instructions for use in more flexible formats (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/instructions-for-use-for-medical-devices-consultation-on-availability-of-instructions-for-use-in-more-flexible-formats-draft-for-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20240401]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://consultations.tga.gov.au/medical-devices-and-product-quality-division/instructions-for-use-ifu-for-medical-devices/supporting_documents/Consultation%20paper%20%20Availability%20of%20Instructions%20For%20Use%20in%20more%20flexible%20formats.PDF]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[instructions-for-use-for-medical-devices-consultation-on-availability-of-instructions-for-use-in-more-flexible-formats-draft-for-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3098]]></id>
		<title><![CDATA[Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products Questions and Answers (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/promotional-labeling-and-advertising-considerations-for-prescription-biological-reference-products-biosimilar-products-and-interchangeable-biosimilar-products-questions-and-answers-draft-for-commen/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240401]]></date_2>
		<product_type><![CDATA[]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/media/134862/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[promotional-labeling-and-advertising-considerations-for-prescription-biological-reference-products-biosimilar-products-and-interchangeable-biosimilar-products-questions-and-answers-draft-for-commen]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3099]]></id>
		<title><![CDATA[Implementation of the Future Regulations]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/implementation-of-the-future-regulations-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240328]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/publications/implementation-of-the-future-regulation-of-medical-devices/implementation-of-the-future-regulations]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[implementation-of-the-future-regulations-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3100]]></id>
		<title><![CDATA[How CEP holders can avoid the rejection of notifications]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/how-cep-holders-can-avoid-the-rejection-of-notifications/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Directorate for the Quality of Medicines and Healthcare]]></health_authority>
		<date_2><![CDATA[20240328]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/how-cep-holders-can-avoid-the-rejection-of-notifications]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[how-cep-holders-can-avoid-the-rejection-of-notifications]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3101]]></id>
		<title><![CDATA[First OMCL analytical procedures for determination of nitrosamine drug substance-related impurities (NDSRIs) and intermediate-related contaminants published]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/first-omcl-analytical-procedures-for-determination-of-nitrosamine-drug-substance-related-impurities-ndsris-and-intermediate-related-contaminants-published/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20240328]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/first-omcl-analytical-procedures-for-determination-of-nitrosamine-drug-substance-related-impurities-ndsris-and-intermediate-related-contaminants-published]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[first-omcl-analytical-procedures-for-determination-of-nitrosamine-drug-substance-related-impurities-ndsris-and-intermediate-related-contaminants-published]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3102]]></id>
		<title><![CDATA[European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/european-medicines-agency-pre-authorisation-procedural-advice-for-users-of-the-centralised-procedure/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240327]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-pre-authorisation-procedural-advice-users-centralised-procedure-document-tracked-changes_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[european-medicines-agency-pre-authorisation-procedural-advice-for-users-of-the-centralised-procedure]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3103]]></id>
		<title><![CDATA[HMA/EMA guidance document on the identification of personal data and commercially confidential information within the structure of the marketing authorization application (MAA) dossier (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/hma-ema-guidance-document-on-the-identification-of-personal-data-and-commercially-confidential-information-within-the-structure-of-the-marketing-authorization-application-maa-dossier-draft-for-comm/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240325]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Quality]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/system/files/documents/other/draft-hma-ema-guidance-document-identification-personal-data-commercially-confiden_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[hma-ema-guidance-document-on-the-identification-of-personal-data-and-commercially-confidential-information-within-the-structure-of-the-marketing-authorization-application-maa-dossier-draft-for-comm]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3104]]></id>
		<title><![CDATA[Guideline on quality, non-clinical and clinical requirements for investigational advanced]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guideline-on-quality-non-clinical-and-clinical-requirements-for-investigational-advanced/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240325]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/guideline-quality-non-clinical-clinical-requirements-investigational-advanced-therapy-medicinal-products-clinical-trials-scientific-guideline]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guideline-on-quality-non-clinical-and-clinical-requirements-for-investigational-advanced]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3105]]></id>
		<title><![CDATA[Anvisa extends the validity period of the Good Manufacturing Practices Certificate to four years]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/anvisa-extends-the-validity-period-of-the-good-manufacturing-practices-certificate-to-four-years/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Brazil]]></country_region>
		<health_authority><![CDATA[Brazilian Health Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240322]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-amplia-para-quatro-anos-prazo-de-validade-do-certificado-de-boas-praticas-de-fabricacao]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[anvisa-extends-the-validity-period-of-the-good-manufacturing-practices-certificate-to-four-years]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3106]]></id>
		<title><![CDATA[Outcome of the consultation on the proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Pharmacovigilance]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/outcome-of-the-consultation-on-the-proposed-updates-to-the-guideline-on-the-regulation-of-therapeutic-products-in-new-zealand-pharmacovigilance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[New Zealand]]></country_region>
		<health_authority><![CDATA[New Zealand Medicines and Medical Devices Safety]]></health_authority>
		<date_2><![CDATA[20240320]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://medsafe.govt.nz/consultations/Outcome-GRTPNZ-Pharmacovigilance.asp]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[outcome-of-the-consultation-on-the-proposed-updates-to-the-guideline-on-the-regulation-of-therapeutic-products-in-new-zealand-pharmacovigilance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3107]]></id>
		<title><![CDATA[Commission takes action to boost biotechnology and biomanufacturing in the EU]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/commission-takes-action-to-boost-biotechnology-and-biomanufacturing-in-the-eu/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20240320]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://ec.europa.eu/commission/presscorner/detail/en/ip_24_1570]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[commission-takes-action-to-boost-biotechnology-and-biomanufacturing-in-the-eu]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3108]]></id>
		<title><![CDATA[IPC signs Memorandum of Understanding with USP]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/ipc-signs-memorandum-of-understanding-with-usp/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Indian Pharmacopoeia Commission]]></health_authority>
		<date_2><![CDATA[20240318]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ipc.gov.in/news-highlights/1273-pc-signs-memorandum-of-understanding-with-usp.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[ipc-signs-memorandum-of-understanding-with-usp]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3109]]></id>
		<title><![CDATA[Guideline on the requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guideline-on-the-requirements-for-demonstrating-therapeutic-equivalence-between-orally-inhaled-products-oip-for-asthma-and-chronic-obstructive-pulmonary-disease-copd/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240316]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-requirements-demonstrating-therapeutic-equivalence-between-orally-inhaled-products-oip-asthma-chronic-obstructive-pulmonary-disease-copd_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guideline-on-the-requirements-for-demonstrating-therapeutic-equivalence-between-orally-inhaled-products-oip-for-asthma-and-chronic-obstructive-pulmonary-disease-copd]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3110]]></id>
		<title><![CDATA[Draft guidance: Review of first-in-human high-risk implantable or cardiac invasive medical device clinical trials and Investigator’s brochures for medical device clinical trials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/draft-guidance-review-of-first-in-human-high-risk-implantable-or-cardiac-invasive-medical-device-clinical-trials-and-investigators-brochures-for-medical-device-clinical-trials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20240315]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://consultations.tga.gov.au/tga/draft-guidance-review-of-high-risk-device-trials/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[draft-guidance-review-of-first-in-human-high-risk-implantable-or-cardiac-invasive-medical-device-clinical-trials-and-investigators-brochures-for-medical-device-clinical-trials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3111]]></id>
		<title><![CDATA[Companion diagnostics guidance update- public consultation (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/companion-diagnostics-guidance-update-public-consultation-draft-for-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20240315]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://consultations.tga.gov.au/medical-devices-and-product-quality-division/companion-diagnostics-guidance-public-consultation/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[companion-diagnostics-guidance-update-public-consultation-draft-for-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3112]]></id>
		<title><![CDATA[MedTech Europe views on the ‘One Substance, One Assessment’ European Commission package of legislative proposals]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/medtech-europe-views-on-the-one-substance-one-assessment-european-commission-package-of-legislative-proposals/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20240314]]></date_2>
		<product_type><![CDATA[Cosmetic]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.medtecheurope.org/resource-library/medtech-europe-views-on-the-one-substance-one-assessment-european-commission-package-of-legislative-proposals/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[medtech-europe-views-on-the-one-substance-one-assessment-european-commission-package-of-legislative-proposals]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3113]]></id>
		<title><![CDATA[New Organization First User EU QPPV/RP or Change of EU QPPV/RP]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-organization-first-user-eu-qppv-rp-or-change-of-eu-qppv-rp/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240313]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Pharmacovigilance]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/system/files/documents/other/new-organization-first-user-qppvrp-change-eu-qppvrp_en_0.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-organization-first-user-eu-qppv-rp-or-change-of-eu-qppv-rp]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3114]]></id>
		<title><![CDATA[Commission proposes new measures for the better lifecycle management of medicine authorisations]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/commission-proposes-new-measures-for-the-better-lifecycle-management-of-medicine-authorisations/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20240311]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://ec.europa.eu/newsroom/sante/items/822032/en]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[commission-proposes-new-measures-for-the-better-lifecycle-management-of-medicine-authorisations]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3115]]></id>
		<title><![CDATA[MHRA response to Equity in Medical Devices: Independent Review]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mhra-response-to-equity-in-medical-devices-independent-review/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240311]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/mhra-response-to-equity-in-medical-devices-independent-review]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mhra-response-to-equity-in-medical-devices-independent-review]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3116]]></id>
		<title><![CDATA[Advertising health services]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/advertising-health-services/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20240307]]></date_2>
		<product_type><![CDATA[Cosmetic]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/resources/resource/guidance/advertising-health-services]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[advertising-health-services]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3117]]></id>
		<title><![CDATA[Update on In-Person Face-to-Face Formal Meetings with FDA]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/update-on-in-person-face-to-face-formal-meetings-with-fda/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240305]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/industry/prescription-drug-user-fee-amendments/update-person-face-face-formal-meetings-fda]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[update-on-in-person-face-to-face-formal-meetings-with-fda]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3118]]></id>
		<title><![CDATA[Public consultation on ICH Guideline E2D(R1) launched in Switzerland]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/public-consultation-on-ich-guideline-e2dr1-launched-in-switzerland/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20240304]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/news/mitteilungen/public-consulation-ici-guideline-e2d-r1-in-ch-eroeffnet.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[public-consultation-on-ich-guideline-e2dr1-launched-in-switzerland]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3119]]></id>
		<title><![CDATA[Clinical Pharmacology Considerations for Antibody-Drug Conjugates]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/clinical-pharmacology-considerations-for-antibody-drug-conjugates/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240301]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/155997/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[clinical-pharmacology-considerations-for-antibody-drug-conjugates]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3120]]></id>
		<title><![CDATA[Guidance on content of the Clinical Investigation Plan for clinical investigations of medical devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-on-content-of-the-clinical-investigation-plan-for-clinical-investigations-of-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20240301]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/document/download/690de85a-ac17-45ea-bb32-7839540c25c4_en?filename=mdcg_2024-3_en_0.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-on-content-of-the-clinical-investigation-plan-for-clinical-investigations-of-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3121]]></id>
		<title><![CDATA[Established medicines: marketing authorisation application changes]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/established-medicines-marketing-authorisation-application-changes/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240301]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/guidance/established-medicines-marketing-authorisation-application-process-changes]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[established-medicines-marketing-authorisation-application-changes]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3122]]></id>
		<title><![CDATA[Select Updates for the Medical Device User Fee Small Business Qualification and Certification Guidance (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/select-updates-for-the-medical-device-user-fee-small-business-qualification-and-certification-guidance-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240222]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/176439/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[select-updates-for-the-medical-device-user-fee-small-business-qualification-and-certification-guidance-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3123]]></id>
		<title><![CDATA[Fraudulent and Unreliable Laboratory Testing Data in Premarket Submissions: FDA Reminds Medical Device Manufacturers to Scrutinize Third-Party-Generated Data]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fraudulent-and-unreliable-laboratory-testing-data-in-premarket-submissions-fda-reminds-medical-device-manufacturers-to-scrutinize-third-party-generated-data/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240220]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/industry-medical-devices/fraudulent-and-unreliable-laboratory-testing-data-premarket-submissions-fda-reminds-medical-device]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fraudulent-and-unreliable-laboratory-testing-data-in-premarket-submissions-fda-reminds-medical-device-manufacturers-to-scrutinize-third-party-generated-data]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3124]]></id>
		<title><![CDATA[Pilot GMP Single Inspection Program]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/pilot-gmp-single-inspection-program/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[TGA]]></health_authority>
		<date_2><![CDATA[20240220]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.tga.gov.au/news/notices/pilot-gmp-single-inspection-program]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[pilot-gmp-single-inspection-program]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3125]]></id>
		<title><![CDATA[Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240216]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2024/02/16/2024-03300/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3126]]></id>
		<title><![CDATA[Launch of new HMA-EMA catalogues of real-world data sources and studies]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/launch-of-new-hma-ema-catalogues-of-real-world-data-sources-and-studies/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[EMA]]></health_authority>
		<date_2><![CDATA[20240215]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/launch-new-hma-ema-catalogues-real-world-data-sources-studies]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[launch-of-new-hma-ema-catalogues-of-real-world-data-sources-and-studies]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3127]]></id>
		<title><![CDATA[Guideline on the pharmaceutical quality of inhalation and nasal medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:55]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guideline-on-the-pharmaceutical-quality-of-inhalation-and-nasal-medicinal-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240212]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-pharmaceutical-quality-inhalation-nasal-medicinal-products_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guideline-on-the-pharmaceutical-quality-of-inhalation-and-nasal-medicinal-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:55]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3128]]></id>
		<title><![CDATA[Biologics License Applications and Master File]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/biologics-license-applications-and-master-file/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240212]]></date_2>
		<product_type><![CDATA[Biologics]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://public-inspection.federalregister.gov/2024-02741.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[biologics-license-applications-and-master-file]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3129]]></id>
		<title><![CDATA[Concept Paper for the Development of a Guideline on Non-Inferiority and Equivalence Comparisons in Clinical Trials]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/concept-paper-for-the-development-of-a-guideline-on-non-inferiority-and-equivalence-comparisons-in-clinical-trials/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[EMA]]></health_authority>
		<date_2><![CDATA[20240212]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-development-guideline-non-inferiority-equivalence-comparisons-clinical-trials_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[concept-paper-for-the-development-of-a-guideline-on-non-inferiority-and-equivalence-comparisons-in-clinical-trials]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3130]]></id>
		<title><![CDATA[Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request-for-comments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240209]]></date_2>
		<product_type><![CDATA[Biologics]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2024/02/09/2024-02709/vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishment-of-a]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request-for-comments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3131]]></id>
		<title><![CDATA[Steps taken to ensure quality of medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/steps-taken-to-ensure-quality-of-medicines/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[CDSCO]]></health_authority>
		<date_2><![CDATA[20240209]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://pib.gov.in/PressReleasePage.aspx?PRID=2004361]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[steps-taken-to-ensure-quality-of-medicines]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3132]]></id>
		<title><![CDATA[Bioequivalence & Ethics Committee Section Activities in 2023: At A Glance (And More)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/bioequivalence-ethics-committee-section-activities-in-2023-at-a-glance-and-more/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Malaysia]]></country_region>
		<health_authority><![CDATA[NPRA]]></health_authority>
		<date_2><![CDATA[20240208]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.npra.gov.my/index.php/en/component/content/article/453-english/announcement-main/announcement-2024/1527568-bioequivalence-ethics-committee-section-activities-in-2023-at-a-glance.html?Itemid=1391]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[bioequivalence-ethics-committee-section-activities-in-2023-at-a-glance-and-more]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3133]]></id>
		<title><![CDATA[Read the top 10 deficiencies observed in new CEP applications for chemical purity assessed in 2023 to improve the quality of your applications!]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/read-the-top-10-deficiencies-observed-in-new-cep-applications-for-chemical-purity-assessed-in-2023-to-improve-the-quality-of-your-applications/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[EC]]></health_authority>
		<date_2><![CDATA[20240208]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/read-the-top-10-deficiencies-observed-in-new-cep-applications-for-chemical-purity-assessed-in-2023-to-improve-the-quality-of-your-applications-]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[read-the-top-10-deficiencies-observed-in-new-cep-applications-for-chemical-purity-assessed-in-2023-to-improve-the-quality-of-your-applications]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3134]]></id>
		<title><![CDATA[Post approval changes in biologics – Quality, safety and efficacy documents]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/post-approval-changes-in-biologics-quality-safety-and-efficacy-documents/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20240202]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTA5NTM=]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[post-approval-changes-in-biologics-quality-safety-and-efficacy-documents]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3135]]></id>
		<title><![CDATA[Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/reporting-amount-of-listed-drugs-and-biological-products-under-section-510j3-of-the-fdc-act/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240201]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/175933/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[reporting-amount-of-listed-drugs-and-biological-products-under-section-510j3-of-the-fdc-act]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3136]]></id>
		<title><![CDATA[Voluntary prior notification of new applications with new active substance for human medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/voluntary-prior-notification-of-new-applications-with-new-active-substance-for-human-medicinal-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[Swissmedic]]></health_authority>
		<date_2><![CDATA[20240201]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/authorisations/information/freiwillige-vorankuendigung-na-mit-neuem-ws.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[voluntary-prior-notification-of-new-applications-with-new-active-substance-for-human-medicinal-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3137]]></id>
		<title><![CDATA[Joint statement supporting the expansion of the use of Electronic Instructions For Use (eIFU) in the medical devices sector]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/joint-statement-supporting-the-expansion-of-the-use-of-electronic-instructions-for-use-eifu-in-the-medical-devices-sector/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[EC]]></health_authority>
		<date_2><![CDATA[20240201]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.medtecheurope.org/wp-content/uploads/2024/02/20240202-joint-statement-supporting-the-expansion-of-eifu-for-md.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[joint-statement-supporting-the-expansion-of-the-use-of-electronic-instructions-for-use-eifu-in-the-medical-devices-sector]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3138]]></id>
		<title><![CDATA[MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mdcg-2024-2-procedures-for-the-updates-of-the-european-medical-device-nomenclature/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[EC]]></health_authority>
		<date_2><![CDATA[20240201]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/document/download/de470384-e8be-45e7-a334-226757f8816d_en?filename=mdcg_2024-2_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mdcg-2024-2-procedures-for-the-updates-of-the-european-medical-device-nomenclature]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3139]]></id>
		<title><![CDATA[Use of Data Monitoring Committees in Clinical Trials Guidance for Industry (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/use-of-data-monitoring-committees-in-clinical-trials-guidance-for-industry-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240201]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/176107/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[use-of-data-monitoring-committees-in-clinical-trials-guidance-for-industry-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3140]]></id>
		<title><![CDATA[Charging for Investigational Drugs Under an IND Questions and Answers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/charging-for-investigational-drugs-under-an-ind-questions-and-answers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240201]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/176308/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[charging-for-investigational-drugs-under-an-ind-questions-and-answers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3141]]></id>
		<title><![CDATA[Delay in medical device database launch]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/delay-in-medical-device-database-launch/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[Swissmedic]]></health_authority>
		<date_2><![CDATA[20240201]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/medical-devices/medizinprodukte-datenbank/swissdamed-ueberblick.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[delay-in-medical-device-database-launch]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3142]]></id>
		<title><![CDATA[CDRH Announces Intent to Initiate the Reclassification Process for Most High Risk IVDs]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cdrh-announces-intent-to-initiate-the-reclassification-process-for-most-high-risk-ivds/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240131]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-announces-intent-initiate-reclassification-process-most-high-risk-ivds]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cdrh-announces-intent-to-initiate-the-reclassification-process-for-most-high-risk-ivds]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3143]]></id>
		<title><![CDATA[Safety Information: Topical Corticosteroids and increased risk of misuse and abuse]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/safety-information-topical-corticosteroids-and-increased-risk-of-misuse-and-abuse/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20240131]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/fda-advisory-no-2024-0197-safety-information-topical-corticosteroids-and-increased-risk-of-misuse-and-abuse/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[safety-information-topical-corticosteroids-and-increased-risk-of-misuse-and-abuse]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3144]]></id>
		<title><![CDATA[MHRA announces two new UK Approved Bodies to certify medical devices]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mhra-announces-two-new-uk-approved-bodies-to-certify-medical-devices/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[United Kingdom]]></country_region>
		<health_authority><![CDATA[UK MHRA]]></health_authority>
		<date_2><![CDATA[20240131]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/mhra-announces-two-new-uk-approved-bodies-to-certify-medical-devices]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mhra-announces-two-new-uk-approved-bodies-to-certify-medical-devices]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3145]]></id>
		<title><![CDATA[Updated requirements for dealing with potential nitrosamine impurities in medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/updated-requirements-for-dealing-with-potential-nitrosamine-impurities-in-medicinal-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[Swissmedic]]></health_authority>
		<date_2><![CDATA[20240130]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/news/mitteilungen/aktualisierte-anforderungen-umgang-nitrosamin-verunreinigungen.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[updated-requirements-for-dealing-with-potential-nitrosamine-impurities-in-medicinal-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3146]]></id>
		<title><![CDATA[Best Practices for Food and Drug Administration Staff in the Post marketing Safety Surveillance of Human Drug and Biological Products; Final Document; Availability]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/best-practices-for-food-and-drug-administration-staff-in-the-post-marketing-safety-surveillance-of-human-drug-and-biological-products-final-document-availability/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240126]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2024/01/26/2024-01584/best-practices-for-food-and-drug-administration-staff-in-the-postmarketing-safety-surveillance-of]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[best-practices-for-food-and-drug-administration-staff-in-the-post-marketing-safety-surveillance-of-human-drug-and-biological-products-final-document-availability]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3147]]></id>
		<title><![CDATA[IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS Q3C(R9)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/impurities-guideline-for-residual-solvents-q3cr9/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Global]]></country_region>
		<health_authority><![CDATA[ICH]]></health_authority>
		<date_2><![CDATA[20240124]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://database.ich.org/sites/default/files/ICH_Q3C%28R9%29_Guideline_MinorRevision_2024_2024_Approved.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[impurities-guideline-for-residual-solvents-q3cr9]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3148]]></id>
		<title><![CDATA[RPM for PLM (Regulatory Procedure Management for the Product Lifecycle Management) – Frequently Asked Questions and Answers]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/rpm-for-plm-regulatory-procedure-management-for-the-product-lifecycle-management-frequently-asked-questions-and-answers/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240123]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/other/regulatory-procedure-management-rpm-product-lifecycle-management-plm-frequently-asked-questions_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[rpm-for-plm-regulatory-procedure-management-for-the-product-lifecycle-management-frequently-asked-questions-and-answers]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3149]]></id>
		<title><![CDATA[Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, information obligation in case of interruption of supply and the transitional]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/amending-regulations-eu-2017-745-and-eu-2017-746-as-regards-a-gradual-roll-out-of-eudamed-information-obligation-in-case-of-interruption-of-supply-and-the-transitional/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Commission]]></health_authority>
		<date_2><![CDATA[20240123]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=COM:2024:43:FIN]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[amending-regulations-eu-2017-745-and-eu-2017-746-as-regards-a-gradual-roll-out-of-eudamed-information-obligation-in-case-of-interruption-of-supply-and-the-transitional]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3150]]></id>
		<title><![CDATA[Innovation in medicines]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/innovation-in-medicines-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240123]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/human-regulatory-overview/research-and-development/innovation-medicines#:https://www.raps.org:text=and%20with%20academia.-,Portfolio%20and%20technology%20meetings%20(new),-New%3A%20Pharmaceutical]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[innovation-in-medicines-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3151]]></id>
		<title><![CDATA[Adoption of International Scientific Guidelines in Australia R01-2023]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/adoption-of-international-scientific-guidelines-in-australia-r01-2023/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Australia]]></country_region>
		<health_authority><![CDATA[Therapeutic Goods Administration]]></health_authority>
		<date_2><![CDATA[20240122]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://consultations.tga.gov.au/tga/international-scientific-guidelines-r01-2023/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[adoption-of-international-scientific-guidelines-in-australia-r01-2023]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3152]]></id>
		<title><![CDATA[EDQM clarifies its policy for confidentiality and declassification of CEP documents]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/edqm-clarifies-its-policy-for-confidentiality-and-declassification-of-cep-documents/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Directorate for the Quality of Medicines and Healthcare]]></health_authority>
		<date_2><![CDATA[20240119]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.edqm.eu/en/-/edqm-clarifies-its-policy-for-confidentiality-and-declassification-of-cep-documents]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[edqm-clarifies-its-policy-for-confidentiality-and-declassification-of-cep-documents]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3153]]></id>
		<title><![CDATA[Cabinet approves Memorandum of Intent (MoI) between India and Netherlands on cooperation in the field of medical products Regulation]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/cabinet-approves-memorandum-of-intent-moi-between-india-and-netherlands-on-cooperation-in-the-field-of-medical-products-regulation/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20240118]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://pib.gov.in/PressReleasePage.aspx?PRID=1997212]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[cabinet-approves-memorandum-of-intent-moi-between-india-and-netherlands-on-cooperation-in-the-field-of-medical-products-regulation]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3154]]></id>
		<title><![CDATA[Launching of additional forms on national single window system]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/launching-of-additional-forms-on-national-single-window-system/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20240116]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTA4NDk=]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[launching-of-additional-forms-on-national-single-window-system]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3155]]></id>
		<title><![CDATA[Concept paper on the revision of the guideline on the clinical evaluation of medicinal products intended for the treatment of Hepatitis B]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/concept-paper-on-the-revision-of-the-guideline-on-the-clinical-evaluation-of-medicinal-products-intended-for-the-treatment-of-hepatitis-b/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[EMA]]></health_authority>
		<date_2><![CDATA[20240115]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-revision-guideline-clinical-evaluation-medicinal-products-intended-treatment-hepatitis-b-revision-1_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[concept-paper-on-the-revision-of-the-guideline-on-the-clinical-evaluation-of-medicinal-products-intended-for-the-treatment-of-hepatitis-b]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3156]]></id>
		<title><![CDATA[Questions and answers for marketing authorization holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/questions-and-answers-for-marketing-authorization-holders-applicants-on-the-chmp-opinion-for-the-article-53-of-regulation-ec-no-726-2004-referral-on-nitrosamine-impurities-in-human-medicinal-produ-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240115]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/documents/referral/nitrosamines-emea-h-a53-1490-questions-answers-marketing-authorisation-holders-applicants-chmp-opinion-article-53-regulation-ec-no-726-2004-referral-nitrosamine-impurities-human-medicinal-products_en.pdf]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[questions-and-answers-for-marketing-authorization-holders-applicants-on-the-chmp-opinion-for-the-article-53-of-regulation-ec-no-726-2004-referral-on-nitrosamine-impurities-in-human-medicinal-produ-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3157]]></id>
		<title><![CDATA[Potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines: PRAC recommends precautionary measures]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/potential-risk-of-neurodevelopmental-disorders-in-children-born-to-men-treated-with-valproate-medicines-prac-recommends-precautionary-measures/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240112]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Safety]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/news/potential-risk-neurodevelopmental-disorders-children-born-men-treated-valproate-medicines-prac-recommends-precautionary-measures]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[potential-risk-of-neurodevelopmental-disorders-in-children-born-to-men-treated-with-valproate-medicines-prac-recommends-precautionary-measures]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3158]]></id>
		<title><![CDATA[Evaluation of fixed dose combination]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/evaluation-of-fixed-dose-combination/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20240111]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTA4NDc=]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[evaluation-of-fixed-dose-combination]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3159]]></id>
		<title><![CDATA[Focus campaigns]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/focus-campaigns/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20240109]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/medical-devices/market-surveillance-of-medical-devices/announcements-on-market-control-issues.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[focus-campaigns]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3160]]></id>
		<title><![CDATA[Administrative Processing of Original Biologics License Applications (BLA) and New Drug Applications (NDA)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/administrative-processing-of-original-biologics-license-applications-bla-and-new-drug-applications-nda/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240108]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/85659/download?attachment]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[administrative-processing-of-original-biologics-license-applications-bla-and-new-drug-applications-nda]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3161]]></id>
		<title><![CDATA[Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/submission-and-review-of-sterility-information-in-premarket-notification-510k-submissions-for-devices-labeled-as-sterile/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240108]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/74445/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[submission-and-review-of-sterility-information-in-premarket-notification-510k-submissions-for-devices-labeled-as-sterile]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3162]]></id>
		<title><![CDATA[SOPP 8401: Administrative Processing of Original Biologics License Applications (BLA) and New Drug Applications (NDA)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/sopp-8401-administrative-processing-of-original-biologics-license-applications-bla-and-new-drug-applications-nda-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240108]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/85659/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[sopp-8401-administrative-processing-of-original-biologics-license-applications-bla-and-new-drug-applications-nda-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3163]]></id>
		<title><![CDATA[Amendment to FDA Circular No. 2022-004 entitled “Implementing Guidelines on the Abridged and Verification Review Pathways for New Drug Registration Applications in accordance with Administrative Order No. 2020-0045 Establishing Facilitated Registration Pathways for Drug Products including Vaccines and Biologicals” to include Generic Drug Registration Applications and update the list of Reference Drug Regulatory Agencies (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/amendment-to-fda-circular-no-2022-004-entitled-implementing-guidelines-on-the-abridged-and-verification-review-pathways-for-new-drug-registration-applications-in-accordance-with-administrati/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20240105]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[http://Regulatory]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[amendment-to-fda-circular-no-2022-004-entitled-implementing-guidelines-on-the-abridged-and-verification-review-pathways-for-new-drug-registration-applications-in-accordance-with-administrati]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3164]]></id>
		<title><![CDATA[FDA Authorizes Florida’s Drug Importation Program]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/fda-authorizes-floridas-drug-importation-program/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240105]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/news-events/press-announcements/fda-authorizes-floridas-drug-importation-program]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[fda-authorizes-floridas-drug-importation-program]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3165]]></id>
		<title><![CDATA[Guidance – MDCG endorsed documents and other guidance]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidance-mdcg-endorsed-documents-and-other-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[EC]]></health_authority>
		<date_2><![CDATA[20240104]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[PV]]></domain>
		<url><![CDATA[https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en#:https://www.raps.org:text=December%202023-,Post%2DMarket%20Surveillance%20and%20Vigilance%20(PMSV),-Reference]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidance-mdcg-endorsed-documents-and-other-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3166]]></id>
		<title><![CDATA[Food and Drug Administration’s Draft Report and Plan on Best Practices for Guidance; Availability]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/food-and-drug-administrations-draft-report-and-plan-on-best-practices-for-guidance-availability/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240103]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2024/01/03/2023-28872/food-and-drug-administrations-draft-report-and-plan-on-best-practices-for-guidance-availability]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[food-and-drug-administrations-draft-report-and-plan-on-best-practices-for-guidance-availability]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3167]]></id>
		<title><![CDATA[MHRA’s new International Recognition Procedure (IRP) goes live from 1 January 2024]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:56]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/mhras-new-international-recognition-procedure-irp-goes-live-from-1-january-2024/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[UK]]></country_region>
		<health_authority><![CDATA[Medicines and Healthcare products Regulatory Agency]]></health_authority>
		<date_2><![CDATA[20240102]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.gov.uk/government/news/mhras-new-international-recognition-procedure-irp-goes-live-from-1-january-2024]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[mhras-new-international-recognition-procedure-irp-goes-live-from-1-january-2024]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:56]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3168]]></id>
		<title><![CDATA[Medical Devices; Quality System Regulation Amendments]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/medical-devices-quality-system-regulation-amendments/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240102]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Quality]]></domain>
		<url><![CDATA[https://www.federalregister.gov/documents/2024/02/02/2024-01709/medical-devices-quality-system-regulation-amendments]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[medical-devices-quality-system-regulation-amendments]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3169]]></id>
		<title><![CDATA[Transition to Electronic Export Documents – Letter to Industry]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/transition-to-electronic-export-documents-letter-to-industry/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240102]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/medical-devices/industry-medical-devices/transition-electronic-export-documents-letter-industry]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[transition-to-electronic-export-documents-letter-to-industry]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3170]]></id>
		<title><![CDATA[Best Practices for Food and Drug Administration Staff in the Post marketing Safety Surveillance of Human Drug and Biological Products]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/best-practices-for-food-and-drug-administration-staff-in-the-post-marketing-safety-surveillance-of-human-drug-and-biological-products/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[US]]></country_region>
		<health_authority><![CDATA[US FDA]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Drug Product]]></product_type>
		<domain><![CDATA[PV]]></domain>
		<url><![CDATA[https://www.fda.gov/media/130216/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[best-practices-for-food-and-drug-administration-staff-in-the-post-marketing-safety-surveillance-of-human-drug-and-biological-products]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3171]]></id>
		<title><![CDATA[Guidelines for the Classification of Vitamins and Minerals for Food/Dietary Supplements under Processed Food Product Repealing the Provisions for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food” (draft for comments)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/guidelines-for-the-classification-of-vitamins-and-minerals-for-food-dietary-supplements-under-processed-food-product-repealing-the-provisions-for-food-in-the-office-order-no-22-s-1991-entitled/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Food & Food Supplement]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/draft-for-comments-guidelines-for-the-classification-of-vitamins-and-minerals-for-food-dietary-supplements-under-processed-food-product-repealing-the-provisions-for-food-in-the-office-order-no-22/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[guidelines-for-the-classification-of-vitamins-and-minerals-for-food-dietary-supplements-under-processed-food-product-repealing-the-provisions-for-food-in-the-office-order-no-22-s-1991-entitled]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3172]]></id>
		<title><![CDATA[Revision in the Process of Application for Certificate of Medical Device Registration (CMDR)/Certificate of Medical Device Notification (CMDN), Initial and Renewal]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/revision-in-the-process-of-application-for-certificate-of-medical-device-registration-cmdr-certificate-of-medical-device-notification-cmdn-initial-and-renewal/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[The Philippines]]></country_region>
		<health_authority><![CDATA[Philippines FDA]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov.ph/fda-advisory-no-2024-0009-revision-in-the-process-of-application-for-certificate-of-medical-device-registration-cmdr-certificate-of-medical-device-notification-cmdn-initial-and-renewal/]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[revision-in-the-process-of-application-for-certificate-of-medical-device-registration-cmdr-certificate-of-medical-device-notification-cmdn-initial-and-renewal]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3173]]></id>
		<title><![CDATA[New guidance document Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-guidance-document-import-of-a-human-medicinal-product-according-to-art-14-para-2-and-3-tpa-parallel-import/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/authorisations/information/neue-wl-parallelimport-ham.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-guidance-document-import-of-a-human-medicinal-product-according-to-art-14-para-2-and-3-tpa-parallel-import]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3174]]></id>
		<title><![CDATA[New organisational structure with separate Medical Devices Surveillance Sector – Eveline Trachsel heads up the Medicinal Product Authorisation and Vigilance Sector]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/new-organisational-structure-with-separate-medical-devices-surveillance-sector-eveline-trachsel-heads-up-the-medicinal-product-authorisation-and-vigilance-sector/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Switzerland]]></country_region>
		<health_authority><![CDATA[The Swiss Agency for Therapeutic Products]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.swissmedic.ch/swissmedic/en/home/news/mitteilungen/neue-organisationsstruktur-mit-bereich-ueberwachung-mep.html]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[new-organisational-structure-with-separate-medical-devices-surveillance-sector-eveline-trachsel-heads-up-the-medicinal-product-authorisation-and-vigilance-sector]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3175]]></id>
		<title><![CDATA[Launching of national new single window system]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/launching-of-national-new-single-window-system/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[India]]></country_region>
		<health_authority><![CDATA[Central Drugs Standard Control Organisation]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Medical Device]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MTA4MTE=]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[launching-of-national-new-single-window-system]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3176]]></id>
		<title><![CDATA[Quality of medicines questions and answers: Part 2]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/quality-of-medicines-questions-and-answers-part-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[Europe]]></country_region>
		<health_authority><![CDATA[European Medicines Agency]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.ema.europa.eu/en/human-regulatory-overview/research-and-development/scientific-guidelines/quality-medicines-qa-introduction/quality-medicines-questions-answers-part-2]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[quality-of-medicines-questions-and-answers-part-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3177]]></id>
		<title><![CDATA[Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/collection-of-race-and-ethnicity-data-in-clinical-trials-and-clinical-studies-for-fda-regulated-medical-products-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Clinical]]></domain>
		<url><![CDATA[https://www.fda.gov/media/175746/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[collection-of-race-and-ethnicity-data-in-clinical-trials-and-clinical-studies-for-fda-regulated-medical-products-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3178]]></id>
		<title><![CDATA[Revising ANDA Labeling Following Revision of the RLD Labeling]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/revising-anda-labeling-following-revision-of-the-rld-labeling/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Labeling]]></domain>
		<url><![CDATA[https://www.fda.gov/media/175654/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[revising-anda-labeling-following-revision-of-the-rld-labeling]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3179]]></id>
		<title><![CDATA[Conducting Remote Regulatory Assessments Questions and Answers (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/conducting-remote-regulatory-assessments-questions-and-answers-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/160173/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[conducting-remote-regulatory-assessments-questions-and-answers-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3180]]></id>
		<title><![CDATA[ANDA Submissions— Amendments and Requests for Final Approval to Tentatively Approved ANDAs]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/anda-submissions-amendments-and-requests-for-final-approval-to-tentatively-approved-andas/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/119718/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[anda-submissions-amendments-and-requests-for-final-approval-to-tentatively-approved-andas]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
	<node>
		<id><![CDATA[3181]]></id>
		<title><![CDATA[Requests for Reconsideration at the Division Level Under GDUFA (draft guidance)]]></title>
		<content><![CDATA[]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[2024-06-27 16:46:57]]></date>
		<posttype><![CDATA[regulatory]]></posttype>
		<permalink><![CDATA[https://clinch.loc/regulatory/requests-for-reconsideration-at-the-division-level-under-gdufa-draft-guidance/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<_wp_page_template><![CDATA[default]]></_wp_page_template>
		<country_region><![CDATA[USA]]></country_region>
		<health_authority><![CDATA[Food and Drug Administration]]></health_authority>
		<date_2><![CDATA[20240101]]></date_2>
		<product_type><![CDATA[Drug]]></product_type>
		<domain><![CDATA[Regulatory]]></domain>
		<url><![CDATA[https://www.fda.gov/media/108398/download]]></url>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[sagefrog]]></authorusername>
		<authoremail><![CDATA[jillf@sagefrog.com]]></authoremail>
		<authorfirstname><![CDATA[]]></authorfirstname>
		<authorlastname><![CDATA[]]></authorlastname>
		<slug><![CDATA[requests-for-reconsideration-at-the-division-level-under-gdufa-draft-guidance]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[0]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[2024-06-27 16:46:57]]></postmodifieddate>
	</node>
</data>
